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ABSTRACT 
Fetal Alcohol Syndrome (F AS), the most severe form of Fetal Alcohol Spectrum 
Disorder (F ASD), has traditionally been associated with maternal alcohol 
consumption during pregnancy. However, a number of animal studies have shown an 
association between paternal preconception alcohol consumption and developmental 
abnormalities in the offspring that resemble the features of F AS. Dysregulation of 
epigenetic factors (such as DNA methylation) in the presence of alcohol may provide 
a plausible mechanism by which paternal alcohol consumption could result in 
offspring affected with features of F AS. Imprinted genes are expressed in a parent-
of-origin manner due to DNA methylation at distinct differentially methylated regions 
(DMRs) and are essential for normal embryonic development. 
There are only two known paternally methylated DMRs in humans, with an additional 
one described in mice - associated with Rasgrfl. The first aim of this study was to 
determine whether the human RASGRFl gene contains a DMR and whether this 
DMR is paternally methylated. In order to assess the imprint status of RASGRF 1, a 
number of computational assessments were done to identify key features of imprinted 
loci. Pyrosequencing analysis was used to assess the methylation status of various 
CpO islands surrounding RASGRFi in peripheral blood and sperm DNA samples. 
The RASGRF i-associated CpO regions were not found to exhibit differential 
methylation in a parent-of-origin manner. 
VI 
The second aIm of the study was to examine the effect of paternal alcohol 
consumption on the methylation status of the IG-DMR locus in male gametes and to 
detennine whether alcohol is correlated with methylation in a dose-dependant 
manner. Methylation assessment was done using the quantitative pyrosequencing 
technology. While an overall reduction in methylation was noted in males who 
consumed alcohol after adjusting for confounding variables, the amount of alcohol 
consumed did not correlate with overall methylation. When analyzed by individual 
CpG sites, alcohol consumption was found to correlate preferentially with 
demethylation at CpG 3 while alcohol-dosage preferentially correlated with 
demethylation at CpG 7. Age was significantly correlated with an increase in the 
overall methylation at JG-DMR and at individual sites within JG-DMR. 
In conclusion, these findings support the hypothesis that paternal preconception 
alcohol consumption can lead to hypomethylation of nonnally hypennethylated 
DMRs of specific imprinted genes in human spenn. This in tum could have 
significant implications with regard to the regulation of developmentally significant 
genes in the zygote and fetus, resulting in developmental, behavioral and neuro-
cognitive disorders. 
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CHAPTER! 
INTRODUCTION 
"It would seem that if alcohol is a vice, then virtue is unattractive, and if drinking is a 
malady, then good health alone is not enough to satisfy man. " 
Jean-Charles Sournia (1917-2000) 
With the many negative consequences associated with alcohol consumption, which 
include harm to the unborn fetus through preconception and prenatal alcohol 
exposure, it is hard to fathom why many people are so easily influenced by the brief 
satisfaction achieved by consuming alcohol. 
CHAPTER 1 - INTRODUCTION 
1.1 ALCOHOL AND THE ASSOCIATED BURDEN IN SOUTH AFRICA 
For many, alcoholism is a disease of the alcoholic and the alcoholic alone. This is 
untrue. Alcoholism is also a disease of the relative, friend and co-worker and affects 
society as a whole. This is because the consequences of drinking go far beyond the 
individual drinker's health and well-being. They include harm to the unborn fetus, 
domestic violence, sexual assault and child abuse, violent crime, vandalism and 
reduced productivity at work. 
At the Sixtieth World Health Assembly in 2007, the World Health Organization 
(WHO) ranked alcohol abuse as the fifth leading risk factor for premature death and 
disability in the world (WHO 2007). In 2002, it was estimated that global alcohol-
related disease accounted for 3.7% of total deaths and 4.4% of all Disability-Adjusted 
Life Years (DALY) (WHO 2007). In 2007, a study was carried out by Schneider et al. 
to estimate the burden of disease attributable to alcohol use in South Africa in the year 
2000. It was discovered that alcohol accounted for 7.1 % of total deaths and 7% of all 
DAL Y s (Schneider et al. 2007). 
1.1.1 THE INFAMOUS "Dop" SYSTEM 
The ramifications of immense alcohol consumption, sculpted by the political history 
of South Africa, are widespread. During the early years of colonial settlement in the 
Cape Colony, indigenous pastoralists and coastal people were enticed into service on 
settler farms with payment taking the form of tobacco, bread and wine (Scully 1992 
as cited in London 1999). This led to the birth of the infamous "dop" system, which 
2 
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would over the next 300 years allow farmers to exert social control over their farm 
workers (Scully 1992 as cited in London 1999). 
Fruit, grape and wine production dominate the Western Cape Province of South 
Africa. For this reason, the farmers in this region distributed alcohol daily to their 
workers as partial payment for labor (May et al. 2005). Although the "dop" system 
has been outlawed for over 40 years now, heavy, episodic alcohol consumption 
remains a major form of recreation in this region. Furthermore, increased availability 
of commercial alcoholic beverages such as beer, distilled spirits and wine has 
exacerbated severe drinking (London et al. 1995 and Parry, Bennets 1998 as cited in 
May et al. 2000). 
1.1.2 FETAL ALCOHOL SYNDROME: A MAJOR HEALTH CHALLENGE IN SOUTH 
AFRICA 
A sustained culture of alcohol intake has led to severe consequences for the 
population residing in the Western Cape Province and nowhere is the effect of 
excessive alcohol consumption more evident than on the children of this region. This 
agricultural and wine-producing region has the highest prevalence of Fetal Alcohol 
Syndrome (FAS) in the world with 68.0 - 89.2 per 1000 children of school-going age 
being affected (May et al. 2007). This figure has drastically increased from the two 
previous studies carried out by May et al. (2000) and Viljoen et al. (2005) in the 
Western Cape Province where the prevalence was found to be 40.5 - 46.4 per 1000 
and 65.3 - 74.2 per 1000 children of school-going age, respectively (May et al. 2000, 
Viljoen et al. 2005). In comparison it is estimated that the rate of F AS in the United 
States of America ranges between 0.5 - 2.0 per 1000 births (May, Gossage 2001). 
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The reason for this high F AS burden is not fully understood. It is however known that 
a large amount of alcohol consumption during pregnancy is a primary risk factor for 
FAS (May et al. 2008). It has been reported that in the Western Cape, almost 34% of 
urban women and 46% - 51 % of rural women consume alcohol during pregnancy in a 
binge pattern (Croxford, Viljoen 1999). 
1.2 FETAL ALCOHOL SPECTRUM DISORDER 
Fetal alcohol spectrum disorders (FASD) is an umbrella term used to encompass a 
spectrum of structural anomalies and behavioral and neuro-cognitive disabilities 
caused by prenatal alcohol exposure (Barr, Streissguth 2001). According to the 
Institute of Medicine's revised classification system, there are currently six 
recognized diagnoses that form part of the F ASD continuum: partial F AS (PF AS) 
with confirmed maternal alcohol exposure; partial F AS (PF AS) without confirmed 
maternal alcohol exposure; alcohol-related birth defects (ARBD); alcohol-related 
neuro-developmental disorder (ARND); F AS without confirmed maternal alcohol 
exposure; and F AS with confirmed maternal alcohol exposure (Hoyme et aL 2005). 
The latter of these diagnoses is the most severe form of F ASD. 
Children born with F AS usually have distinct anomalous features. These include 
distinct facial dysmorphology (shortened palpebral fissures, smooth philtrum and thin 
vermilion border of the upper lip), pre- and post-natal growth retardation and mental, 
behavioral and social deficits (Jones, Smith 1973). 
4 
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1.2.1 FETAL ALCOHOL SYNDROME: AN HISTORICAL OVERVIEW 
An understanding of the teratogenic potential of alcohol dates back many centuries to 
ancient Roman and Greek mythology, where it was believed that intoxication at the 
moment of conception could lead to the birth of a defective child (Haggard, Jellinek 
1942 as cited in Jones, Smith 1973). However, it was only during England's 'Gin 
Epidemic' (1720 - 1751) that the ill effects of alcohol consumption on reproduction 
were first observed. A group of physicians called gin "a cause of weak, feeble, and 
distempered children" (Warner, Rosett 1975 as cited in Sanders 2009). In a report to 
the House of Commons it was noted, "Unhappy mothers habituate themselves to these 
distilled liquors, whose children are born weak and sickly, and often look shrivel'd 
and old as though they had numbered many years" (George 1966 as cited in Abel 
2001). A decrease in fertility and fecundity was also observed during this time (Abel 
1998 as cited in Abel 2001). In spite of this, it is only in the last hundred years that 
concrete evidence has been found linking prenatal alcohol exposure to deleterious 
effects in offspring (Jones, Smith 1973, Lemoine et al. 1968 as cited in Hoyme et al. 
2005, Sullivan 1899 as reviewed in Calhoun, Warren 2007). 
In 1899, Dr. W.C. Sullivan undertook the first empirical study linking maternal 
alcohol consumption to fetal damage. He described offspring born to imprisoned 
alcoholic women as having a characteristic pattern of birth defects (Sullivan 1899 as 
cited in Hoyme et al. 2005). He also noticed an increase in the rate of infant mortality 
and stillbirths when he compared children of alcoholic women to those of controls 
(Sullivan 1899 as reviewed in Calhoun, Warren 2007). No correlation was observed 
between these effects and alcohol consumption of the fathers (Sullivan 1899 as cited 
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in Hoyme et al. 2005). From this study it was deduced that maternal drinking was the 
primary cause of damage to the fetus (Golden 2005 as reviewed in Calhoun, Warren 
2007). 
Approximately 70 years later, Lemoine et al. (1968) documented common physical, 
behavioral and neuro-developmental patterns in children born to mothers who drank 
heavily during pregnancy. Despite this insight, this study did not present any 
definitive diagnostic criteria for diagnosing F AS or F ASD (Lemoine et al. 1968 as 
cited in Hoyme et al. 2005). 
It was only in 1973 that two dysmorphologists, Jones and Smith, described in detail 
the consistent pattern of malformations among children affected by in utero alcohol 
exposure (Jones, Smith 1973). These malformations included microcephaly, prenatal 
and postnatal growth deficiency, developmental delay, short palpebral fissures, 
epicanthal folds, flattened midface, and altered palmer crease patterns. They also 
provided diagnostic criteria for the condition which they coined Fetal Alcohol 
Syndrome (Jones, Smith 1973). 
1.2.2 RISK FACTORS FOR F AS 
The primary risk factor for F AS is alcohol consumption during pregnancy (Abel, 
Hannigan 1995). In addition, there must be certain permissive and provocative factors 
that serve to mediate the effects of alcohol in the fetus, since not all children exposed 
to alcohol prenatally are diagnosed with FAS (Abel 1984, Abel, Hannigan 1995). The 
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estimated incidence of F AS among women who drink heavily is 4.3% of all live 
births (Abel 1995). 
Abel and Hannigan (1995) put forth an hypothesis, integrating maternal SOCIO-
behavioral risk factors with biological conditions, to explain why only a small 
proportion of women who consume alcohol during pregnancy give birth to children 
with FAS (Figure 1.1). There are a number of permissive (socio-behavioral) factors 
such as excessive alcohol consumption, smoking, low socio-economic status (SES), 
fewer social resources such as education, income and spirituality and culture that 
increase fetal vulnerability to alcohol's teratogenic effects (May et al. 2005, Abel, 
Hannigan 1995, Warren et al. 2001). These external factors are responsible for 
creating certain internal biological conditions that are "provocative" for F AS such as 
high blood alcohol concentrations (BAC), under-nutrition or increased stress (Abel, 
Hannigan 1995, May et al. 2005). The severity of FAS depends upon the interplay 
between these permissive and provocative factors, triggering a number of cellular 
events responsible for alcohol-related damage to the fetus - such as the accumulation 
of free radicals, hypoxia and apoptosis. 
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Figure 1.1: Schematic representation of the complex interplay between various 
permissive and provocative maternal risk factors and the mechanisms responsible for 
Alcohol-Related Birth Defects (ARBDs), including FAS. Pennissive factors are found 
inside the circles; Provocative factors are found inside solid squares. These risk factors act on 
the maternal/placental and fetal units via several pathways, which show associations among 
various environmental, demographic and behavioral variables (dotted-line arrows). Biological 
relationships and physiological pathways are indicated by solid-line arrows. Obtained from 
(Abel, Hannigan 1995). 
Another set of risk factors that may influence fetal vulnerability to F AS is genetic 
variation. Animal models, in particular mouse models, have been extensively studied 
in an effort to elucidate the genetic factors that govern susceptibility to the teratogenic 
effects of alcohol. The reason for this is that mice exposed to alcohol in utero 
manifest the same full spectrum of F AS anomalies as those observed in affected 
humans (Becker, Diaz-Granados & Randall 1996). 
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Chernoff et al. (1980) carried out one of the first animal studies focusing on genetics 
and prenatal alcohol risk. Diallelic crosses were performed on three mouse strains 
with each strain differing in their ability to metabolize ethanol. This resulted in the 
dams of each strain having a different peak blood ethanol concentration, which 
correlates to alcohol dehydrogenase (ADH) activity. Thus the severity of the 
teratogenic effects of ethanol was, at least in part, dependant on the genetics of the 
mother (Chernoff 1980). In addition, Ogawa et al. (2005) demonstrated that fetal 
genetics also had a part to play in developing F AS. In this study, two mouse strains 
were exposed in utero to the same amount and pattern of alcohol during the same 
developmental period. This resulted in each strain displaying unique vulnerability in 
specific organs - suggesting that this differential vulnerability is also attributed by the 
fetal genetic make-up (Ogawa et al. 2005). A number of other mouse studies have 
demonstrated similar strain-related differences depending on the frequency, quantity 
and timing of alcohol exposure (Boehm et al. 1997, Gilliam et al. 1997, Thomas et al. 
1998). 
In humans, just as in the mouse models, the teratogenic effects of alcohol show much 
inter-individual variability. A number of studies done in humans have related these 
differences to polymorphisms in alcohol-metabolizing enzymes such as alcohol 
dehydrogenase (ADH), aldehyde dehydrogenase (ALDH) and cytochrome P450 2El 
(CYP2El) (McCarver 2001, Viljoen et al. 2001, Jacobson et al. 2006). Studies done 
on twin-pairs have shown higher rates of discordance for F AS in dizygotic twins 
when compared to monozygotic twins (Streissguth, Dehaene 1993). 
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The majority of F AS research conducted thus far has focused on maternal and fetal 
genetic risk factors following maternal alcohol consumption during pregnancy. 
However, studies have shown that preconception paternal alcohol abuse could result 
in offspring born with characteristic F AS symptoms. One study reported that 75% of 
children with FAS were fathered by heavy drinkers or alcoholics (Abel 1993). This 
suggests that preconception paternal alcohol abuse could result in alcohol-induced 
alterations in the paternal genome, which could be passed onto the offspring through 
the male gamete, resulting in F AS-like features. 
1.3 RELATIONSHIP BETWEEN PRECONCEPTION PATERNAL 
ALCOHOL CONSUMPTION AND FASD 
There is a growing body of evidence, both from animal and human studies, linking 
the adverse effects of paternal alcohol abuse to offspring development. While a 
number of animal studies have indicated an association between preconception 
paternal alcohol consumption and malformations (Mankes et al. 1982, Abel 1993, 
Bielawski, Abel 1997), altered organ weights (Abel 1993) and behavioral and 
developmental anomalies (Abel, Tan 1988, Ledig et al. 1998, Meek et al. 2007), some 
studies have found no effect of paternal alcohol consumption on fetal growth and 
development(Randall et al. 1982, Abel, Tan 1988). 
A number of studies conducted on humans have investigated the effects of 
preconception alcohol consumption on offspring and the results are in agreement with 
those found in animal studies. While some studies have found no association between 
paternal alcohol consumption and low infant birth weight - one of the attributes 
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associated with F AS (Savitz et al. 1992, Windham et al. 1995, Passaro et al. 1998) - a 
number of studies have reported on the negative outcomes observed in children 
fathered by heavy drinkers. A study conducted by Little et al. (1987) found that 
infants fathered by regular drinkers were found to weigh significantly less then those 
fathered by occasional drinkers (Little, Sing 1987). Children of alcoholic fathers have 
also been found to be more prone to psychiatric disorders including generalized 
anxiety and a higher rate of substance abuse (Mathew et al. 1993, Malone, Iacono & 
McGue 2002). There is also some suggestive evidence indicating that children born to 
alcoholic fathers, rather than having adoptive alcoholic fathers, suffer more often 
from psychosocial adjustment (Andreas, O'Farrell 2007) and intellectual and 
cognitive deficit (Hegedus, Alterman & Tarter 1984, Noll et al. 1992, Weinberg 1997, 
Ozkaragoz, Satz & Noble 1997). This suggests that genetic factors playa crucial role 
in male-mediated effects on offspring. 
It has been postulated that the adverse effects noted in offspring, due to paternal 
alcohol consumption, could be mediated through direct effects of alcohol on the male 
gametes (Abel, Moore 1987). 
1.3.1 THE EFFECT OF ALCOHOL ON MALE GERM CELLS 
Chronic alcohol consumption in men has been associated with infertility (Donnelly et 
al. 1999). Alcohol is a direct testicular toxin that can cause the atrophy of testes, alter 
testosterone production, disrupt spermatogenesis and adversely affect sperm 
concentration, morphology and motility in humans and animals (Van Thiel et al. 
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1975, Lester, Van Thiel 1977, Pajarinen et al. 1996, Muthusami, Chinnaswamy 2005, 
Gaur, Talekar & Pathak 2010). 
Charles Stockard in 1913 provided the first empirical evidence associating 
preconception paternal alcohol exposure with "definite injury" to male gametes 
(Stockard, Papanicolaou 1916). He subjected male guinea pigs to alcohol fumes and 
noted that these males "beget defective offspring" after being mated with normal 
vigorous females. These defects, affecting the central nervous system and including 
gross deformities of the eyes and paralysis of limbs, got progressively worse in each 
subsequent generation. Stockard suggested that alcohol could potentially alter the 
chromatin within the male gametes and this could result in the transmission of 
deformities seen through three generations (Stockard, Papanicolaou 1916). 
At present very little evidence exists to support the effects of the teratogenic 
properties of alcohol on sperm. 
A study carried out by Bielawski et al. (2002) was the first to demonstrate the effect 
of alcohol on sperm cytosine methyltransferase messenger RNA (mRNA) levels. 
These methyltransferase enzymes are crucial for maintaining correct DNA 
methylation patterns in imprinted genes (Li, Bestor & laenisch 1992). The sperm of 
alcohol-treated male mice was found to have significantly lower levels of cytosine 
methyltransferase mRNA. The authors suggested that decreased mRNA levels, 
following chronic ethanol exposure, are associated with decreased enzyme levels that 
can subsequently lead to a decrease in DNA methylation levels (hypomethylation). 
This could result in the expression of paternal alleles that would not normally be 
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expressed. As a consequence, abnormally high levels of gene products could 
accumulate, resulting in decreased fetal weight and an increased frequency of fetal 
runts (Bielawski et al. 2002). 
Another such study done by Ouko et al. (2009) in human sperm found chronic alcohol 
consumption to be associated with modestly decreased methylation levels at specific 
CpG sites of two normally methylated, male imprinted loci (H19 and IG-DMR). 
These loci are involved in regulating the expression of genes that are important for 
normal embryonic growth and development (Wylie et al. 2000, Gabory, lammes & 
Dandolo 2010). The study demonstrated an inverse correlation between the amount of 
alcohol consumed and the degree of methylation at the IG-DMR locus, with the 
lowest methylation levels observed in heavy drinkers and the highest methylation 
levels observed in non-drinkers (Ouko et al. 2009). 
Both the above-mentioned studies have shown that chronic alcohol consumption has 
the ability to alter DNA methylation levels in male germ cells, indicating that this 
epigenetic modification may be a possible mechanism underlying the paternally 
mediated effects on F ASD. 
1.4 EPIGENETIC THEORY 
The term epigenetics has been defmed a number of times since Conrad Waddington 
first coined the word. Initially the term was used to explain "the interactions of genes 
with their environment, which bring the phenotype into being" (Waddington, 1942 as 
cited in Dolinoy, Weidman & lirtle 2007). Today epigenetics can be simply defined 
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as referring to the heritable and transient changes in gene expression that do not entail 
a change in the DNA sequence but requires an interplay of epigenetic marks such as 
DNA methylation, histone modifications and non-coding RNAs (ncRNAs) (as 
reviewed in Reamon-Buettner, Borlak 2007, Hirst, Marra 2009). 
The genetic make-up of almost all nucleated somatic cells of a multi-cellular 
organism is identical. However, during development cells undergo differentiation to 
generate a diversity of cell types. Each cell type has its own epigenetic signature, 
which together with the genotype and the environmental influences (i.e. hormone, 
morphogen or growth factor), gives rise to the phenotype and hence determines the 
function of the cell type (as reviewed in Morgan et al. 2005, Crews 2008). This 
process of cellular decision-making during development was metaphorically 
illustrated by Waddington and referred to as the "epigenetic landscape" (Figure 1.2). 
Figure 1.2: Conrad Waddington's illustration of the epigenetic landscape. During 
development the undifferentiated cell, at the top, travels down a landscape of ridges and 
valleys where multiple factors influence the cell to travel down a certain course. The fate of 
the cell is dependant upon the course traveled. Modified from (Goldberg, Allis & Bernstein 
2007). 
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More recently, Waddington's classical epigenetic landscape illustration has been 
modified to include all known epigenetic factors responsible for regulating gene 
expression. This is important for generating a diversity of cell types during 
mammalian development (Figure 1.3). 
Figure 1.3: A current view of the epigenetic landscape. During cellular development and 
tissue differentiation, cells will be directed down a certain course by a complex interplay 
between various epigenetic regulatory factors such as DNA methyltransferases (DNMTs), 
chromatin remodelers (ChR), histone-modifying proteins (HDACs, histone deacetylases; 
HATs, histone acetyltransferases; HDMs, histone demethylases) and transcription factors 
(TFs). Modified from (Goldberg, Allis & Bernstein 2007). 
Apart from playing an important role in generating a diversity of cell types during 
development, epigenetic regulation is also critical in maintaining the stability and 
integrity of the genome and in the silencing of repetitive transposable elements, 
thereby inhibiting their transcription (as reviewed in Reamon-Buettner, Borlak 2007, 
Slotkin, Martienssen 2007). Environmental, toxicological and nutritional factors can 
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affect the maintenance of epigenetic patterns leading to epigenetic dysregulation (Feil 
2006). The latter can lead to neuro-developmental and neuro-degenerative disorders 
as well as several cancers and autoimmune diseases (Vaissiere et al. 2009, Feng et al. 
2008, Huang, Akbarian 2007, Wang, Oelze & Schumacher 2008, Javierre et al. 2010). 
There are three epigenetic regulatory mechanisms that form part of the epigenetic 
regulatory network: DNA methylation, histone modifications and RNA-associated 
pathways. Since this study focuses on DNA methylation, it will be discussed in more 
detail in the subsequent sections. Histone proteins are crucial for packaging DNA into 
nucleosomes. Histones are subject to numerous post-translational modifications of 
their N-terminal tails including acetylation, phosphorylation, ubiquitination and 
methylation, all of which can influence gene activity (Kouzarides 2007). Histone 
acetylation, phosphorylation and ubiquitination are associated with a transcriptionally 
active chromatin structure while histone deacetylation is associated with an inactive 
chromatin structure leading to transcriptional repression (Hebbes, Thome & Crane-
Robinson 1988, Nickel, Allis & Davie 1989, Kadosh, Struhl 1998, Nowak, Corces 
2000). Histone methylation on the other hand, depending on its position, is either 
associated with transcriptional repression or activation (Bannister, Kouzarides 2005). 
Regulatory non-protein-coding RNAs (ncRNAs) are critical for transcriptional and 
post-transcriptional regulation and in modifying chromatin structure. There are a large 
number of ncRNAs, each with a different regulatory function. These ncRNAs include 
small interfering RNAs which are responsible for the silencing of transposable 
elements (as reviewed in Carthew, Sontheimer 2009), microRNAs that regulate gene-
expression in a sequence-specific manner (as reviewed in He, Hannon 2004) and long 
RNAs which are involved in X-chromosome inactivation and DNA imprinting 
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(Redrup et al. 2009). Together DNA methylation, histone modifications and ncRNAs 
all interact to establish cell-type specific epigenomes. 
1.4.1 DNA METHYLATION -A KEy EPIGENETIC MARK 
DNA methylation is the most widely studied epigenetic regulatory mechanism. It is a 
covalent modification in which methyl groups are added to the 5-C position of 
cytosine residues, predominantly within CpG dinucleotides. CpG dinucleotides tend 
to cluster in regions referred to as CpG islands. Approximately 80% of the CpG 
dinucleotides in the human genome are methylated (silenced) with the exception of 
CpG islands (as reviewed in Jaenisch, Bird 2003). CpG islands are generally 
unmethylated and associated with the 5' end of housekeeping and tissue-specific 
genes, with the exception of CpG islands at loci that undergo genomic imprinting and 
X-chromosome inactivation (Shen et al. 2007). 
The primary role of DNA methylation is in cellular differentiation and tissue-specific 
gene regulation during development. Apart from this, DNA methylation is also 
involved in X-chromosome inactivation, genomic imprinting and in silencing of 
transposable elements (as reviewed in Bird 2002, Miranda, Jones 2007). DNA 
methylation is associated with repressed chromatin and inhibition of promoter 
activity, either directly by preventing the binding of transcription factors to their 
target sequences or indirectly by the recruitment of methyl-binding proteins and 
histone deacetylases (Ng, Jeppesen & Bird 2000). 
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Various factors including carcinogen exposures, inflammation, stress and diet have 
the ability to alter DNA methylation patterns (Jirtle, Skinner 2007, Christensen et al. 
2009, Murgatroyd et al. 2009). Disruptions in normal DNA methylation patterns can 
result in several human diseases including cancer, a number of imprinting disorders 
and DNA repeat-instability disorders such as Fragile X mental retardation (as 
reviewed in Robertson 2005). 
1.4.2 DNMT ENZYMES AND DNA METHYLATION 
DNA methylation is mediated by DNA methyltransferase (DNMT) enzymes that 
catalyze the transfer of methyl groups from S-adenosylmethionine (SAM), a methyl 
donor, to cytosine residues of CpG dinucleotides (Bestor 2000). These enzymes are 
crucial in maintaining the DNA methylation patterns following DNA replication 
thereby stabilizing the cellular identity of daughter cells. There are four known 
DNMT enzymes: DNMTl; DNMT3A; DNMT3B and DNMT3L but only the first 
three display catalytic activity. DNMTI plays a role in the maintenance of parental 
methylation patterns in daughter cells following DNA replication (Leonhardt et al. 
1992). DNMT3A and DNMT3B are referred to as de novo methyltransferases and are 
responsible for establishing methylation patterns during embryogenesis (Okano et al. 
1999). The third member of the DNMT3 family, DNMT3L, lacks catalytic activity 
but is capable of establishing methylation imprints in male and female germ-lines 
during gametogenesis through interactions with the other DNMT3 enzymes 
(Bourc'his et al. 2001, Kato et al. 2007). 
18 
CHAPTER 1 - INTRODUCTION 
A number of mouse studies have been done to determine the importance of DNMT 
enzymes in development. Dnmtl null mice exhibited genome-wide hypomethylation 
and did not survive past embryonic development (Li, Bestor & laenisch 1992). In 
comparison, Dnmt3a null mice developed normally but became runted and died 
approximately 4 weeks after birth while Dnmt3b null mice were not viable due to 
multiple developmental defects. Dnmt3a and Dnmt3b double mutant mice displayed 
abnormal morphology and died shortly after gastrulation (Okano et al. 1999). Lastly, 
the Dnmt3! null mice exhibited hypomethylation of specific imprinted regions in 
oocytes and male sterility due to a loss of spermatogonia (Bourc'his et al. 2001, La 
Salle et al. 2007). In humans there is only one known genetic disease associated with 
a DNMT enzyme - Immunodeficiency, Centromeric instability and Facial anomalies 
(lCF) syndrome. The majority of the patients presenting with ICF have mutations in 
the DNMT3B gene that leads to hypomethylation of specific regions of the genome 
(Hansen et al. 1999, Kondo et al. 2000, Tao et al. 2002). Apart from this, these 
patients present with impaired cellular immunity, facial anomalies, mental retardation 
and numerous cytogenetic abnormalities primarily involving the juxtacentromeric 
heterochromatin (Jin et al. 2008). 
Thus it can be seen that these enzymes are crucial for generating and maintaining 
epigenetic control of gene expression during embryogenesis, gametogenesis and 
genomic imprinting. 
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1.5 GENOMIC IMPRINTING 
The discovery of genomic imprinting In mammals occurred in the mid-1980s 
following nuclear transplantation studies conducted in mice. Diploid androgenotes 
derived from two male pronuclei and diploid gynogenotes derived from two female 
pronuclei failed to develop beyond mid-gestation, thereby suggesting that diploidy 
alone is not sufficient for normal embryonic growth and development (Barton, Surani 
& Norris 1984, Surani, Barton & Norris 1984). It was proposed that the maternal and 
paternal genomic contributions to the embryo are functionally different with certain 
genes being inherited in a functional form from one parent, and a non-functional form 
from the other (McGrath, Solter 1984). The mono-allelic behavior of these genes, 
now referred to as imprinted genes, is dependent on the parental origin of the gene (as 
reviewed in Jirtle, Skinner 2007). 
1.5.1 THE EVOLUTIONARY THEORIES OF IMPRINTING 
Almost all placental mammals studied to date have retained imprinted genes in their 
genomes (Jirtle, Weidman 2007). Imprinted genes are effectively haploid and 
therefore confer a selective disadvantage to mammals, making them vulnerable to 
recessive mutations and epigenetic modifications. Although several hypotheses have 
been put forth explaining this paradox, only two of the more plausible hypotheses will 
be discussed here. 
The ovanan time bomb hypothesis proposes that genomIc imprinting may have 
evolved to prevent the spontaneous development of unfertilized oocytes (a process 
also known as parthenogenesis), which could lead to ovarian trophoblastic disease 
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(Weisstein, Feldman & Spencer 2002). Therefore inactivating the maternal copy of 
the growth-enhancing gene in the embryo reduces this risk while the addition of a 
single paternal copy of the growth-inhibitor to the embryo creates a balanced 
environment for successful embryogenesis (as reviewed in Morison, Ramsay & 
Spencer 2005). It is possible that the action of imprinted genes in preventing 
parthenogenesis has certain advantages in mammalian development. 
The most widely accepted theory for the evolution of imprinting is the conflict 
hypothesis. This theory states that there are conflicting interests between the males 
and females over the allocation of maternal resources during the growth and 
development of offspring, especially in the event of multiple paternities (Moore, Haig 
1991). Therefore if a father is to ensure that his genome is most efficiently 
propagated, his germ-line will have to imprint genes in a manner that will promote the 
growth and survival of his offspring by demanding more nutrient resources from the 
mother (as reviewed in Tycko, Morison 2002). Conversely, if the mother is to have 
her genome propagated successfully her genes need to be imprinted such that her 
resources are equally allocated to all her current and future offspring, regardless of 
paternity (Das, Hampton & lirtle 2009). Evidence for this theory comes from mice 
with germ-line knockouts of Igf2 and Igf2r imprinted genes. The Igf2 gene encodes an 
embryonic growth factor and is expressed from the paternal chromosome only, while 
the Igf2r gene is expressed from the maternal chromosome only and encodes a 
receptor that binds and transports the Igf2 protein to lysosomes (DeChiara, Robertson 
& Efstratiadis 1991, Lau et al. 1994). A study carried out by DeChiara et al. (1991) 
demonstrated that a loss of function of Igf2 resulted in growth deficient offspring 
(DeChiara, Robertson & Efstratiadis 1991). On the contrary, mutations of the 
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maternal Igf2r gene resulted in embryonic over-growth and perinatal lethality (Lau et 
al. 1994). The resulting aberrant prenatal growth seen in both knockouts demonstrates 
the balance required between maternal and paternal genomes for the regulation of 
nonnal embryonic growth. 
1.5.2 IMPRINTED GENES 
To date approximately 100 imprinted genes have been identified in mIce 
(http://www.har.mrc.ac.uk/research/genomic imprintingO and only 80 identified in 
humans (Cooper, Constancia 2010). While the majority of the human imprinted genes 
have mouse orthologs and share a conserved imprint status, some imprinted genes in 
the mouse have human orthologs that fail to exhibit an imprint status (as reviewed in 
Morison, Ramsay & Spencer 2005). Many of these genes play a vital role in 
embryonic growth and regulation of cellular proliferation 
(http://www.har.mrc.ac.uk/research/genomic imprinting/), while others influence 
behavior and neuro-developmental processes (as reviewed in Wilkinson, Davies & 
Isles 2007). 
Imprinted genes are regulated by DNA methylation (Li, Beard & laenisch 1993). 
Allele-specific DNA methylation is confined to differentially methylated regions 
(DMRs) and these are found in close proximity to imprinted genes. There are two 
classes of DMRs: primary DMRs (also referred to as Imprinting Control Regions 
[ICRs]), which acquire gamete-specific methylation during spennatogenesis or 
oogenesis and secondary DMRs, which acquire differential methylation patterns 
following fertilization (Kobayashi et al. 2006). To date only 18 known maternally 
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methylated pnmary DMRs have been identified in mice and only four known 
paternally methylated primary DMRs (Smith et al. 2003, Kobayashi et al. 2006, 
Wood et al. 2007, Hiura et al. 2010). Of the four paternally methylated DMRs found 
in mice, only three are known to share an imprint status with human orthologs: the 
H191IGF2 DMR, the DLKlIGTL2 locus DMR (known as IG-DMR) and the 
GPRlIZDBF2 locus DMR (Davis et al. 1999, Geuns et al. 2007, Kobayashi et al. 
2009b). These DMRs are all intergenic. The additional mouse locus displaying a 
paternal-specific DMR, Rasgrfl, has a human ortholog but the imprint status thereof 
is unknown (de la Puente et al. 2002). 
Poorly established DNA methylation patterns of imprinted genes have been the cause 
of a number of behavioral and developmental disorders such as Prader-Willi 
syndrome (PWS), Angelman syndrome (AS) and Beckwith-Weidemann syndrome 
(Buiting et al. 1995, Brown et al. 1996). 
1.5.3 EPIGENETIC REPROGRAMMING OF IMPRINTED GENES 
There are two critical periods in mammalian development when DNA methylation 
undergoes genome-wide reprogramming (Figure 1.4). This reprogramming is not only 
crucial in erasing and re-establishing the correct epigenetic marks during embryonic 
development but also in restoring the totipotency of the fertilized egg (as reviewed in 
Reik, Dean & Walter 2001). 
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Figure 1.4: Epigenetic reprogramming in mammalian development Obtained from 
(Murphy, Jirtle 2003). 
The first wave of demethylation occurs in early embryogenesis when the maternal and 
paternal genomes come together to form a zygote. Upon fertilization, the paternal 
genome undergoes chromatin remodeling whereby protamines are replaced by 
histones, this is followed by rapid and active demethylation that occurs prior to DNA 
replication. During this time the maternal genome completes meiosis and undergoes 
passive demethylation in a replication-dependant manner (as reviewed in Morgan et 
al. 2005). The methylation marks on imprinted genes resist this wave of global 
demethylation and maintain their parent-of-origin specific methylation patterns 
throughout development (as reviewed in Guibert, Forne & Weber 2009). Around the 
time of implantation, the embryo undergoes a wave of de novo methylation in a 
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lineage-specific manner (Kafri et al. 1992). These methylation patterns are then 
faithfully maintained throughout the lifespan ofthe individual. 
The second wave of demethylation occurs during gametogenesis in the primordial 
germ cells (PGCs) of the embryo. This coincides with the migration of PGCs into the 
genital ridge (Hajkova et al. 2002). This particular wave of global demethylation 
includes the erasure of imprinting marks. Upon sex determination, methylation 
patterns are re-established both globally and at imprinted loci where the methylation 
of the imprints is dependant on the sex of the offspring (as reviewed in Murphy, lirtle 
2003). This germ-line epigenetic reprogramming is not only important for resetting of 
parental imprints for the next generation but is also equally important in preventing 
epimutations from being passed onto the next generation. 
The gonadal sex determination stage in embryonic development is most sensitive to 
environmental insults that could alter the epigenome of the gamete. This together with 
incomplete erasure and re-establishment of epigenetic marks in the germ-line could 
allow for the transmission of incorrect epigenetic signatures to the subsequent 
generation (as reviewed in Skinner, Guerrero-Bosagna 2009). 
1.6 THE EFFECT OF ETHANOL ON ONE-CARBON METABOLISM 
Folate, a member of the B-complex vitamins, is a cofactor in one carbon transfer. It 
not only plays a key role in nucleic acid biosynthesis but is also responsible for 
maintaining DNA methylation in conjunction with another cofactor, S-
adenosylmethionine (SAM) (as reviewed in Appling 1991, Hitchler, Domann 2007). 
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SAM plays a role in DNA and histone methylation reactions by acting as a methyl 
group donor (Hitchler, Domann 2007). Both these co-factors are biochemically linked 
via the folate and methionine cycles (Figure 1.5). 
+ Methylati 
of DNA, 
RNA, etc. 
~ S-AdoMet ::r~ethionine 
dmg 
Betaine 
t S-AdOHCyst 4 · t.lomOCysteine 
CBS l B, 
Cystathionine 
Formyl 
THF 
t 
Metheny. 
THF 
MTHFR U 
ethyl THF~~MethYlene 
2 THF 
•• -------------------------------------+ ••• -------------+. 
Biologic methylation Nucleotide 
synthesis 
Figure 1.5: Schematic representation of the biochemical pathway of one-carbon 
metabolism. Shown here are the intricate interactions between the folate and methionine 
cycles. Two key enzymes, MS and MTHFR, link these two cycles. Modified from (Mason, 
Choi 2005). The red arrows indicate the effects that ethanol consumption can have on each 
substrate. DHF Dibydrofolate; dmg dimethylglycine; S-AdoHcyst S-
adenosylhomocysteine; S-AdoMet (SAM) = S-adenosylmethionine; THF = tetrahydrofolate; 
MS = methionine synthase; MAT = methionine adenosyltransferase; BHMT = 
betaine:homocysteine methyltransferase; MTHFR = methylenetetrahydrofolate reductase; 
SHMT = serine hydroxymethyltransferase; CBS = cystathionine p-synthase. 
Intracellularly, folate as 5-methyl THF functions as a methyl donor for homocysteine 
remethylation. The resulting THF is converted to methylene THF by SHMT, which 
donates a methyl group to uracil converting it to thymidine. This is used for DNA 
synthesis and repair (as reviewed in Hamid, Wani & Kaur 2009). The MTHFR 
enzyme has the ability to reduce methylene THF to 5-methyl THF donating a methyl 
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group to homocysteine to produce methionine. The B12-dependant MS enzyme 
catalyzes this conversion of homocysteine to methionine. Hereafter, MAT catalyses 
the addition of ATP to methionine, generating S-AdoMet. S-AdoMet then serves as a 
universal donor of methyl groups in various methylation reactions (Schalinske, 
Nieman 2005). 
Mammals cannot synthesize folate and thus must obtain the vitamin from exogenous 
nutritional sources via intestinal absorption (Balamurugan, Said 2006). Chronic 
ethanol consumption has a multifaceted impact on the bioavailability of dietary folate 
and subsequent metabolism of folate and methionine (Mason, Choi 2005). Excessive 
ethanol consumption has been reported to interfere with the absorption of dietary 
folate (Halsted, Robles & Mezey 1973, Halsted et al. 2002). This can have an indirect 
impact on folate and methionine metabolism. However, ethanol can also have a direct 
impact on one-carbon metabolism (Figure 1.5). It has the ability to inhibit the reaction 
catalyzed by MS. This wi11lead to the subsequent decrease of downstream products 
such as methionine and S-AdoMet and an increase of some of the precursors of the 
reaction such as homocysteine and S-AdoH-cyst. S-AdoH-cyst is a potent inhibitor of 
methyltransferase enzymes - enzymes that are crucial for maintaining the correct 
DNA methylation patterns. An increase in S-AdoH-cyst can result in a considerable 
degree of genomic hypomethylation (Lu et al. 2000, Castro et al. 2005). In addition, 
inhibition of MS by ethanol results in an increase of 5-methyl THF, which cannot be 
catalyzed into THF resulting in a loss ofmethylene-, methenyl- and formyl THF. This 
loss leads to defective DNA synthesis and repair (Mason, Choi 2005). 
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Disruption in the folate and methionine metabolism can lead to several human 
diseases including several types of cancers, neural tube defects and neuro-
degenerative diseases (van Engeland et al. 2003, Pitkin 2007, Flatley et al. 2009, Naj 
et al. 2010). 
1.7 A PLAUSIBLE EPIGENETIC MECHANISM FOR FAS - FROM A 
PATERNAL PERSPECTIVE 
The first paper to demonstrate the link between the long-term effects of preconception 
and prenatal alcohol exposure and epigenetic changes established in the fetus was 
only recently published (Kaminen-Ahola et al. 2010). In this study the researchers 
used a mouse model demonstrating that maternal ethanol consumption, prior to or 
following fertilization, has the ability to alter the expression of AVY, an epigenetically 
sensitive allele, in the offspring. The resulting phenotypes were comparable to the 
F ASD phenotypes, which included a small skull size, differences in the shape of the 
skull and postnatal growth restriction (Kaminen-Ahola et al. 2010). These results 
display the direct relationship between maternal alcohol consumption before and 
during pregnancy and changes in DNA methylation in the offspring. It is known that 
DNA methylation plays a crucial role in regulating the expression of imprinted genes 
during embryogenesis and that environmental insults (such as alcohol) during this 
time can promote developmental abnormalities as seen in offspring affected with F AS 
(Skinner, Manikkam & Guerrero-Bosagna 2010). 
However, paternal preconception alcohol consumption can also have an impact on the 
development of the offspring - indirectly through the male gametes. It is known that 
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alcohol consumption has a negative impact on spenn cytosine methyltransferase 
mRNA levels possibly through the effect of alcohol on one-carbon metabolism 
(Bielawski et al. 2002). This leads to a decrease in DNA methylation that could result 
in the expression of paternal alleles that would not nonnally be expressed (Bielawski 
et al. 2002, Ouko et al. 2009). Could this alteration in gene expression be transmitted 
to the offspring and result in early life origins of disease? A study done by Knezovich 
and Ramsay (awaiting publication) on preconception paternal alcohol exposure on 
three paternally imprinted loci (H19, Rasgrfl and Ig-DMR) did not find any of these 
loci to be significantly demethylated in the spenn samples of the alcohol-exposed 
males. However, the offspring sired by alcohol treated males had significantly lower 
weights during the weaning period when compared to the controls and this was 
accompanied by significant reductions in DNA methylation at the H19 ICR in the 
fonner. The lack of demethylation in spenn samples due to alcohol exposure and the 
significant reduction in methylation at the same loci in the offspring suggests that 
alcohol could have potentially induced the oxidation of 5-methylcytosine (5-mc) to 
fonn 5-hyroxymethylation (5-hmc) - an intennediary modification found at the stage 
between demethylation in gametes and remethylation of differentiated cells in 
embryos. This 5-hmc is found at high levels in the male pronucleus, Purkinje cells 
and embryonic stem cells (Wossidlo et al. 2011). This intennediary in the male spenn 
could then later manifest as demethylated DNA in the offspring. Another study 
looking at the impact of diet on offspring development, done by Ng et al. (2010), 
demonstrated that a father's high-fat diet resulted in a diabetes-like condition only in 
his daughters. The paternal high-fat diet resulted in the altered expression of 
numerous genes belonging to regulatory pathways involved in insulin and glucose 
metabolism in the offspring. This study suggested that diet could have an impact on 
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spermatogenesis and on the epigenetic reprogramming of the germ-line (Ng et al. 
2010). These two studies demonstrate the link between a paternal environmental 
exposure and a negative outcome in the offspring through altered DNA methylation 
levels. 
1.8 STUDY HYPOTHESIS 
Hypothesis: Alcohol consumption induces hypomethylation of normally 
hypermethylated DMRs, associated with paternally imprinted genes, in the sperm of 
men who consume alcohol. This alteration in methylation occurs in a dose-dependant 
manner such that men with higher drinking frequencies display a higher level of 
hypomethylation compared to men with lower drinking frequencies. 
Rationale: Alcohol is a direct testicular toxin and is known to disrupt 
spermatogenesis. Alcohol is also known to affect one-carbon metabolism by 
decreasing S-AdoMet, the methyl donor and increasing S-AdoH-cyst, a potent 
inhibitor of methyltransferase enzymes. Thus alcohol could have a negative impact on 
spermatogenesis resulting in the hypomethylation of DMRs and subsequent 
expression of paternally imprinted loci in the sperm. This could have significant 
implications with regard to the regulation of developmentally significant genes in the 
zygote and fetus resulting in developmental, behavioral and neuro-cognitive 
disorders. 
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1.9 AIM OF THE STUDY 
The current study had two aims. 
The first aim of the study was to determine whether the human RASGRF 1 gene 
contains a DMR and whether this DMR is paternally methylated. 
The second aIm of the study was to examme the effect of paternal alcohol 
consumption on the methylation status of the RASGRF 1 DMR (if one was identified) 
and the IG-DMR loci in male gametes and to determine whether alcohol affects 
methylation in a dose-dependant manner. While RASGRF 1 is a developmentally 
significant gene, IG-DMR is a key regulator of the DLKl/GTL2 imprinted gene 
cluster. Therefore if a link between alcohol consumption in men and hypomethylation 
of normally hypermethylated loci is found, this will allow for a better understanding 
of the possible epigenetic mechanism underlying the paternally mediated effects on 
FASD. 
1.9.1 OBJECTIVES OF THE STUDY 
Objective 1: To determine the methylation status of RASGRF 1 in human sperm and 
peripheral blood samples. 
Objective 2: To quantitatively assess the overall methylation status of the RASGRFI 
DMR (if one was identified) and IG-DMR and to assess the methylation status of 
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each individual CpG site within the respective DMRs, following alcohol 
consumption. 
Objective 3: To quantitatively assess the effect of drinking frequency on the overall 
methylation status of the RASGRF 1 DMR (if one was identified) and IG-DMR and to 
assess the methylation status of each individual CpG site within the respective DMRs. 
The objectives will be discussed separately with Chapter 2 dedicated to RASGRF 1 
and Chapter 3 dedicated to IG-DMR. 
32 
CHAPTER 2 
IN SEARCH OF A PATERNALLY 
METHYLATED DMR FOR HUMAN 
RASGRFl 
CHAPTER 2 - IN SEARCH OF A PATERNALLY METHYLATED DMR FOR HUMAN RASGRF 1 
2.1 INTRODUCTION 
2.1.1 COMMON FEATURES OF IMPRINTED GENES 
The differential marking of imprinted genes at the primary DMRs (also known as 
ICRs) in a parent-of-origin manner is a key feature of all imprinted genes. Most ICRs 
overlap with CpG islands and the imprints at these regions are established during 
gametogenesis and are maintained throughout development (Hutter, Helms & Paulsen 
2006, Lim, Ferguson-Smith 2010). Differential marking of imprinted genes can also 
occur at secondary DMRs following fertilization. The establishment of the secondary 
DMRs is thought to be set up by the ICRs (Lopes et al. 2003). Although DNA 
methylation at the ICR is key for the reciprocal expression of these genes, differences 
in histone modifications at the ICR of the two parental chromosomes are also found to 
contribute to the reciprocal expression profiles (as reviewed in Kacem, Feil 2009). 
Histone H3 di- and tri-methylation at lysine 9 (H3K9me2/3) and histone H3 di- and 
tri-methylation at lysine 27 (H3K27me2/3) are found to be preferentially enriched on 
the methylated allele, while histone H3 acetylation, H4 acetylation and histone H3 di-
and tri-methylation at lysine 4 (H3K4me2/3) are found to be enriched on the 
unmethylated allele (Fournier et al. 2002, Umlauf et al. 2004, Barski et al. 2007). 
However, it is important to note that DNA methylation is the most consistent hallmark 
of imprinting and is crucial for establishing and maintaining imprints (Delaval, Feil 
2004). 
The frequent presence of tandem repeats, simple repeats and long interspersed nuclear 
elements (LINEs) in the vicinity of imprinted regions is another common feature of 
imprinted genes (Allen et al. 2003, Hutter, Helms & Paulsen 2006). Tandem repeat 
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elements tend to occur more frequently within or adjacent to CpG islands associated 
with imprinted genes than they do with CpG islands of biallelically expressed genes 
(Hutter, Helms & Paulsen 2006). It is thought that these repeat elements play an 
essential role in regulating the establishment of methylation of the adjacent ICR, in 
addition they are involved in various epigenetic silencing and heterochromatin 
formation processes (Volpe et al. 2002, Reinhart, Paoloni-Giacobino & Chaillet 2006, 
Brideau et al. 2010). 
Transcription factors and chromatin insulators, Yin-Yang 1 (YY1) and CTCF, present 
within the ICR have prominent roles in the epigenetic modifications and 
transcriptional control of associated imprinted genes (Filippova et al. 1996, Kim et al. 
2006). However, it should be noted that these factors are not exclusively located 
within ICRs. YYl binding sites are found in many heterochromatic regions 
throughout the genome while CTCF-binding sites are ubiquitous throughout the 
genome (Kim T.H. et al. 2007, Kim 2008). 
Having listed all the common features of imprinted genes, it is the ICR that is the key 
feature of imprinted genes due to its regulatory function. It is the methylation status of 
the ICR that has direct influence on the expression of genes at the locus (Yoon et al. 
2002). 
2.1.2 THE IMPORTANCE OF IMPRINTING CONTROL REGIONS IN NORMAL 
DEVELOPMENT 
A number of studies have emphasized the role of the ICR in establishing and 
maintaining imprints. A mouse study done by Williamson et al. (2006) focused on the 
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targeted deletion of the Nespas ICR at the complex Gnas cluster. Upon inheriting the 
deletion on the paternal allele, offspring did not survive past postnatal day two. This 
was ascribed to the altered expression of all transcripts in the Gnas cluster and altered 
methylation of the Nesp DMR and the ExonlA DMR (Williamson et al. 2006). 
Another such study demonstrated the effect of deleting the ICR that regulated the 
H19/Jgf2 locus in mice. Under normal circumstance, H19 is hypermethylated on the 
paternal allele while Jgf2 is hypermethylated on the maternal allele. Targeted deletion 
of the ICR in mice has shown that when the ICR deletion is paternally inherited H19 
is activated and Jgf2 is silenced. The opposite is true when the deletion is maternally 
inherited where the H19 locus is silenced and Jgf2 is expressed (Thorvaldsen, Duran 
& Bartolomei 1998). In humans, there exists a large imprinted domain on 
chromosome 15qIl-13. This region houses a number of maternally and paternally 
expressed genes and ncRNAs that are regulated by a bipartite ICR (Prader-Willi 
syndrome [PWS]-ICR and Angelman syndrome [AS]-ICR). Microdeletions on the 
paternally inherited PWS-ICR result in the silencing of the paternally expressed genes 
resulting in PWS syndrome while microdeletions on the maternally inherited AS-ICR 
results in AS (Buiting et al. 1995, as reviewed in Edwards, Ferguson-Smith 2007). 
One would expect these important regulatory elements, that establish and maintain 
gene imprints, to be conserved between various species. However, studies have shown 
that some genes display discordant imprinting between the mouse and human 
genomes (Li et al. 2005, Monk et al. 2006). 
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2.1.3 FEATURES OF THE PATERNALLY IMPRINTED RASGRF lIN MICE 
Rasgrf1 (Ras protein-specific guanine nucleotide-releasingfactor 1) forms part of the 
MAPK signaling pathway and has been found to play a role in long-term memory 
consolidation and growth control (Brambilla et al. 1997, Itier et al. 1998). Rasgrf1, 
found on mouse chromosome 9 [NCB I Gene ID: 19417], contains a paternally 
imprinted DMR and is exclusively expressed from the paternal allele in the neonatal 
brain and liver (Dockery et al. 2009). A binary switch located 30 kb upstream of the 
Rasgrf1 promoter is responsible for controlling the imprint status of the gene in mice 
(Figure 2.1). The first component of this binary switch is a repeat unit consisting of 
forty copies of a 41 bp repeat element, which is responsible for establishing 
methylation of the second component of the switch, the DMR (Holmes, Chang & 
Soloway 2006). This DMR serves as a CCCTC-binding factor (CTCF) binding site on 
the unmethylated maternal allele. Binding of a CTCF protein blocks enhancer-to-
promoter interactions resulting in the silencing of the maternal allele of Rasgrf1. On 
the paternal allele, the CTCF-binding factor is unable to bind to the methylated DMR 
resulting in expression of Rasgrfl from the paternal allele (Y oon et al. 2005). 
Mouse: 
Paternal 
@ 
~ 
41bps (x40) Chromosome ~----~--~~~~~~~-------
Okb 
Figure 2.1: A schematic representation of a binary switch located upstream of RasgrfJ. 
Shown here is the paternal allele with a methylated DMR (indicated by the filled in lollipops), 
which prevents the CTCF binding factor from binding to the DMR thereby allowing 
promoter-to-enhancer interactions. 
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The mouse DMR is a primary DMR established in the male germ-line (Y oon et al. 
2002). It is located between Rasgrfl and a brain-specific micro-RNA (Mir-184) that is 
imprinted and expressed from the paternal allele in the brain (Figure 2.2) (Nomura et 
al. 2008). Both these genes have human homologs and they are transcribed in 
opposite directions. The mouse and human genomes display conserved synteny of 
Rasgrfl and Mir-184. 
Mouse: 
DMR 
Paternal 
80kb 30kb 
Figure 2.2: A schematic representation of the position of the mouse DMR relative to 
Rasgrj1 and the Mir-184. 
The human ortholog of Rasgrfl is found on chromosome 15 [NCB I Gene ID: 5923] 
but its imprint status is unknown. The reason for focusing on this gene is that studies 
conducted by Brambilla et al. (1997) have shown that mice lacking the Rasgrfl 
protein demonstrated severely impaired memory consolidation (Brambilla et al. 
1997). Another study done in mice by Itier et al. (1998) observed that mice lacking 
the Rasgrfl gene suffered from postnatal growth retardation, which persisted into 
adulthood (!tier et al. 1998). The phenotypes observed in both these studies are 
similar to those seen in offspring affected by F ASD. Therefore if this gene is found to 
be paternally imprinted in humans and if a link between alcohol consumption in men 
and hypomethylation of the normally hypermethylated allele is found, this will allow 
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for a better understanding of the possible epigenetic mechanism underlying the 
paternally mediated effects on F ASD. 
Therefore the aim of this part of the study was to determine whether the human 
RASGRF 1 gene contains a DMR and whether this DMR is paternally methylated. In 
order to assess the imprint status of RASGRF 1, a number of computational 
assessments were done to identify key imprinting features, while pyrosequencing 
analysis was used to assess the methylation status of various CpG islands surrounding 
RASGRF1. 
2.2 SUBJECTS AND METHODOLOGY 
2.2.1 COMPUTATIONAL ASSESSMENT 
2.2.1.1 SEARCHING FOR SEQUENCE SIMILARITY 
The BLAST-like Alignment Tool (BLAT) was used to identify sequence similarity 
using the mouse DMR [NCBI Reference Sequence: NT_039476.7] and the 40 copies 
of the 41 bp repeat element unit as query sequences and comparing them against the 
human genome on Ensembl. The Ensembl database can be found at 
http://www .ensembl.orglindex.html. 
2.2.1.2 IDENTIFICATION OF CTCF BINDING SITES 
Knowing that the mouse Rasgrfl DMR is regulated by a CTCF-binding protein (Yoon 
et al. 2005), a starting point for assessment was to identify all CTCF binding sites 
39 
CHAPTER 2 - IN SEARCH OF A PATERNALLY METHYLATED DMR FOR HUMAN RASGRF 1 
within human RASGRF1 and between RASGRF1 and the M7R-184. The in silica 
CTCF Binding Site Database (CTCFBSDB) (http://insulatordb.uthsc.edulstorm.php) 
contains both experimentally identified and computationally predicted CTCF binding 
sites. The query sequence was uploaded in the CTCFBS prediction tool. This tool 
searches the query sequence for CTCFBS core motifs, which are represented by 
position weight matrices (PWM). A match between a query sequence and a PWM is 
represented by a score that corresponds to the log-odds of the observed sequence 
being generated by the motif versus being generated by the background. A large 
positive score is indicative of a good match for a potential CTCFBS. 
2.2.1.3 IDENTIFICATION OF EVOLUTIONARY CONSERVED REGIONS AMONG 
VARIOUS SPECIES 
The mouse DMR is located between Rasgrf1 and a brain-specific micro-RNA (Mir-
184). The mouse and human genomes display conserved synteny of Rasgrf1 and Mir-
184. Identifying regions of conservation between these two genes in multiple species 
could suggest the presence of regulatory elements. The start co-ordinate of Rasgrf1 
(mouse chr9: 89,804,613 [NCBI37/mm9]; human chrl5: 77,041,341 [NCBI36/hgI8]) 
and the start co-ordinate of Mir-184 (mouse chr9: 89,697,098 [NCBI37/mm9]; human 
chrI5: 77,289,185 [NCBI36/hgI8]), in mice and in humans, was obtained from the 
UCSC Genome Browser and used in the Evolutionary Conserved Region (ECR) 
browser to visualize conservation-profiles (Ovcharenko et al. 2004). These co-
ordinates gave a defined region in which the mouse DMR lies. Hence, the mouse was 
used as a base genome first, followed by using the human (hgI8) as a base genome. 
The ECRs were identified using a minimum identity of 70% per 100 bp sequence. 
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The ECR browser can be found at http://ecrbrowser.dcode.org/ whilst the UCSC 
Genome browser is accessible at http://genome.ucsc.edulindex.html. 
2.2.1.4 SEARCHING FOR CpG ISLANDS AS POTENTIAL SITES FOR DIFFERENTIAL 
METHYLATION 
It is known that DMRs in mice have an average G+C content of 54%, suggesting that 
these regions are generally CpG rich (Kobayashi et al. 2006). Identifying CpG rich 
regions between the human RASGRFI and MIR-184 would allow for identification of 
possible DMRs that would need to be validated in the laboratory. 
A CpG Island (CGI) Prediction tool, part ofUCSC's plethora ofbioinformatic tools, 
was used to identify CGIs between RASGRFI and MIR-184. All CpG islands on this 
webpage are scored quantitatively based on their CGI strength. High CpG island 
strength is indicated by: 
1. An absence of DNA methylation 
2. Presence of promoter activity 
3. Open chromatin structure. 
The scores allow bona fide CGIs - which have high CGI strength - to be 
distinguished from CpG rich regions devoid of bona fide CGI characteristics (Bock et 
al. 2007). The best indicator of CGI strength and most predictive of bona fide CGI is 
the "combined epigenetic score", which can assume one of three scores: 
• 0.67 - high confidence for at least two of the three high CGI strengths 
• 0.50 - equal chance of the CGI to be a bonafide island or a false positive 
• 0.33 - high confidence for at least one of the three high CGI strengths 
(Bock et al. 2007) 
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The CGI Prediction tool can be found under "Custom Annotation Tracks" on the 
UCSC Genome Browser website. 
2.2.1.5 SEARCH FOR TANDEM REPEATS WITHIN AND ADJACENT TO PREDICTED 
CpGISLANDS 
The presence of tandem repeats within or adjacent to the CGIs predicted using the 
CGI Prediction Tool would allow for the identification of CGIs that could serve as 
potential ICRs. 
The sequences of the CGIs, together with 1000 bp up- and downstream of the CGI 
regions, were used in the Tandem Repeat Finder (TRF) program (version 4.03) to 
identify tandem repeats. The reason behind using 1000 bp up- and downstream was 
that tandem repeats associated with ICRs are either found within or adjacent to the 
ICRs (Thorvaldsen, Duran & Bartolomei 1998, Okamura et al. 2000, Takada et al. 
2002). The repeats associated with Rasgrfl in mice are found within the ICR (Brideau 
et al. 2010). 
This program utilizes an algorithm to detect tandem repeats and does not require the 
need to specify the repeat pattern or repeat size. The repeats are modeled based on the 
percentage identity and frequency of indels between adjacent repeat copies in the 
sequence (Benson 1999). Default parameters were used for this study. The TRF 
program can be found at http://tandem.bu.edultrfitrf.html. 
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2.2.2 MOLECULAR ASSESSMENT 
All reagent and equipment suppliers are listed in Appendix C. 
2.2.2.1 STUDY PARTICIPANTS 
The methylation status of the putative DMRs was assessed using peripheral human 
blood (n = 10) and human sperm (n = 8) samples from unrelated participants, after 
obtaining written informed consent. The random blood DNA samples that were used 
in this study were collected over a number of years from members of the laboratory. 
The male volunteers were recruited through the Cryobank, a private andrology 
laboratory and sperm bank in Parktown, Johannesburg, South Africa. Detailed 
information regarding the collection of samples from the male volunteers is given in 
Chapter 3, section 3.2.2. Eight random sperm samples were selected and used for this 
part of the project. 
Ethics approval for sample collection was obtained from the University of the 
Witwatersrand, Committee for Research on Human Subjects - Medical (M050706 
and M090555; shown in Appendix A.l and A.2, respectively). 
2.2.2.2 DNA EXTRACTION 
Following routine semen analysis, samples collected were stored at -40°C upon arrival 
at the laboratory. Batches of samples were defrosted and DNA extracted using the 
QIAamp® DNA Micro Kit. The supplementary protocol "Purification of DNA from 
43 
CHAPTER 2 - IN SEARCH OF A PATERNALLY METHYLATED DMR FOR HUMAN RASGRF 1 
epithelial cells mixed with sperm cells" was used (full protocol shown in Appendix F). 
This protocol utilizes a differential extraction method (Gill, Jeffreys & Werrett 1985). 
On average 1 ml of sperm sample was added to a 1.5 ml microcentrifuge tube, 
containing buffer ATL and Proteinase K. This step allowed for the preferential lysis 
of epithelial cells by Proteinase K. These cells were removed from the cell mixture 
following four wash and centrifugation steps at 14000 rpm for 5 min. The remaining 
pellet containing sperm cells was subjected to Proteinase K and dithiothreitol (DTT) 
treatment. The latter is responsible for disrupting the sulfur bonds in the outer 
membrane of the sperm cell, releasing the DNA into solution. The sperm cell pellet 
together with the Proteinase K and DTT solution was incubated overnight, at 56°C, to 
ensure complete digestion of the sperm heads (Voorhees, Ferrance & Landers 2006). 
Following incubation, buffer AL and carrier RNA were added to all samples, with the 
latter enhancing binding of DNA to the QIAamp MinElute column membrane. The 
addition of carrier RNA is important especially when relatively few target molecules 
are present as is the case with sperm DNA. The buffer AL, carrier RNA and sperm 
cell DNA mixture was incubated at 70°C for 10 min, where after two wash and 
centrifugation steps at 14000 rpm for 1 min ensured the removal of all excess buffers 
and other solutions. 
Sperm DNA was eluted in 35 III of buffer AE and stored at -20°C. The DNA was 
quantified using the Nanodrop® ND-lOOO Spectrophotometer. DNA yields ranged 
from 13 ng/1l1 to 338 ng/Ill. The DNA concentration together with the purity of the 
samples is shown in Appendix F. 
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The diagnostic staff members in the laboratory were responsible for extracting DNA 
from the random blood samples. The salting out procedure was used (Miller, Dykes & 
Polesky 1988). The DNA samples were resuspended in TE buffer and stored at 4°C. 
DNA yields ranged from 100 ng/Ill to 398 ng/Ill. 
2.2.2.3 BISULFITE MODIFICA TlON 
Bisulfite modification is used to detect and quantify the level of DNA methylation at 
specific CpG sites within the genome. The principle of bisulfite modification lies in 
the fact that it is a selective chemical conversion method (Hayatsu, Wataya & 
Kazushige 1970). Treatment of DNA with bisulfite converts all unmethylated 
cytosines to uracil bases by a process of deamination, while all methylated cytosines 
(referred to as 5-methylcytosine) remain unchanged. During subsequent PCR 
reactions, uracil bases are complemented with adenosine bases, which are in tum used 
as a template for thymine complementation. Thus, the UpG dinucleotides are 
converted to TpG dinuc1eotides during peR. The methylated cytosines are resistant to 
bisulfite treatment and will therefore remain as cytosines following PCR (Figure 2.3). 
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Figure 2.3: Principle of bisulfite modification. All unmethylated cytosines (C) are first 
converted to uracil (U) and then to thymine (T) during PCR (top strand), while all methylated 
cytosines (Cm) remain as Cs (bottom strand). Obtained from (Hayatsu 2008) 
Following DNA extraction, 400 ng of DNA was subjected to bisulfite modification 
using the EZ DNA Methylation Gold™ Kit. The procedure was carried out according 
to the manufacturer's specifications (full protocol shown in Appendix G). 
2.2.2.4 PYROSEQUENCING TECHNOLOGY FOR QUANTITATIVE METHYLATION 
ANALYSIS 
Pyrosequencing is a quantitative real-time sequencing-by-synthesis technique that 
reqUires bisulfite modified single-stranded DNA templates to synthesize 
complementary strands. This method utilizes a cascade of enzymatic reactions that 
generates light in a quantitative manner, which is directly proportional to the number 
ofnucleotides incorporated into the complementary strand (Figure 2.4) (Ronaghi et al. 
1996). The light generated is sequentially displayed as peaks in a pyrogram. 
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Figure 2.4: The principle of pyrosequencing. This technique relies on the release of 
pyrophosphate (PPi) following the successful incorporation of a nucleotide, which is 
complementary to the nucleotide in the single-strand template. The PPi is used in a 
sulfurylase reaction, releasing ATP. A luciferase enzyme uses the released ATP to convert 
luciferin to oxyluciferin. This reaction produces a light signal proportional to the quantity of 
PPi released. The light is captured by a CCD camera and recorded as peaks in a pyrogram 
Obtained from (England, Pettersson 2005). 
This technique was initially developed for the analysis of single nucleotide 
polymorphism (SNP) variation. The resulting pyrogram would indicate the genotype 
of the sample - whether the sample is heterozygous or homozygous at the specific 
SNP position. 
It is only recently that pyrosequencing has been adapted to study DNA methylation. 
The technique requires PCR amplification of the target region, using bisulfite treated 
genomic DNA. During PCR amplification the cytosine nucleotide, if methylated, will 
remain cytosine (C) while the unmethylated cytosine will be converted to thymine 
(T). This in essence is reflected as a CIT SNP. However, the difference with DNA 
methylation is that unlike traditional SNP analysis, the C (methylated):T 
(unmethylated) ratio at a specific CpG may vary between samples. In this way, the 
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pyrophosphate released following the successful incorporation of the C and T alleles 
is quantified and expressed as a percentage on the pyrogram. 
Pyrosequencing is capable of analyzing all amplicons within a pooled PCR sample 
thereby accurately quantifying multiple CpG sites with high resolution and 
reproducibility. Furthermore, the pyrosequencing assays contain several internal 
controls for bisulfite treatment to evaluate the completion of the bisulfite conversion 
step thereby ensuring reliable data (England, Pettersson 2005). 
2.2.2.4.1 PSQ ASSAY DESIGN SOFTWARE 
Pyrosequencing assays were designed using the PSQ Assay Design software version 
1.0.6 (Biotage, Uppsala, Sweden). The sequences of interest were imported into the 
design software with the CG sites denoted by the rUPAC codes as YG (for the 
forward strand) and CR (for the reverse strand). With this information, the software 
automatically generates a series of suitable primer sets for PCR and pyrosequencing. 
For each CGr predicted using the CGr Prediction tool, three primers were designed, a 
forward, reverse and a sequencing primer. To reduce the cost per assay, a biotin-
labeled universal primer was used to generate labeled PCR products (Colella et al. 
2003). A 23 bp complementary tag (5' - GACGGGACACCGCTGATCGTTTA - 3') 
off which the universal primer will prime was added to the 5' end of the primer 
designated to be biotin-labeled (Biotin; Table 2.1). 
Since this study focused on assessing the methylation status of loci in sperm samples, 
it was imperative to control for potential contamination with somatic cell DNA. 
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Therefore a DMR associated with SNRPN, a small nuclear ribonucleoprotein 
polypeptide N gene, was used as a control for somatic cell contamination in the sperm 
samples. This DMR is located 5'ofthe gene and is found to be completely methylated 
in oocytes, completely unmethylated in human sperm and shows an average of 53% 
methylation in embryos suggesting the imprints that were established during 
gametogenesis are stably maintained throughout development (Geuns et al. 2003). 
Therefore in this study, if the DMR is found to be methylated in the sperm samples 
this would indicate somatic cell contamination while an absence of methylation would 
indicate a lack of somatic cell contamination. 
2.2.2.4.2 peR AMPLIFICATION FOR PYROSEQUENCING REACTIONS 
Amplicons, for all the CGI loci and the SNRPN locus, were generated in a 50 JlI 
reaction containing 2 JlI of bisulfite-treated DNA, 0.2 JlM each of the forward and 
reverse PCR primers (see list of primers Table 2.1) and 0.02 JlM of the universal 
primer, 0.125 mM deoxynuc1eoside triphosphates (Bioline, London, United 
Kingdom), 2.0 mM MgCh, 1 x Buffer (Applied Biosystems, NJ, United States), 1 M 
Betaine (Sigma-Aldrich, Seelze, Germany) and 1 U of AmpliTaq Gold (Applied 
Biosystems, NJ, United States). 
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Table 2.1: peR primers for pyrosequencing PCR reactions 
Locus Primer Sequence (5' - 3') tAmplicon Annealing 
Length Temperature 
CGI1973a 
Forward GTGCGGAAAGATGGTGTTTT 269bp 60°C 
Reverse (Biotin) 'CTCTCATTCGCCTACACAATTAC 
CGI1973b 
Forward GAGGGAGGGTAGGGTTTGAGTG 292 bp 63°C 
Reverse (Biotin) *AACCCCAATACCCGAAAAATAC 
CGI1974 
Forward GGTTTGTTTGGGTTTAGTAGAGAA 235 bp 60°C 
Reverse (Biotin) *ACAACCTACCTTCAAAATCATCTC 
CGI1975a 
Forward AGGAGAGAAGATGGAATTTGATT 186 bp 59°C 
Reverse (Biotin) *AATTTCCCCACACTCCTAAAATAA 
CGI1975b 
Forward (Biotin) *TTAGGAGTGTGGGGAAATTATTG 110 bp 59°C 
Reverse TCTCTCCCTTCAAAACACAAAAT 
§SNRPN 
Forward AGGGAGTTGGGATTTTTGTATT 261 bp 58°C 
Reverse (Biotin) 'CCCCAAACTATCTCTTAAAAAAAAC 
t Amplicon length includes the 23 bp complementary tag sequence 
* A 23 bp complementary tag (5'- GACGGGACACCGCTGATCGTTTA - 3 ') was added to 
the 5' end of all biotin-labelled primers (Colella et al. 2003) 
§ Published primer set (White et al. 2006) 
The PCR for each CGI locus was performed in a GeneAmp® 2720 thermal cycler 
(Applied Biosystems, NJ, United States) with the following conditions for all 
reactions; 95°C for 5 min, followed by 50 cycles of 95°C for 15 sec, TaoC for 30 sec 
(see Table 2.1 for TaOC), and 72°C for 15 sec; with a fmal extension step of72 °c for 
5 min; and a final hold at 15°C. The PCR amplifications for each sperm sample and 
each blood sample were performed in duplicate and triplicate, respectively. 
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The PCR for the SNRPN locus was perfonned in a GeneAmp® 2720 thennal cycler 
(Applied Biosystems, NJ, United States) with the following conditions for all 
reactions; 94°C for 7 min, followed by 50 cycles of 94°C for 30 sec, 58°C for 30 sec, 
and 72°C for 30 sec; with a final extension step of 72°C for 7 min; and a final hold at 
15°C. The PCR amplifications for each spenn sample were done in triplicate. 
Standard electrophoretic techniques were used to resolve the PCR amplified products. 
A 3% (w/v) agarose gel containing 1 mg/L ethidium bromide was used to visualize 
the amplified products at 6 V/cm in 1 x TBE buffer. A 50 bp DNA molecular size 
marker was used as a size standard. 
2.2.2.4.3 PYROSEQUENCING REACTIONS AND DATA ANALYSIS 
A mix consisting of 6 III of Streptavidin Sepharose ™ HP and 40 III of binding buffer 
was added to each well of a 96-well PCR plate containing bisulfite modified PCR 
products (45 Ill). The plate was left on a shaker for 10 min at 300 rpm. This was done 
to facilitate binding of the PCR products to the sepharose beads via the biotin-labeled 
universal primer. The vacuum prep tool was used to capture the sepharose beads 
containing the PCR products. In order to prepare single-stranded PCR products, the 
vacuum prep tool was placed in four different troughs containing 70% ethanol, 
denaturation solution, washing buffer and ddH20 for 60 sec each. The sepharose beads 
with the single-stranded PCR products were released into a PSQ 96 Plate LOW™ 
containing a mix of 45 III annealing buffer and 1.6 III of a 10 11M corresponding 
sequencing primer (Table 2.2). The PSQ 96 Plate LOW™ was heated to 80°C for 3 
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mIll to facilitate binding of the sequencing pnmer to the single-stranded PCR 
products. 
A reagent cartridge was prepared with the required amounts of enzyme, substrate and 
dNTPs using the PyroMark® Gold Q96 Kit (Qiagen, Valencia, CA, United States). 
The PSQ 96 Plate LOW™ was placed into the PSQ 96MA instrument along with the 
cartridge, prior to starting the run. Pyrosequencing data was analysed using the Pyro 
Q-CpG Software (Biotage, Uppsala, Sweden). The full pyrosequencing protocol is 
shown Appendix H. 
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Table 2.2: Primers for pyrosequencing assays 
Locus Sequencing Primer Sequence 
(5' - 3') 
CGI1973a F:GGTGTTTTTTTTTTATAGGG 
CGI1973b F:GGAGGTATTAAGTTGTA 
CGI1974a F:GATTAGTTTTTTATAGTGTT 
CGI1974b F:GTGGGTGTATGGGAAG 
CGI1975a F: AGAGTTTTTTTTGAAGGTAG 
CGI1975b R:CCCTTCAAAACACAAAAT 
SNRPN F:GTAGAGGTAGGTTGG 
Number of 
CpG Sites 
Analyzed 
-13 
8 
3 
4 
4 
3 
4 
§Sequence to Analyze 
TTGYGYGGGTATTTATTTTYGTTGTAAAGYGTTYGGGTTAGGYGYGGTTTGTTTYGG 
GTYGGGGYGAGTTYGTTGTTTTTTGYGGTAGATAGYGATG 
GTTTGYGYGYGGTTTTGYGTTTYGGYGGGGTTGYGTGYGTGTGTTTTTGTT 
YGGTTTTGTAGTTTGAAGGTTTGAGAATATYGGYGGGGAGTGGGTG 
GAYGATGGTTTTAYGGTTTTGTYGTTAAYGGTGGTTTTTAGAGATAATGTG 
YGAGAGGGGYGTTTAYGTGGTYGATTTATAGAGTT 
TCRCATAAAACRTAAAACTAAACCCTCCCCRTATTTTTAAA 
YGYGTATGTTTAGGYGGGGATGTGTGYGAAG 
~The sequence to analyze is immediately 3' to the sequencing primer binding site on the biotinylated strand 
The positions of the CpG sites analyzed are shown by their IUPAC codes in bold font. 
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2.3 RESULTS 
2.3.1 COMPUTATIONAL ASSESSMENT 
2.3.1.1 SEARCHING FOR SEQUENCE SIMILARITY 
The BLAST algorithm was used to identify regions in the human genome that had 
sequence similarity to the mouse DMR and the 40 copies of the 41 bp repeat element. 
No sequence similarity was identified. 
2.3.1.2 IDENTIFICATION OF CTCF BINDING SITES 
REN _20, MIT _ LM2, MIT _ LM7 and MIT _ LM23 are PWM motif sequences that 
correspond to CTCF binding sites (Kim T.H. et al. 2007, Xie et al. 2007). The in 
silica CTCFBS prediction tool used these four motifs to search for putative CTCF 
binding sites in a region spanning 249 841 bp (Ensembl co-ordinates chr15: 
79252289-79502130 [release 61, GRCh37.p2]). This region included RASGRFJ and 
118 915 bp upstream of the gene to the first base of MIR-184. Four putative CTCF 
binding sites were identified each with a PWN score greater than 3.0 (Table 2.3). A 
score greater than 3.0 indicates that the putative CTCF binding site matches more 
closely to the PWM motif compared with the random background sequence (Pan, 
Phan 2008). 
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Table 2.3: In sitico predicted CTCF binding site motif sequences within RASGRFI and 
between RASGRFI and MIR-184 
MotifPWN* Putative CTCF Binding Site Motif Start Motif Motif 
Sequence Location§ Length Orientation 
REN 20 TGAGCCACCAGAGGGCGGAG 182100 20 + 
MIT LM2 ATGCCACCAGGTGGCAGTT 1433 19 + 
MIT LM7 TAAGCACCAGAGGGCGCTGT 205840 20 + 
MIT LM23 TCACCACCAGGTGGCGCTTG 25632 20 + 
• The in silico CTCFBS prediction tool used four PWM motifs to search for putative CTCF 
binding sites between RASGRFI and MlR-184. 
§ The motif start location is based on the 249 841 bp (Ensembl co-ordinates chrl5: 79252289-
79502130 [release 61, GRCh37.p2]) query sequence and gives the exact location of the 
putative CTCF binding site within this sequence. In this table the motif start location uses 
Ensembl co-ordinate 79502130 as point 0 and all motif start locations are relative to this 
point. 
The putative CTCF binding site sequences corresponding to REN _20 and MIT _ LM7 
were found within RASGRF 1. MIT LM2 and MIT LM23 were both found in the 
- -
intergenic region between MIR-184 and RASGRF1. 
2.3.1.3 IDENTIFICATION OF EVOLUTIONARY CONSERVED REGIONS AMONG 
VARIOUS SPECIES 
The mouse genome was selected as the base genome and the intergenic regIOn 
(indicated by the red peaks) between Rasgrf1 and the Mir-184, within which the 
mouse DMR lies, was visualised for conservation-profiles. The mouse genome was 
compared to eight vertebrate species including Homo sapiens (humans), Pan 
troglodytes (chimp), Macaca mulatta (rhesus macaque), Xenopus tropicalis (frog), 
Gallus gallus (chicken), Fugu rubripes (pufferfish) and the Monodelphis domestica 
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(opossum). A number of conserved intergenic regions were identified (Figure 2.5). 
The mouse DMR co-ordinates (chr9: 89774524-89774827) from UCSC were used to 
search for conservation between species in the ECR browser. This DMR was not 
conserved in any of the eight vertebrate species. 
ECR Browser on Mouse (rnm9) htto:fJecrbrQWSer depUe org 
ECR ECR Layer Coorolnate 
gene Of position (ChlN.flom-to) 
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Figure 2.5: Conservation profiles of various vertebrate species between the Rasgrfl and 
Mir-184 loci, using the mouse genome as the base genome. In order to identify regions of 
conservation the genomes of eight vertebrate species were compared relative to the mouse 
genome. The red peak represents intergenic regions while the pink bars above the peak 
indicate conservation. The height of the peak indicates degree of conservation. The blue 
bubble to the right of AK015891 represents the MIR-184 in the human genome. The figure 
was generated using http://ecrbrowser.dcode.org/. PanTro2 (Pan troglodytes) , hg18 (Homo 
sapiens), rheMac2 (Macaca mulatta), canFam2 (Canis familiaris) , monDom4 (Monodelphis 
domestica), fr2 (Fugu rubripes), galGa13 (Gallus gallus), xenTro2 (Xenopus tropicalis). 
The human genome (hg18) was then used as a base genome and the region between 
RASGRF 1 and .MlR -184 was assessed to identify evolutionary conserved intergenic 
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regions. The intergenic region at the promoter of RASGRF 1 was conserved in five of 
eight species while the first coding exon (indicated by the blue peak) was conserved 
in all eight vertebrate species. The MIR-184 was conserved in five of the eight species 
(Figure 2.6). 
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ECR ECR Layer Coordinat. 
"" ... ""810: Graph length similarity height system 
~ smooth 100 70 55 relative 
( ( ( ( ( E ( ( (( ( tiE ( ( E E E ( :, RASGRF1 Ref Seq Genes 
gene or position (chrN·1rom-to) 
/Chr15:77146293-7731 1745 JEI!ID 
GENOME ALIGNMENT; Align your sequence to a genome 
\00'. 
20TI)2 
____________ L-____ ~ ________ ~ __ ~~~ ____________ ~ __________ ~~ __________________ ~~ •• 
t2 
______ ~ ____ L-____ ~ ________ ~ __ ~~~ ____________ ~ __________ ~ ____________________ ~OO·. 
100'. 
~ __________ ~ ____ ~ ________ ~ __ ~~~ ________________________ ~ ________ ~~ ________ ~oo·. 
( ( E ( ( " ( ( ( ( ( ( ( E ( ( E ( ( (Il ENSTOOOOO2617S2 
(( «( fE! (( ( ({ (( (( (( (I RA.SGRF1 
ucsc Kno¥tn Gal_ 
RefSeq Genes 
IENSTOOOOO362185 
I ENsmooOO~2850 
Figure 2.6: Conservation profiles of various vertebrate species between the RASGRFI 
and MIR-184 loci, using the human genome as the base genome. In order to identify 
regions of conservation the genomes of eight vertebrate species were compared relative to the 
human genome. The red peaks represent intergenic regions while the pink bars above the 
peaks indicate conservation. The height of the peak indicates degree of conservation. The 
blue bubble to the right represents the Mir-184 in the mouse genome. The figure was 
generated using http://ecrbrowser.dcode.org/. PanTro2 (Pan troglodytes), hg18 (Homo 
sapiens), rheMac2 (Macaca mulatta), canFam2 (Canis jamiliaris), monDom4 (Monodelphis 
domestica), fr2 (Fugu rubripes), galGa13 (Gallus gallus), xenTro2 (Xenopus tropicalis). 
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2.3.1.4 SEARCHING FOR CpG ISLANDS AS POTENTIAL SITES FOR DIFFERENTIAL 
METHYLATION 
All the CGI tracks were viewed simultaneously on UCSC's CGI prediction tool. The 
panel containing the combined epigenetic scores was used to select the appropriate 
CGI. The reason behind choosing this specific score is that it provides a precise 
estimate of CGI strength. The CGI strength indicates the CGI's inherent tendency to 
exhibit an open and transcriptionally competent chromatin structure (Bock et al. 
2007). Three CGIs were identified between the human RASGRFJ and MlR-184: 
CGI_1973 (chrI5: 77168729-77171326) at the promoter of RASGRFJ; CGI_1974 
(chrI5: 77258299-77258552) and CGI 1975 (chrI5: 77269392-77269597) 
[NCBI36/hgI8]. 
2.3.1.5 IDENTIFICATION OF TANDEM REPEATS WITHIN OR ADJACENT TO CpG 
ISLANDS 
The TRF program only detects repeats which occur in a head-to-tail manner (Hutter, 
Helms & Paulsen 2006). Only one out of the three CGIs identified, using the CGI 
Prediction tool, had direct tandem repeats associated with it. There were a total of 
eight repeat elements found within and directly adjacent to CGC 1973 (Table 2.4). 
However, the TRF program identifies overlapping repeat elements therefore two 
elements were regarded as one if the smaller one overlapped with the larger one. The 
smaller repeat motif was chosen as a consensus sequence (Hutter, Helms & Paulsen 
2006). 
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Table 2.4: Tandem repeats detected within and adjacent to CGI_1973 
Indices* 
2608--2638 
13537--4321 ',{,' 
3537--4315 
3537--4329 
" 
3537--4329 
3537--4321 
4356--4433 
Period 
Size 
12 
7 
9 
"14 
'" 
'Y' 16 
2 
2 
Copy 
Number 
2.6 
110.4 
86.9 
56.4 
49.4 
424.5 
39.5 
Percent Percent Consensus Sequence 
Matches Indels 
89 o CACACACACACG 
71 20 ACACACC 
72 20 ACACACACC 
, 69 17 ACACACACCACACA 
" 
q49 17 ACAC~CACACCACACA " 
" 
" 
71 17 AC 
74 12 CA 
,!Ii , :11, 
4356--4406 23 2.3 86 3 CACACAACACACGCAGCACACCA 
* Indices represent the position of the beginning of the repeat relative to the detected pattern. 
All rows highlighted in grey indicate overlapping repeat elements with the smallest repeat AC 
overlapping with all the other repeats detected. Rows highlighted in pink represent 
overlapping repeat elements, which can be represented by one repeat element with consensus 
sequence CA. 
2.3.1 MOLECULAR ASSESSMENT OF THE PUTATIVE CpG ISLANDS WHICH 
COULD SERVE AS SITES OF DIFFERENTIAL METHYLATION 
Bisulfite-treated PCR products for each of the three CGIs and SNRPN (used as a 
control for somatic cell contamination) were quantitatively assayed using 
pyrosequencing technology. Pyrosequencing was perfonned on PCR products from 
spenn (in duplicate on n=8) and blood (in triplicate on n= 10) DNA samples, 
respectively. The average methylation percentage for each CpG site was calculated by 
averaging the duplicate and triplicate values for each CpG site per spenn and blood 
sample, respectively (shown in Appendix 1- RASGRFJ and SNRPN Data). The C 
(methylated) and the T (unmethylated) alleles were quantified and subsequently 
expressed as a percentage. When examining the duplicate data set for each spenn 
sample and the triplicate data set for each blood sample, a greater than 6% 
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methylation difference per CpG site was used as a cut-off value for unsuccessful 
replication. As a result, certain replicates on the sperm and blood samples were 
excluded due to more than one of the CpG site differing by more than 6% when 
comparing across the duplicate and triplicate data sets, respectively. It should be 
noted that the triplicate data set obtained for each blood sample was not as 
reproducible as the duplicate data set obtained for each sperm sample. Technical 
variation could be one possible reason for the degree of variability observed within 
the triplicate data sets. The blood samples were done first before much experience 
was built up. In addition, blood samples contain double the chromosome complement 
of sperm samples. This could add to the variability observed within triplicate data 
sets. 
Figure 2.7 illustrates the methylation percentages in each tissue type for each region 
evaluated. 
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Figure 2.7: A schematic representation of RASGRFI and MIR-184 and the positions of the putative CpG islands relative to the two genes. 
The box and whisker plots above (a - f) represent the methylation percentages based on the average of the duplicate and triplicate results obtained 
for individual CpG sites for the sperm (n=8) and blood (n=10) samples, respectively. 
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Due to the size of CGI_1973, found at the promoter of RASGRF1, a smaller region 
found to be rich in CG dinucleotides within this CGI was selected for further analysis. 
This smaller region was then split into two sub-regions CGC1973a and CGI_1973b 
(bordering exonl of RASGRF1) and each was assayed separately. CGC1974 and 
1975 were difficult regions not easily amenable to pyrosequencing and therefore 
CGI_1974 was covered using two sequencing primers while CGI_1975 was amplified 
in two separate PCR reactions using two sets of PCR primers. It should be noted that 
the data from sub-region CGI_1973a and CGI_1973b were analyzed collectively as 
one region. This also applies to the data obtained from sub-region CGI_1974a and 
CGI 1974b and CGI 1975a and CGI 1975b. 
- - -
The entire CGI_1973 region was 2598 bp in length with a G+C content of 64%. 
However, only a region spanning 515 bp with a G+C content of 70% was 
investigated. CpG sites 1 to 13 were found to be hypomethylated in blood and sperm 
DNA. The methylation percentages for blood samples were very variable and 
displayed considerable inter-site and inter-individual variation at CpG sites 14 to 21 
(Figure 2.7a). It should be kept in mind that these CpG sites border exonl of the 
RASGRF 1 gene. In comparison the methylation percentages of the sperm samples 
showed relative hypomethylation of this region with little or no inter-site and inter-
individual variation (Figure 2.7b). 
CGI_1974 was 212 bp in length with a G+C content of 56%. The methylation 
percentages of the blood and sperm samples showed relative hypermethylation 
(Figure 2.7c and 2.7d). 
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The CGI 1975 region was 231 bp in length with a G+C content of 51%. The 
methylation percentages of the blood and sperm samples showed relative 
hypermethylation. The blood samples showed a methylation percentage of between 
50% and 60% at CpG site 4 and the two sites (CpG 3 and 5) on either side displayed a 
methylation level of between 70% and 90% (Figure 2.7e). The methylation 
percentages of the sperm samples at these sites ranged between 90 and 100% except 
for site 5 where the methylation percentage was between 70% and 90% (Figure 2.7f). 
The methylation status of the SNRPN DMR (found to be hypermethylated on the 
maternal allele) was assessed to detect the presence of somatic cell DNA 
contamination in sperm samples. Only 22 (19.5%) of the 113 sperm samples collected 
were used for the somatic cell contamination assessment. The mean methylation of 
this DMR was found to be 2.43% with a standard deviation of 1.35. The theoretical 
methylation value for DMRs in somatic tissue is 50% (Cooper, Constancia 2010). 
However studies have shown that somatic DMRs display methylation levels between 
35% and 65% (Woodfine, Huddleston & Murrell 2011). Therefore the low level of 
methylation at the SNRPN DMR within the sperm samples may suggest that the 
paternal allele may not be completely devoid of methylation but rather displays basal 
levels of methylation or that there could have been low levels of contamination with 
somatic cells. However, it was concluded that the samples were not significantly 
contaminated with somatic cells. 
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2.4 DISCUSSION 
The primary aim of this part of the study was to determine whether the human 
RASGRF 1 gene has a DMR that is paternally methylated. Methylation analysis of 
three putative DMRs in the vicinity of this gene in sperm and blood samples indicate 
that RASGRFl-associated CpG rich regions do not exhibit differential methylation in 
a parent-of-origin manner, as is seen in its mouse counter-part. 
The results presented in this study demonstrate that the human genome does not 
contain any homologous sequences to the mouse DMR and to the 40 copies of the 41 
nucleotide repeat element. Two of the most common features of any imprinted region 
are the presence of a DMR and adjacent to this, tandem repeats. It is often expected 
that DMRs among various mammalian species have a conserved DNA sequence 
because of their key regulatory function in imprinted regions. However this is not 
universally true. Instead, the presence of tandem repeats is a common feature of 
functionally orthologous DMRs (Hutter et al. 2010). There are only a handful of 
repeats that are highly conserved between the mouse and human. In all other cases, 
the number of repeat elements and their arrangement within the DMRs tend to be 
highly variable (Paulsen et al. 2005). 
The mouse Rasgrfl and the human ortholog RASGRF 1 display both organisational 
similarities and differences. The mouse gene contains 26 exons while the human gene 
possesses two extra exons. The sizes of exons and intron-exon junction sequences are 
highly conserved. The 5' sequence upstream of exon 1 is not only highly conserved 
between the mouse and the human but is also highly conserved in other vertebrates. 
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This is consistent with the presence of important regulatory elements in this region 
(de la Puente et al. 2002). However it should be noted that organizational similarity in 
the genomes of species does not necessarily relate to the conservation of imprinting 
between species (Okamura et al. 2000). As an example, the mouse and human IGF2R 
genes share conserved intronic CpG islands with large direct repeats that are 
maternally expressed in the mouse but are biallelically expressed in humans (Kim 
K.P. et al. 2007). 
The CTCF binding protein is a ubiquitously expressed 11 zinc finger protein that 
plays a key role in chromatin insulation and is the only protein known to exhibit 
enhancer-blocking activity (Bao, Zhou & Cui 2008, Williams, Flavell 2008). In this 
study two of the four putative CTCF binding sites corresponding to MIT _ LM2 and 
MIT_LM2 were located in the intergenic region between MlR-184 and RASGRF1. 
The position of these binding sites is consistent with a potential role of CTCF as an 
insulator protein (Kim T.H. et al. 2007). The other two putative binding sites 
corresponding to REN_ 20 and MIT _LM7 were found within RASGRF 1. It is known 
that almost half of the CTCF binding sites within the human genome are located 
within genes and many of these segregate alternative promoters of a single gene (Kim 
T.H. et al. 2007). The protocadherin gamma locus, the T-cell receptor locus and the 
immunoglobulin heavy chain locus all have intragenic CTCF binding sites that 
segregate transcriptional start sites that display differential activities across tissues 
(Kim T.H. et al. 2007). RASGRF1 is known to have four transcripts and therefore the 
identification of two putative CTCF binding sites within this gene may have a role in 
segregating the transcriptional start sites based on their activities across various 
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tissues. Functional studies would need to be done to determine whether these putative 
CTCF binding sites actually bind the CTCF protein. 
In some instances CTCF binding sites are found within DMRs. An example of such a 
CTCF binding site is that which is present at the mouse Rasgrfl DMR (Y oon et al. 
2005). Another example is the CTCF binding site present at the H19//gf2 ICR, which 
serves as a primary DMR established in the germ-line (Szabo et al. 2004). The 
hypomethylated maternal ICR serves as a binding site for the CTCF protein. Once the 
protein binds to this region it acts as an insulator preventing the interactions of the 
enhancers with the promoter of Igf2 (Szabo et al. 2004). In this study the putative 
CTCF binding sites were not found to occur in the predicted CpG islands. This 
suggests that RASGRF 1, if imprinted, would be unlikely to be regulated by a CTCF 
binding protein as is its mouse ortholog. However, if RASGRF 1 is imprinted in 
humans there are other factors, besides the CTCF binding protein, which could 
mediate imprinting. These factors could be cis- or trans-acting and could contain 
multiple elements that work in synergy to establish and maintain the imprint status 
(Ogawa et al. 2006). 
The mouse and human genomes display conserved synteny of Rasgrfl and Mir-184. 
In mice the Rasgrfl DMR is found in the intergenic region. The ECR browser results 
demonstrate that the majority of the intergenic regions are conserved in the Pan 
troglodytes, Macaca mulatta, Canis familiaris, Mus musculus and Monodelphis 
domestica. The conservation of these regions across multiple vertebrate species 
suggests that one or more of these regions could contain possible cis-regulatory 
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elements such as enhancers or repressors crucial for gene regulation (Visel, Bristow & 
Pennacchio 2007, Nakagawa et al. 2008). 
The majority of the CGIs in the mouse and human genomes are hypomethylated and a 
small proportion of the hypermethylated CGIs are located at imprinted loci in the 
germ-line (Henckel, Arnaud 2010). The hypermethylated CGIs of potential imprinted 
loci are expected to display monoallelic methylation (50% methylation) in somatic 
tissues (Strichman-Almashanu et al. 2002). For a region to be regarded as a DMR, it 
is proposed that the following criteria need to be fulfilled: the sequence should be rich 
in CpG dinucleotides with an average G+C content of 54% (Kobayashi et al. 2006) or 
above and display methylation levels between 35% and 65% in somatic tissue 
(Woodfine, Huddleston & Murrell 2011) over four consecutive CpG sites (Kobayashi 
et al. 2006). 
CGI_1973, a putative CGI identified using the CGI Prediction tool, is located in the 
5' sequence upstream of exon 1, a region that harbors the promoter sequence for 
RASGRF 1 and has been found to share high homology with the mouse sequence (de 
la Puente et al. 2002). The methylation assessment of this region in blood samples 
displayed a deviation from the expected 50% methylation for imprinted loci in 
somatic tissue, indicating that the selected CGI is not differentially methylated. This 
is due to the fact that CGIs associated with promoters of tissue-specific genes are 
generally unmethylated in both expressing and non-expressing tissues although 
exceptions are being identified (Bird 2002, Song et al. 2005, Weber et al. 2007). It is 
however interesting to note that part of this CGI (CpG sites 14 to 21) displays great 
inter-individual and inter-site variation in blood samples only. The difference in 
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methylation patterns between individuals in peripheral blood samples is unlikely to be 
attributed to technical errors. To test the reproducibility of the PCR and 
pyrosequencing results, we performed each PCR and pyrosequencing reaction in 
duplicate for sperm samples and in triplicate for blood samples. The similar 
methylation profiles observed between individuals in the sperm samples, for this 
region and other regions, demonstrates that our techniques were reproducible. The 
possible reason behind the high inter-individual variation observed in peripheral 
blood could be that CpG sites 14 to 21 in this specific region are not tightly regulated, 
making this region more responsive to the effects of various environmental factors 
including carcinogen exposures, inflammation, stress and diet which all have the 
ability to alter DNA methylation patterns (lirtle, Skinner 2007, Christensen et al. 
2009, Murgatroyd et al. 2009). 
The other two putative CGIs identified in this study, CGI_1974 and CGC1975, lie in 
the intergenic region between RASGRFI and the MlR-184. Both sample types were 
found to be hypermethylated in these regions and showed a lack of inter-individual 
variation. This suggests that this region is under tight regulation and may harbor 
transposable elements that are normally hypermethylated in the genome (Geiman, 
Robertson 2002, Slotkin, Martienssen 2007). The methylation profiles of the sperm 
samples for regions CGI_1974 and CGI_1975 displayed tight methylation patterns. 
These results are contrary to that found by Flanagan et al. (2006) who demonstrated 
the presence of significant inter-individual DNA methylation variation in human male 
germ cells. However, studies in mice and other organisms have shown that certain 
loci display partial epigenetic stability during meiosis, which may be a possible 
explanation for the results obtained in this study (Flanagan et al. 2006). In somatic 
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tissues DMRs are expected to exhibit 50% average methylation over several 
consecutive CpG sites (Cooper, Constancia 2010). However the paternal allele, as 
shown by the sperm samples, is found to be almost completely hypermethylated over 
seven CpG sites of the CGI_1975 region, with a methylation level between 90% and 
100%, suggesting a possible paternal parent-of-origin effect. In the blood samples 
only one CpG site, CpG 4, displayed a methylation percentage between 50% and 
60%. The surrounding CpG sites had significantly higher methylation, indicating that 
this is not a DMR for RASGRFJ. 
Tandem repeats are found to occur frequently within the human genome, however 
they tend to occur more frequently within or adjacent to CpG islands associated with 
imprinted genes (Hutter, Helms & Paulsen 2006). The tandem repeats identified using 
the TRF tool were found to be associated with only one of the CGIs identified, 
CGC1973. This CGI is located at the promoter region of RASGRFJ and was found to 
be hypomethylated both in the peripheral blood and in the sperm samples. Owing to 
the fact that the CGI_1973 was unmethylated in both tissue types, it can be deduced 
that the tandem repeats associated with this promoter CGI is not involved in 
establishing methylation at this locus but rather plays a role in regulating gene 
expression by binding transcription factors and influencing splicing efficiency, RNA 
stability and RNA-to-protein interactions (Martin et aL 2005, Shah, Hile & Eckert 
2010). The presence of repeats but the absence of differential methylation at 
CGI_1973 in peripheral blood suggests that this CGI does not serve as a DMR for 
RASGRFJ. 
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2.5 LIMITATIONS OF THE STUDY 
One of the limitations of this part of the study is that no expression data was available 
to confirm the imprint status of RASGRF 1. Rasgrf1 is expressed in the neonatal brain 
and liver, in mice. Therefore, in order to assess allele-specific expression in humans 
large numbers of neonatal human brain and liver samples would be needed to identify 
an individual heterozygous for a SNP in the coding region of the gene. This sample 
would then be subjected to allele-specific real-time peR to quantitate the amount of 
paternally and maternally derived RASGRF1 RNA present in the brain and liver. This 
would indicate the imprint status of this gene in both tissue types. Ethics approval and 
sample collection would be required and due to the sensitive ethical issues this was 
not done. 
Tissues are composed of multiple cell types, with each cell type displaying a unique 
epigenetic signature (Morgan et al. 2005). The use of peripheral blood in this study 
was not ideal as blood is made up of various cells types, including monocytes, 
basophils and lymphocytes. As a result, DNA from peripheral blood constitutes a 
mixture of epigenomes from a diversity of cells. Therefore, differences between 
individuals in terms of blood cell populations may itself contribute to or mask 
epigenetic differences. 
In this study DNA methylation of the putative DMRs was only analyzed using sperm 
and peripheral blood samples. The methylation profiles of the DMRs in various other 
tissues including ovarian teratomas, brain tissue and liver tissue would be useful in 
the event that RASGRF 1 displays tissue-specific differential methylation. 
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2.6 CONCLUSION 
The CGIs evaluated in this study did not fit the criteria of being a DMR. The human 
RASGRF I-associated CpG rich regions do not exhibit differential methylation in a 
parent-of-origin manner. However, gene expression studies would need to be 
performed to confirm the imprint status of this gene. Due to the absence ofa DMR for 
RASGRFI, no further work relating to alcohol exposure was carried out on the 
methylation status at this locus. 
71 
CHAPTER 3 
THE EFFECT OF ALCOHOL 
CONSUMPTION ON IG-DMR IN MALE 
GAMETES 
72 
CHAPTER 3 - THE EFFECT OF ALCOHOL CONSUMPTION ON IG-DMR IN MALE GAMETES 
3.1 INTRODUCTION 
3.1.1 THE ROLE OF THE SPERM EPIGENOME IN OFFSPRING DEVELOPMENT 
There are two critical periods during the spennatogenic process where vanous 
environmental and lifestyle factors can have a direct or indirect impact on the male 
gametes (Figure 3.1). 
¥ L-1 ____ I_ife_S_Iy_le_/e_n_vi_ro_n_me_nta_l_e_tr._ec_I ___ --'1 ~ 
7 
likely 10 be irreversible 
24 37 
weeks of gestation 
foetal period 
risc' 
neonatal 
period 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I testlculat and reproductive 
I IllICt • uiescence' 
infancy/childhood 
(7.ero 10 six months) 
birth 
puberty 
testosterone 
adulthood 
Figure 3.1: A schematic representation of two critical time points at which 
environmental factors can have a negative impact on spermatogenesis. Obtained from 
(Sharpe 2010). 
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The first critical period is during gonadal sex determination when the foundations for 
spermatogenesis are laid down and primordial germ cell development occurs. During 
this period a wave of demethylation is responsible for erasing the imprint marks and 
re-establishing methylation patterns. This occurs both globally and at imprinted loci 
where the methylation of the imprints occur in a sex-dependant manner (as reviewed 
in Murphy, lirtle 2003). This germ-line epigenetic reprogramming is not only 
important for resetting of parental imprints for the next generation but also in 
preventing epimutations from being passed onto the next generation (Godmann, 
Lambrot & Kimmins 2009). 
A classic study carried out by Anway et al. (2005) looked at the effect of exposing a 
gestating rat to vinclozolin, an endocrine disruptor, during the fetal gonadal sex 
determination stage. This resulted not only in the F 1 male offspring having an 
increase in spermatogenic cell apoptosis and a decrease in sperm number and motility 
but this indirect exposure also had a negative impact on the health of these offspring 
in later life. The negative effects were a result of altered DNA methylation of the 
male germ line that occurred due to maternal vinclozolin exposure and did not only 
affect the Fl male generation but all males in many subsequent generations (F2-F4) as 
well (Anway et al. 2005). Another more recent study done in mice focused on the 
effect of prenatal alcohol exposure on DNA methylation levels of five imprinted 
genes in male offspring. The F 1 male offspring displayed hypomethylation of the 
normally hypermethylated H19-ICR in sperm only. These males were then mated to 
normal females and the resulting offspring (F2) displayed considerable 
hypomethylation of H19-ICR in whole brain regions. This study demonstrated that 
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the altered H19-ICR in the sperm of the F1 males might have been passed onto the F2 
generation (Stouder, Somm & Paoloni-Giacobino 2011). 
The second period during which environmental and lifestyle factors can impact on 
spermatogenesis extends from the onset of puberty through to adulthood. It is during 
this period that the spermatogenic process is directly vulnerable to the adverse effects 
of toxic agents associated with the general environment and lifestyle of the individual 
(Sharpe 2010). 
In 2005, Barton et al. carried out a study looking at the effect of chronic paternal 
exposure of a widely used anticancer agent, cyclophosphamide, on rat offspring 
development. Chronic exposure of male sperm to cyclophosphamide did not affect the 
viability of the sperm but affected the epigenetic reprogramming of the zygotes. This 
led to disrupted embryonic development and resulted in an increase in neurological 
deficits and malformations (Auroux et al. 1990, Hales, Crosman & Robaire 1992, 
Barton, Robaire & Hales 2005). These abnormalities were found to be transmitted to 
subsequent generations (Auroux et al. 1990, Hales, Crosman & Robaire 1992). A 
similar study focused on the consequences of long-term paternal cocaine exposure in 
mice. Male mice were trained to self-administer cocaine in multi-hour inhalation 
sessions prior to coitus. Following mating with females not exposed to cocaine, the 
offspring were found to have impaired visuo-spatial attention and spatial working 
memory. This negative effect was thought to be a consequence of altered DNMT1 
levels in the male gametes, which resulted in the alteration of normal parental imprint 
patterns found in the sperm (He, Lidow & Lidow 2006). Another such study looking 
at male rats exposed to tamoxifen, a selective estrogen receptor modulator, found a 
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significant decrease in DNA methylation at the H19/Jgf2 ICR in the spermatozoa. 
Following mating, an increase in post-implantation embryo loss was noted and this 
was found to be significantly associated with hypomethylation of the H19/Jgf2 ICR, a 
key regulator of growth control. This suggests that the hypomethylated H19/Jgf2 ICR 
in the spermatozoa was inherited by the subsequent generation (Pathak et al. 2009). 
There has been one study done in humans that looked at the effect of alcohol 
consumption on two paternally imprinted ICRs, the H19 JeR and IG-DMR in male 
gametes. These ICRs are associated with the imprinted H19/JGF2 and DLKlIGTL2 
loci, respectively. While a general trend towards reduced overall methylation was 
noted at the H1910cus, a modestly significant difference was noted in the methylation 
levels of the non-drinkers and heavy-drinkers at the IG-DMR locus (Ouko et al. 
2009). 
All of the studies mentioned above demonstrate the ability of environmental insults 
(e.g. irradiation, therapeutic drugs, pesticides, endocrine disruptors, smoking and 
alcohol) to alter the epigenome of the gametes either at the point where the foundation 
for spermatogenesis is laid down or when spermatogenesis is initiated during the 
pubertal stage. This consequently affects the fertility and the health of future 
offspring. 
3.1.2 METHYLATION DEFECTS ASSOCIATED WITH DISRUPTIVE 
SPERMATOGENESIS 
Male infertility accounts for roughly 40% of the cases of infertility (Gaur, Talekar & 
Pathak 2010). A number of lifestyle, environmental, genetic and epigenetic factors 
contribute towards this etiology. 
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Alcohol and cigarette smoke are two major lifestyle factors that have a negative 
impact on male fertility. Alcohol has been shown to not only adversely affect the 
normal morphological development and maturation of spermatozoa resulting In 
teratozoospermia but also decrease spermatozoa production known as 
oligozoospermia (as reviewed in Emanuele, Emanuele 1998, Gaur, Talekar & Pathak 
2010, Sermondade et al. 2010). The toxins produced by cigarette smoke have been 
found to have a negative effect on the motility of the sperm resulting in 
asthenozoospermia (Kunzle et al. 2003, Gaur, Talekar & Pathak 2010). 
Several recent studies have focused on imprinting defects in sperm from men 
suffering from severely reduced sperm counts or oligozoospermia (Marques et al. 
2004, Kobayashi et al. 2007, Marques et al. 2008). The altered imprint patterns in 
these infertile men can have serious implications for children conceived by assisted 
reproductive techniques (ART). This is due to the fact that imprinted genes resist the 
wave of global demethylation that occurs following fertilization. This would prevent 
the erasure of any epimutations present in imprinted genes in the sperm at the time of 
fertilization. 
Two independent studies focused on the methylation defects at the Hi91IGF2 
paternally methylated ICR and MEST a maternally imprinted locus in sperm from 
infertile men suffering from oligozoospermia. Global DNA methylation levels of non-
imprinted repetitive elements (Alu and LINE-i) were found to be normal in these 
men. However, both studies found the Hi91IFG2 ICR to be hypomethylated and 
MEST to be hypermethylated, suggesting that altered methylation patterns are specific 
and affect imprinted loci in different ways (Kobayashi et al. 2007, Marques et al. 
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2008). These aberrant methylation patterns may contribute significantly to Silver-
Russell syndrome in children born through ART (Bliek et al. 2006, Kagami et al. 
2007). Another study done by Kobayashi et al. (2009a) showed methylation defects at 
the H 19 and GTL2 imprinted loci in 17 out of 78 ART embryos. Altered methylation 
patterns at these loci were also found in the sperm of the infertile fathers suggesting 
that the abnormal hypomethylation at these loci were transmitted to the offspring via 
the sperm and not as a consequence of ART (Kobayashi et al. 2009a). These findings 
suggest an association between the epigenetic regulation of imprinted genes and 
defects in spermatogenesis, raising concerns about the effect that these aberrant 
imprints in male gametes could have on the subsequent generation (as reviewed in 
Filipponi, FeiI2009). 
Several growth and developmental disorders such as Beckwith-Weidemann 
syndrome, Angelman syndrome and Prader-Willi syndrome are a result of aberrations 
in the methylation patterns ofICRs (Buiting et al. 1995, Brown et al. 1996, Gicquel et 
al. 2005). 
3.1.3 IG-DMR - A KEy REGULATOR OF THE DLKI-DI03 IMPRINTED DOMAIN 
The majority of imprinted genes tend to occur in discrete clusters throughout the 
genome with their expression being coordinately regulated by the differentially 
methylated ICRs (Edwards, Ferguson-Smith 2007). One such region of the human 
genome that harbors an imprinted gene cluster is 14q32.2. This 1 Mb imprinted 
domain carries a number of paternally expressed genes (PEGs) such as DLK1, DID3 
and RTL1 and non-coding maternally expressed genes (MEGs) such as GTL2, RTL1as 
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and MEG8 (Irving et al. 2010). This region is regulated by a germ-line derived 
primary intergenic DMR, IG-DMR, and a post-fertilization derived secondary MEG3-
DMR. IG-DMR acts in a hierarchical manner to regulate the methylation of MEG3-
DMR in somatic tissue (Kagami et al. 2010). For the purpose of this study only IG-
DMR will be discussed further. 
The IG-DMR acquires its methylation mark in the male germ-line while the oocytes 
carry the unmethylated maternally inherited copy (Takada et al. 2002). It is only one 
of three known paternally methylated primary DMRs in humans (Cooper, Constancia 
2010). This DMR lies in the intergenic region between two reciprocally expressed 
genes, the paternally expressed DLKl gene and the maternally expressed GTL2 gene 
and is required for maintaining the correct imprint status of these genes (Figure 3.2). 
The human, mouse and sheep genomes display conserved synteny of this region 
(Paulsen et al. 2001). 
Maternal 
Chromoso~m~e~L-J-__ ~L-.Jllliil __ JlII'-______ ~ ______ It1-__ 
GTL2 RTL1as 
Paternal 
OLK1 IG-DMR RTL1 0103 
Figure 3.2: Schematic representation of the 1 Mb imprinted domain found on human 
chromosome 14q32.2. The IG-DMR lies between DLKl and GTL2 and is found to be 
hypennethylated on the paternal allele and hypomethylated on the maternal allele. The 
MEG3-DMR is a secondary DMR and is found at the promoter of GTL2 (also known as 
MEG3) . 
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The DLKl (Drosophila homologue-likel) gene fonns part of the Notch-Delta gene 
family, encoding transmembrane proteins containing epidennal growth factor-like 
repeats (Wylie et al. 2000). It is involved in cellular signaling and differentiation, 
postnatal growth and tumorigenesis (Laborda 2000, Moon et al. 2002, Yin et al. 
2006). The maternally expressed GTL2 (Gene Trap Locus 2) gene produces a non-
coding RNA transcript with an unknown function (Schuster-Gossler et al. 1998). 
Mouse, human and sheep studies, focusing on imprinting anomalies, have provided 
evidence for the role of the intergenic DMR (IG-DMR), found between the DLKl and 
GTL2 genes, in growth regulation. A number of case studies have reported that loss of 
methylation at IG-DMR on the paternal allele leads to a clinical presentation of 
maternal uniparental disomy [UPD(14)mat] of chromosome 14 with biparental 
inheritance of chromosome 14 (Temple et al. 2007, Buiting et al. 2008). Patients with 
UPD(14)mat present with pre- and post-natal growth retardation, developmental delay 
and short stature (Buiting et al. 2008). Paternal UPD of chromosome 14 [UPD(14)pat] 
is less common but a few case studies have shown that hypennethylation at IG-DMR 
on the maternal allele can result in paternalization of this region (Kagami et al. 2008). 
The characteristics associated with UPD(14)pat are usually severe and include distinct 
facial dysmorphology including short palpebral fissures, severe developmental delay, 
growth retardation and skeletal anomalies (Murphy et al. 2003, Stevenson et al. 
2004). Epimutations at the IG-DMR result in the aberrant expression of imprinted 
genes within the 1 Mb domain with an increased expression of PEGs and absent 
expression of MEGs in UPD(14)pat and increased expression of MEGs and absent 
expression of PEGs in UPD(14)mat. The phenotypes associated with UPD(14)pat and 
UPD(14)mat have similarities to those phenotypes seen in offspring affected by F AS. 
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The primary aIm of this study was to examme the effect of paternal alcohol 
consumption on the methylation status of IG-DMR in sperm DNA and to determine 
whether alcohol is correlated with methylation in a dose-dependant manner. This 
assessment was conducted on sperm samples donated by men who consume alcohol 
and those who do not drink. The IG-DMR is found between two paternally imprinted 
genes that are critical for embryonic development. Therefore if a link between alcohol 
consumption in men and hypomethylation of the normally hypermethylated DMR is 
found, this would contribute to a better understanding of the possible epigenetic 
mechanism underlying the paternally mediated effects on FASD. 
3.2 SUBJECTS AND METHODOLOGY 
Reagent and equipment suppliers are listed in Appendix C. 
3.2.1 STUDY PARTICIPANTS 
The male volunteers were recruited through the Cryobank, a private andrology 
laboratory and sperm bank in Parktown, Johannesburg, South Africa. The main 
reason for these men attending the sperm bank was for routine semen analysis; an 
initial evaluation to determine whether the couples' infertility is attributed to male 
infertility (Lamb 2010). 
Ethics approval for sample collection was obtained from the University of the 
Witwatersrand, Committee for Research on Human Subjects - Medical (M090555; 
shown in Appendix A.2). 
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3.2.1.1 SAMPLE COLLECTION 
The male volunteers were invited to participate and if they agreed, were asked to fill 
out an informed consent form and were given a detailed information sheet together 
with a brief verbal information session (Consent form and Information sheet are 
shown in Appendix B.1 and B.2, respectively). A questionnaire was administered to 
these volunteers to assess their drinking patterns and recreational drug and cigarette 
use. A small section of the questionnaire incorporated questions from the short 
Michigan Alcoholism Screening Test (sMAST) (Participant questionnaire is shown 
in Appendix B.3). This was used to assess the psychological aspects of alcohol 
consumption (Selzer, Vinokur & van Rooijen 1975). 
The volunteers were requested to abstain from sexual intercourse and/or ejaculation 
48 hours prior to semen sample collection. This was followed by routine semen 
analysis, done at the Cryobank. The analysis was done to assess sperm concentration, 
count, morphology and motility. The World Health Organization (WHO) has defined 
the following as lower reference limits for the parameters assessed during semen 
analysis: 
• Semen Volume: 1.5ml 
• Total sperm number: 39 million per ejaculate 
• Sperm concentration: 15 million per ml 
• Total (progressive and non-progressive) motility: 40% 
• Morphologically normal forms: 4% (Cooper et al. 2010) 
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A total of 149 sperm samples were collected from the Cyrobank, of which only 113 
were used in this study. Of the 36 samples that were not used, 7 were azoospermic 
and did not contain any sperm cells while the remaining 29 samples were disregarded 
on the basis of insufficient information. A summary of the participant information and 
semen parameters is shown in Table E.1, Appendix E. 
3.2.1.2 SAMPLE CLASSIFICATION 
A dichotomous classification approach was used for this part of the study, based on 
questionnaire information (shown in Appendix B.3). Individuals were either classified 
as non-drinkers (controls) or as drinkers based on their reported alcohol consumption. 
The non-drinkers were individuals who were teetotalers or those individuals who had 
not consumed alcohol in the past two years. Men consuming as little as one drink per 
month were placed into the alcohol-consuming group. The amount of alcohol 
consumed by the men in this group was calculated as a product of the number of 
drinks consumed per session and the number of sessions per month. This was referred 
to as drinking frequency and gave an indication of the dosage of alcohol consumed by 
the men on a monthly basis. 
The breakdown of the ethnicities within each treatment group is shown in Table E.2, 
Appendix E. 
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3.2.3 METHODOLOGY 
Molecular methods mentioned here are described in detail in Chapter 2, section 
2.2.2. 
Once the samples were collected, DNA was extracted and stored at -20°C. Batches of 
samples were subjected to bisulfite modification followed by PCR. 
3.2.3.1 peR AMPLIFICATION FOR PYROSEQUENCING REACTIONS 
A nested PCR was performed for this locus. This involved two consecutive rounds of 
PCR, where the first round made use of outer primers to amplify the target region 
while the second round used inner or nested primers to amplify a smaller region 
within the target region amplified during the first round of PCR (see list of primers 
Table 3.1). This technique is useful in maximizing amplification when dealing with 
relatively low quantities of DNA, as is the case with sperm samples. The outer primer 
set was previously published (Kagami et al. 2010) while the inner primer set was 
designed using the PSQ Assay Design Software version 1.0.6 (Biotage, Uppsala, 
Sweden), mentioned in Chapter 2. 
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Table 3.1: PCR primers for pyrosequencing PCR reactions 
IG-DMR Primer Sequence (5' - 3') t Amplicon Annealing 
Locus Length Temperature 
§Outer Primers Forward *GTTAAGAGTTTGTGGATTTGTGAGAAA TG 452 bp 
Reverse CT AAAAA TCACCAAAACCCATAAAA TCAC 
Inner Primers Forward *TTTATTGGGTTGGGTTTTGTTAG 290bp 
Reverse AACCAATTACAATACCACAAAATT 
§ Published primer set (Kagami et al. 2010) 
t Amplicon length includes the 23 bp complementary tag sequence 
* A 23 bp complementary tag (5'- GACGGGACACCGCTGATCGTTT A - 3') was added to 
the 5' end of all biotin-labelled primers (Colella et al. 2003) 
For round 1 PCR, amp1icons were generated in a 50 J..ll reaction containing 2 J..ll of 
bisulfite-treated DNA, 0.4 J..lM each of the outer forward and reverse PCR primers, 
0.125 mM deoxyribonucleotide triphosphates (Bioline, London, United Kingdom), 
2.0 mM MgCb, 1 x Buffer (Applied Biosystems, NJ, United States), Ix GC-rich 
solution (Roche, Mannheim, Germany) and 1 U of AmpliTaq Gold (Applied 
Biosystems, NJ, United States). Round 2 PCR amplicons were generated in a 50 J..ll 
reaction containing 2 J..ll of round 1 PCR product, 0.02 J..lM of the inner forward and 
0.2 J..lM of the reverse PCR primers and 0.2 J..lM of the universal primer, 0.125 mM 
deoxyribonucleotide triphosphates (Bioline, London, United Kingdom), 2.0 mM 
MgCb, 1 x Buffer (Applied Biosystems, NJ, United States), 1 M Betaine (Sigma-
Aldrich, Seelze, Germany) and 1 U of AmpliTaq Gold (Applied Biosystems, NJ, 
United States). 
PCR was performed in a GeneAmp® 2720 thermal cycler (Applied Biosystems, NJ, 
United States) with the following conditions for both PCR reactions; 95°C for 5 min, 
followed by 30 cycles of 95°C for 15 sec, TaoC for 30 sec (see Table 3.1 for TaOC), 
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and noc for 15 sec; with a final extension step of 72°C for 5 min; and a final hold at 
15°C. The PCR amplifications for each sperm sample were performed in triplicate. 
The maternally imprinted SNPRN DMR, mentioned in Chapter 2, was also amplified 
during this part of the study to assess potential somatic cell contamination. The PCR 
reaction and thermal cycling condition for this DMR region was described in Chapter 
2. 
Standard electrophoretic techniques were used to resolve the PCR amplified products. 
A 3% (w/v) agarose gel containing 1 mg/L ethidium bromide was used to visualize 
the amplified products at 6 V Icm in 1 x TBE buffer. A 50 bp DNA molecular size 
marker was used as a size standard. 
3.2.3.2 PYROSEQUENCING REACTIONS AND DATA ANALYSIS 
Due to the length of the IG-DMR PCR product (290 bp), two sequencing primers 
were used to cover the region in order to assess the quantitative methylation of the all 
the CpGs within IG-DMR using pyrosequencing technology (Table 3.2). 
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Table 3.2: Primers for pyrosequencing assays 
Locus 
IG-DMRJegl 
IG-DMRJeg2 
Sequencing Primer Sequence 
(5' - 3') 
R:CAATTACAATACCACAAAAT 
R:CCATAAACAACTATAAACCT 
Number of §Sequence to Analyze 
CpG Sites 
Analyzed 
7 TACRAATTTAACRAACCRCRAACAACTAACRAACCACTCRCAATTAA 
3 
CAAATCRCTAACAATTAACAAACCATAAACAA 
CRAACAACTATAAACCACRAACAACTAATAAACCACRAACAACTAA 
TAAACCACAAACAACT 
§The sequence to analyze is immediately 3' to the sequencing primer binding site on the biotinylated strand 
The positions of the CpG sites analyzed are shown by their IUPAC codes in bold font. 
87 
CHAPTER 3 - THE EFFECT OF ALCOHOL CONSUMPTION ON IG-DMR IN MALE GAMETES 
The assays have several built-in bisulfite conversion quality control checks. These 
checks are designed to analyze cytosines that do not form part of CpG dinucleotides 
and are therefore analyzed as C to T sequence variation. All cytosines not part of CpG 
dinucleotides are expected to be unmethylated and therefore should undergo complete 
bisulfite conversion. 
The pyrosequencing data were analyzed using the Pyro Q-CpG software (Biotage, 
Uppsala, Sweden). The data generated can either be scored as passed, check or failed. 
This gives the user confidence in the quality of the assay and the resulting data 
generated. Pyrosequencing was performed in triplicate for each sample. When 
examining the triplicate data set for each sample, a greater than 6% methylation 
difference per CpG site was used as a cut-off value for unsuccessful replication. As a 
result, one sample was excluded from this part of the study due to the replicates 
displaying a greater than 6% methylation difference at more than one CpG site. 
3.2.3.3 STATISTICAL ANALYSES 
All statistical analyses were performed using Statistic a (StatSoft, Inc., version 8.0) 
unless specified otherwise. 
The methylation status of each individual CpG site within the IG-DMR was assessed. 
In addition, the total methylation of all the CpG sites making up the IG-DMR was 
also assessed. 
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Descriptive statistics was done to summarize the data in a quantitative manner. The 
data were described in terms of central tendency (the means and medians of the data) 
and dispersion (the standard deviation and range of the data). The data obtained from 
this part of the study were continuous in nature. Normality testing was done using the 
Shapiro-Wilks test to determine whether the data was normally distributed (normal 
distribution if p > 0.20). Due to the non-normal distribution of DNA methylation 
across certain CpG sites, non-parametric analyses were performed. These analyses use 
the median values rather than mean values. 
3.2.3.3.1 HYPOTHESIS TESTING 
In this study it was hypothesized that alcohol consumption results in the 
hypomethylation of the paternally methylated IG-DMR in men who consume alcohol 
compared to the non-drinkers or controls. It was also hypothesized that alcohol could 
affect methylation in a dose-dependant manner such that men with higher drinking 
frequencies tend to display a higher level of hypomethylation compared to men with 
lower drinking frequencies. 
To determine whether DNA methylation differences exist between the control and the 
alcohol-consuming groups, the non-parametric Mann-Whitney U test was done. Both 
the methylation of individual CpG sites and the total methylation across all CpG sites 
were assessed. Spearman's correlations were performed, on the combined group, to 
determine whether methylation at individual CpG sites or across all CpG sites is 
influenced by alcohol in a dose-dependent manner. 
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Significant inter-individual epigenetic variation has been reported to occur in human 
germ cells (Flanagan et al. 2006). To visualize this variation within and between the 
two treatment groups the DNA methylation percentage of each individual CpG site 
for each sperm sample and the total DNA methylation percentage across all CpG sites 
for each sample were represented in variability plots. 
3.2.3.3.2 CONFOUNDING VARIABLES 
A number of potential confounding variables were identified in this study due to the 
nature of the study. These included: 
• Age, 
• Smoking, 
• Drug use, 
• Sperm concentration (million/mI), 
• Sperm morphology (percentage of normal sperm) and 
• Sperm motility (percentage progressive and non-progressive). 
These variables may influence DNA methylation. 
Spearman's correlations were performed for the continuous variables (age, sperm 
concentration, sperm morphology and sperm motility) while the Mann-Whitney U test 
was performed for binary variables (smoking and drugs). These analyses were done 
on the combined group, to determine the relationship between each variable and DNA 
methylation at the level of individual CpG sites and across all CpG sites within IG-
DMR. Once significant associations were identified with particular CpG sites, the 
responsible confounding variables were used to build a multiple regression model. 
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These variables were entered into the model such that the effect of each independent 
variable on the single dependant variable (in this case methylation) could be estimated 
when in the presence of other variables. In situations where two independent variables 
were found to highly correlated, a forward stepwise method was used for multiple 
regression analysis. This advanced method enters independent variables into the 
model, one at a time in sequence. If the variable contributes to the model, it is retained 
but all other variables in the model would be re-tested to see whether they still 
contribute to the success of the model. If a variable is not found to significantly 
contribute to the model, it will be excluded. 
Multiple regressIOn analysis was done twice for each CpG site, first including 
treatment (no alcohol consumption vs. alcohol consumption) followed by including 
drinking frequency into the analysis. These two independent variables were most 
important in terms of testing the hypothesis. The resulting model equation has been 
written in the form of: 
Y= Bo+ BIXI 
Methylation (%) = Intercept + Regression coefficient (Independent variable) 
where Y is the dependent variable that was to be predicted; Xl represents the 
independent variable that was used to predict Y; B I is the regression coefficient that 
describes the size of the effect that the independent variable Xl has on the dependent 
variable Y, and Bo is the value Y is predicted to have when all the independent 
variables are equal to zero. 
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3.2.3.3.3 ABNORMAL SPERM PARAMETERS, METHYLATION AND ALCOHOL 
Literature has shown that altered imprint patterns can be associated with sperm 
parameter abnormalities. The WHO reference values for human sperm parameters 
(Cooper et al. 2010) were used to classify individuals into various sperm abnormality 
groups. Individuals with 3 or less abnormal parameters were included in this study. It 
was important to ascertain whether methylation differences exist between the group of 
individuals with normal sperm parameters and those with abnormal sperm parameters. 
Due to the effect of alcohol on the overall DNA methylation status, only the control 
samples (non-drinkers) were categorized according to sperm abnormality parameters. 
Alcohol is known to adversely affect the production, development and maturation of 
sperm. The Mann-Whitney U test was performed to assess whether sperm parameters 
differ between the control and alcohol-consuming group. The effect of alcohol dosage 
on the sperm parameters was also assessed using Spearman's correlations. Finally, the 
Fisher's exact test was used to determine whether the number of individuals with 
abnormal parameters within the alcohol-consuming group was significantly different 
to the number of individuals with abnormal parameters within the control group. 
For all statistical tests performed, a p-value < 0.05 was considered to be significant. 
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3.3 RESULTS 
All samples were assayed in triplicate on the Pyrosequencer. The average methylation 
percentage for each CpG site was calculated by averaging the triplicate values for 
each CpG site per sample. The average methylation percentage per CpG site was then 
averaged across all CpG sites analyzed to give an average methylation precentage per 
sample (shown in Appendix 1- IG-DMR Data and SNRPN Data). This was then used 
to calculate the average methylation percentage per group. 
3.3.1 DETECTION OF SOMATIC DNA CONTAMINATION IN SPERM SAMPLES 
As discussed in Chapter 2, a DMR associated with SNRPN, a maternally imprinted 
locus was used to control for somatic cell DNA contamination in the sperm samples. 
A total of 22 (19.5%) samples out of the 113 samples collected were assayed for this 
locus (shown in Appendix 1- SNRPN Data). The mean methylation of this DMR was 
found to be 2.43% with a standard deviation of 1.35. The theoretical methylation 
value for DMRs in somatic tissue is 50% (Cooper, Constancia 2010). However 
studies have shown that somatic DMRs display methylation levels between 35% and 
65% (Woodf'ine, Huddleston & Murrell 2011). Therefore the low level of methylation 
at the SNRPN DMR within the sperm samples indicates that the paternal allele may 
not be completely devoid of methylation but rather displays basal levels of 
methylation. It was concluded that the samples were not significantly contaminated 
with somatic cells. The sole purpose of incorporating this locus into the study was as 
a proxy for somatic cell contamination and therefore the data for SNRPN was not 
included in subsequent analyses. 
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3.3.2 THE EFFECT OF ALCOHOL CONSUMPTION ON DNA METHYLATION 
3.3.2.1 CHARACTERISTICS OF THE DATASET 
Complete results were obtained for 112 (99%) of the 113 samples. One sample was 
removed from this study due to inconsistent triplicate results. Of the 16 CpG sites 
present within the IG-DMR CpG island, only ten were analyzed using 
pyrosequencing. Consistent results could not be obtained for the remaining six CpG 
sites due to the number of repeats in the region (Geuns et al. 2007). 
3.3.2.2 DNA METHYLATION ANALYSIS OF INDIVIDUAL CpG SITES IN SPERM 
SAMPLES 
The methylation levels of the individual CpG sites are given in Table 3.3. 
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Table 3.3: Per group and individual CpG methylation levels for the IG-DMR locus within the two treatment groups (N = 112) 
Controls Alcohol Consumers §Mann-Whitney U Test 
Sample size (N) 34 78 
tMean (SD) Median (Range) Mean (SD) Median (Range) P-Values 
Average Methylation (%) per CpG site: 
CpGl 93.25 (1.15) 93.33 (90.67-96.33) 92.82 (1.93) 93.00 (83.67-96.00) 0.527 
CpG2 93.99 (0.92) 94.00 (91.67-96.00) 92.57 (6.81) 93.67 (48.00-95.67) 0.133 
CpG3 97.54 (1.18) 97.67 (94.67-100.00) 96.96 (1.34) 97.33 (89.67-99.33) 0.032 * 
CpG4 67.33 (4.63) 67.00 (59.33-78.67) 66.15 (5.89) 66.50 (50.67-78.67) 0.569 
CpG5 77.52 (2.76) 78.50 (70.00-82.00) 77.38 (3.38) 78.33 (66.00-82.67) 0.914 
CpG6 96.46 (1.65) 97.00 (91.33-98.67) 96.42 (2.01) 97.00 (90.33-99.33) 0.709 
CpG7 98.05 (0.96) 98.00 (96.00-100.00) 97.39 (1.73) 98.00 (88.33-99.67) 0.070 
CpG8 88.03 (1.49) 88.33 (85.00-90.33) 87.50 (1.86) 87.67 (80.67-90.67) 0.179 
CpG9 97.42 (0.91) 97.33 (95.00-99.33) 96.39 (5.74) 97.33 (51.00-99.33) 0.314 
CpGIO 97.86 (0.70) 98.00 (96.67-99.33) 97.71 (0.77) 98.00 (95.00-99.33) 0.595 
Average Methylation (%) per group 90.76 (0.90) 90.83 (89.10-92.47) 90.13 (1.43) 90.50 (86.23-93.23) 0.052 
Drinking Frequency (drinks/month) N/A N/A 35.94 (51.45) 15.00 (1.00-360.00) N/A 
§ The Mann-Whitney U test evaluates the differences in the medians of the two groups based on assigning a rank to each data value 
t The mean values of the individual CpG sites were used for constructing the bar graph 
* Significant at p<0.05 level 
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The mean methylation for the individual epG sites and per group was marginally 
higher in the controls when compared to the alcohol consumers. The overall 
methylation and individual epG methylation between individuals within the control 
group ranged between 89.10% and 92.47% while the methylation between individuals 
within the alcohol-consuming group was between 86.23% and 93.23%. The standard 
deviation, which gives an indication of the spread of the data from the mean, was 
found to be lower in the controls compared to the alcohol-consuming group. The data 
of the alcohol-consuming group were spread over a larger range of values when 
compared to the controls. The variability of the methylation within and between 
groups as well as within and between individual epG sites is shown in Figure 3.3 and 
Figure 3.4, respectively. 
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Figure 3.3: Variability plot illustrating the spread in average methylation percentage at 
IG-DMR, within and between the two treatment groups. 
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Figure 3.4: Variability plots illustrating the spread in methylation percentage at individual CpG sites within and between the two treatment groups. 
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The non-parametric Mann-Whitney U test was performed to assess whether a 
significant difference exists between the medians of the two groups at each CpG site, 
following alcohol consumption (Mann-Whitney p-values are indicated in Table 3.3). 
Only one of the ten CpG sites was found to be significantly different between the two 
groups (Figure 3.5). The methylation percentage at CpG 3 was significantly different 
(p=O.032) between the two groups with the alcohol-consuming group showing a 
reduction in methylation at this site. CpG 7 was the only other site that showed a trend 
towards being significantly different (p=O.070) between the two groups, with the 
alcohol-consuming group showing a modest reduction in methylation at this site. 
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Figure 3.5: Average DNA methylation levels for individual CpG sites between the two 
treatment groups. Note: The error bars represent the standard deviation around the 
mean. 
Spearman's correlations were performed to determine the presence of relationships, if 
any, between drinking frequency and DNA methylation at individual CpG sites. 
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These correlations were done on the combined (controls and drinkers) group. A 
notable trend towards a reduced methylation level at CpG 3 was observed with 
increasing drinking frequency (Spearman's rho=-0.179, p=O.059). A similar but 
significant relationship was observed between the DNA methylation level at CpG 7 
and drinking frequency. DNA methylation significantly decreased at this site as 
drinking frequency increased (Spearman's rho=-O.197, p=O.037), however, the effect 
size is very small (Figure 3.6). 
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Figure 3.6: Correlation plot displaying the relationship between the methylation levels 
at CpG site 7 and drinking frequency. 
3.3.2.3 DNA METHYLATION ANALYSIS PER GROUP 
The methylation levels per group are shown in Table 3.3. Alcohol consumption was 
correlated with a borderline significant decrease in methylation (p=O.052) in the 
alcohol-consuming group without taking any confounders into account (Figure 3.7). 
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Figure 3.7: Box plot illustrating the difference in average methylation levels between the 
control and alcohol-consuming groups. 
No association was noted when correlating drinking frequency with average 
methylation (Spearman's rho=0.009; p=0.920). 
3.3.2.4 THE EFFECT OF CONFOUNDING VARIABLES ON DNA METHYLATION 
The quantitative statistics of the potential confounding variables are shown in Table 
3.4. 
No significant differences were noted between the two groups for five of the six 
variables. However, a trend towards increased cigarette use was observed within the 
alcohol-consuming group. 
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Table 3.4: Potential confounding variables within the two treatment groups 
Controls Alcohol Consumers §Mann-Whitney U Test 
Sample size (N) 34 78 
Variable Mean (SD) Median (Range) Mean (SD) Median (Range) P-Value 
Age (years) 34.32 (5.87) 35.00 (22.00-50.00) 33.86 (5.45) 34.00 (20.00-49.00) 0.697 
Sperm Concentration (million/ml) 51.96 (35.32) 43.00 (11.00-167.00) 58.39 (58.43) 41.50 (4.20-310.00) 0.626 
Sperm Morphology (% normal) 11.00 (5.64) 10.50 (1.00-21.00) 11.21 (6.38) 12.00 (1.00-25.00) 0.859 
Sperm Motility (%) 54.41 (10.57) 52.50 (30.00-70.00) 55.64 (11.18) 60.00 (20.00-75.00) 0.440 
Count (Frequency) Count (Frequency) 2 X Test 
Cigarette Use 6 (17.65%) 31 (39.74%) X2= 3.500, df=l, p=0.061 
Drug Use 1 (2.94%) 5(6.41%) X2 = 0.532, df=l, p=0.466 
§ The Mann-Whitney U test evaluates the differences in the medians of the two groups based on assigning a rank to each data value 
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The effect of the six confounding variables on methylation was assessed at individual 
CpO sites and across all CpO sites. The effects were assessed on the combined group. 
3.3.2.4.1 THE EFFECT OF CONFOUNDERS ON METHYLATION LEVELS OF 
INDIVIDUAL CpG SITES 
Only those confounders that had a significant relationship with DNA methylation at 
individual CpO sites and those that had a relationship that tended towards significance 
are represented in Table 3.5. 
Table 3.5: Spearman's correlation analysis between the confounding variables and DNA 
methylation at specific CpG sites 
Confounding Variable CpG Site Spearman's rho P-value 
Age CpG3 0.188 0.048 * 
CpG4 0.411 0.00001 * 
CpG5 0.189 0.046 * 
CpG6 0.183 0.054 
CpG7 0.169 0.074 
Sperm Concentration CpG8 0.195 0.039 * 
Sperm Morphology CpG8 0.292 0.002 * 
Sperm Motility CpG4 -0.184 0.052 
*Significant at p<0.05 level 
It should be noted that the relationship between the confounders and methylation was 
site-specific. 
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Age and DNA methylation displayed a significantly positive relationship at three of 
the ten CpG sites analyzed. The methylation levels at CpG sites 3, 4 and 5 
significantly increased as age increased. In addition, methylation levels at CpG sites 6 
and 7 showed a trend towards higher methylation as age increased. 
The methylation level at CpG 8 displayed a significant positive relationship with 
sperm concentration (p=O.039) and sperm morphology (p=O.002). Therefore 
methylation levels increased as sperm concentration increased and as the percentage 
of morphologically normal sperm increased. 
A negative correlation was noted between the methylation level at CpG 4 and sperm 
motility, with a trend towards increased methylation with a decrease in sperm motility 
(p=O.052). 
The Mann-Whitney U test was done to assess the effect of drugs and smoking on 
DNA methylation. DNA methylation levels at only one out of the ten CpG sites 
analyzed was affected by drugs and smoking. The methylation level at CpG 3 was 
significantly reduced in the presence of drug usage (p=O.048). In addition the 
methylation level at CpG 3 showed a modest trend towards lower methylation in the 
presence of smoking (p=O.085). 
Multiple regressIOn analyses were performed for select CpG sites where the 
methylation at these sites was significantly influenced by more than one independent 
variable (Table 3.6). The analysis was done twice for each CpG site. While treatment 
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was incorporated into the first model, the second model incorporated drinking 
frequency. 
Table 3.6: Multiple regression analysis for specific CpG sites 
Methylation 
Variable 0/0 SE P-value 
Alcohol Consumption 
CpG3 Intercept 97.08 1.03 0.000 
Treatment -0.52 0.26 0.046 * 
Age 0.05 0.02 0.015 * 
Drug usage -0.81 0.53 0.128 
Adjusted R2= 0.09 
CpG4 Intercept 52.26 3.41 0.000 
Treatment -0.97 1.01 0.338 
Age 0.47 0.08 0.000 * 
Adjusted R2= 0.22 
CpG8 Intercept 87.81 0.68 0.000 
Treatment -0.55 0.35 0.123 
Sperm Morphology 0.06 0.03 0.010 * 
Adjusted R2 = 0.06 
Drinking Frequency 
CpG3 Intercept 96.20 0.96 0.000 
Drinking Frequency 0.0003 0.003 0.899 
Age 0.05 0.02 0.014 * 
Drug usage -0.89 0.54 0.102 
Adjusted R2 = 0.05 
CpG4 Intercept 50.26 2.93 0.000 
Drinking Frequency 0.006 0.01 0.563 
Age 0.47 0.08 0.000 * 
Adjusted R2=0.21 
CpG5 Intercept 73.48 1.87 0.000 
Drinking Frequency 0.009 0.006 0.168 
Age 0.11 0.05 0.044 * 
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Adjusted R2 =0.03 
CpG 8 Intercept 
Spenn morphology 
Adjusted R2 =0.05 
*Significant at p<0.05 level 
86.89 
0.06 
0.34 
0.03 
0.000 
0.011 * 
While treatment displayed a negative regression coefficient for each of the CpG sites 
in Table 3.6, it was only found to significantly predict a decrease in methylation (%) 
at CpG 3 when in the presence of other variables. Contrary to this, drinking frequency 
displayed a positive coefficient for each of the CpG sites. However, these coefficients 
were so close to zero that drinking frequency was not considered to be a predictor of 
methylation at any of the sites when in the presence of other variables. 
Age was a significant predictor of methylation (%) at CpG 3 and 4 in the presence of 
alcohol consumption. For every year increase in age, methylation (%) significantly 
increased. In contrast, age was not found to be a significant predictor of methylation 
(%) at CpG 5 (shown in Table J.J, Appendix J). When including drinking frequency 
into the model, in place of treatment, age was still found to significantly predict 
methylation (%) at CpG 3 and 4. 
Sperm concentration and sperm morphology were both significantly correlated with 
methylation at CpG 8 (Table 3.5). However, multicollinearity was observed between 
these two predictor variables (Spearman's rho=0.493, p=O.OOO). Due to this strong 
positive correlation, a forward stepwise method was used for multiple regression 
analysis. Sperm morphology was found to significantly predict methylation at CpG 8 
when incorporating treatment into the model. For every percentage increase in normal 
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sperm morphology, methylation would increase by 0.06%. When the stepwise method 
was used incorporating drinking frequency, sperm concentration and sperm 
morphology, sperm morphology was found to be the only predictor variable that 
contributed significantly to the success of the model. 
The variance in methylation (%), explained by the adjusted R2 value in each of the 
models, at each epG site was minimal. This suggests that other variables could be 
responsible for the remaining variance that is unaccounted for. 
3.3.2.4.2 THE EFFECT OF CONFOUNDERS ON METHYLATION LEVELS ACROSS ALL 
CpGSITES 
Age was the only confounder significantly associated with average methylation across 
all epG sites. A strong positive correlation was noted (Spearman's rho=0.280; 
p=0.003). As age increased so did the average methylation across all epG sites. While 
no correlation was observed between sperm concentration and DNA methylation 
(Spearman's rho=-0.002, p=0.984), a slight positive correlation was observed 
between sperm morphology and DNA methylation (Spearman's rho=0.050, p=0.603). 
On the other hand, sperm motility displayed a negative but non-significant association 
with methylation (Spearman's rho=-0.126, p=0.187). 
The Mann-Whitney U test found no influence of smoking and drugs on methylation 
across all epG sites (p=0.627 and p=0.220, respectively). 
Two multiple regression analyses were performed, with both analyses incorporating 
age as the independent variable. In addition one model incorporated treatment as the 
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second variable and the other model incorporated drinking frequency as the second 
variable. 
Modell: 
Average Methylation (%) = 89.72 - 0.61 (Treatment) + 0.05(Age) 
The average methylation (%) across all CpG sites was predicted to significantly 
decrease by 0.61 % in the presence of alcohol consumption (p=0.021) and increase by 
0.05% for every year increase in age (p=0.029). In the event that the regression 
coefficients for the two independent variables were zero, average methylation was 
predicted to be 89.72%. This model accounted for 7.31% of variation in average 
methylation across all CpG sites. 
Model 2: 
Average Methylation (%) = 88.50 + 0.002(Drinking frequency) + 0.05(Age) 
Drinking frequency was not considered to be a predictor of average methylation (%) 
due to the regression coefficient being so close to zero (p=0.285). However, age was 
found to be a significant predictor of average methyaltion with methylation 
significantly increasing by 0.05% for every year increase in age (p=0.022). Average 
methylation was predicted to be 88.50% in the event that the regression coefficients 
of the two independent variables were zero. These two predictor variables only 
accounted for 3.70% of the variation in average methylation across all CpG sites. 
107 
CHAPTER 3 - THE EFFECT OF ALCOHOL CONSUMPTION ON IG-DMR IN MALE GAMETES 
Therefore modeling both treatment and age together revealed highly significant, 
independent associations with DNA methylation. Alcohol dosage did not seem to play 
an important role in predicting methylation. 
3.3.3 THE ASSOCIATION BETWEEN ABNORMAL SPERM PARAMETERS AND DNA 
METHYLATION 
Three sperm parameters were assessed in this study: sperm concentration, sperm 
morphology and sperm motility. Individuals with sperm concentration levels less than 
15 million per ml were classified as being oligozoospermic, while individuals with a 
sperm morphology percentage less than four percent were classified as being 
teratozoospermic and individuals with total sperm motility percentage less than 40% 
were classified as being asthenozoospermic. It should be noted that some samples had 
more than one sperm abnormality. The control samples were categorized into the 
various sperm abnormality groups (shown in Table K.l, Appendix K). However, due 
to the small sample size of each category, no statistical analysis could be performed to 
determine whether abnormal sperm parameters are correlated with alterations in 
methylation patterns. 
3.3.4 THE EFFECT OF ALCOHOL ON ABNORMAL SPERM PARAMETERS 
No significant differences were observed in the sperm parameters between the control 
and alcohol-consuming groups when performing the Mann-Whitney U test (Table 
3.4). 
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When correlating alcohol dosage to the sperm parameters, no relationship was 
observed between drinking frequency and sperm morphology (Spearman's rho=-
0.035, p=0.715) while drinking frequency and sperm motility displayed a slight 
positive but non-significant correlation (Spearman's rho=0.068, p=0.477). There was 
only one slight trend with drinking frequency, which was towards decreasing sperm 
concentration (Spearman's rho=-0.161, p=0.091). 
The numbers of individuals with abnormal sperm parameters in the control group 
were lower than the numbers of individuals with abnormal sperm parameters in the 
alcohol-consuming group (shown in Table L.1, Appendix L). No significant 
differences were observed between the numbers of individuals with abnormal 
parameters in the alcohol-consuming group and the numbers of individuals with 
abnormal parameters in the control group. 
In summary the results of this study show no alteration in methylation levels between 
the normal and abnormal sperm parameter groups. The sperm parameters were not 
statistically influenced by alcohol consumption nor were they influenced by the 
amount of alcohol consumed. 
3.4 DISCUSSION 
The primary aim of this part of the study was to determine whether paternal alcohol 
consumption is correlated with an altered methylation status of IG-DMR and to 
determine whether there is a dose-dependant correlation. The results presented here 
demonstrate that paternal alcohol consumption is correlated with a modest decrease in 
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the overall methylation at the IG-DMR locus regardless of the amount of alcohol 
consumed thus supporting the hypothesis put forth in Chapter 1. These results are in 
agreement with those published by Ouko et al. (2009) who also focused on the IG-
DMR locus in human sperm (Ouko et al. 2009). 
3.4.1 EFFECT OF ALCOHOL ON METHYLATION AT IG-DMR 
Alcohol is known to be correlated with methylation changes in a locus-specific 
manner, with increased methylation at certain loci and decreased methylation at other 
loci (Liu et al. 2009). A recent study conducted to determine the effect of alcohol on 
global methylation in human sperm found a trend towards decreased methylation 
(personal communication) suggesting that more loci could be hypomethylated 
following alcohol exposure. A modest decrease in the overall methylation at the IG-
DMR locus was observed in this study. Alcohol consumption is known to interrupt 
the critical one-carbon metabolism pathway by inhibiting the reaction catalyzed by 
methionine synthase. This subsequently leads to an increase of potent inhibitors of the 
DNMT enzymes that are critical for establishing and maintaining methylation patterns 
(Halsted, Villanueva & Devlin 2002, Liu et al. 2009). This serves as a possible 
explanation for the overall decrease in methylation observed at IG-DMR. 
In addition to the overall reduction in methylation following alcohol consumption, 
CpG 3 showed significantly reduced DNA methylation levels in the alcohol-
consuming group while another site, CpG 7, showed a trend towards reduced 
methylation in the same group. It is not uncommon to observe reduced methylation 
levels at specific CpG sites following alcohol exposure and these findings agree with 
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prevIOUS findings (Haycock, Ramsay 2009, Ouko et al. 2009, Qiang et al. 2010 
Stouder, Somm & Paoloni-Giacobino 2011). The mechanism and reason behind why 
certain CpG sites are preferentially demethylated remains unclear. However, a study 
done by Oka et al. (2006) found certain CpG sites within the Fgf-l gene to be 
preferentially methylated by Dnmt3a (Oka et al. 2006). Therefore the single CpG site 
found to be preferentially demethylated in this study might fall within a DNMT3L 
recognition sequence. This DNMT enzyme is responsible for establishing methylation 
imprints in the male and female germ-lines (Kato et al. 2007). Alcohol consumption is 
known to inhibit DNMT enzymes through the one-carbon metabolism pathway 
(Halsted, Villanueva & Devlin 2002) therefore this recognition site would unusually 
be hypomethylated due to the inhibition of DNMT enzymes and this could trigger a 
wave of demethylation across adjacent CpG sites. The mechanism underlying this 
preferential demethylation of select CpG sites remain undetermined. However, a 
possible reason for the preferential demethylation of specific CpG sites may lie in the 
conformation of the chromatin. Under normal circumstances the chromatin is highly 
condensed and hypermethylated at this region. Specific CpG sites that serve as 
DNMT recognition sites may be preferentially exposed for easy accessibility. 
Following alcohol consumption, these specific CpG sites become preferentially 
demethylated due to the inhibition of the DNMT enzymes via the one-carbon 
metabolism pathway. The other CpG sites that are less accessible due to the 
conformation of the chromatin remain methylated until a wave of demethylation 
spreads from the preferentially demethylated CpG site. It is important to note that IG-
DMR does not bind a CTCF-binding protein nor is it known to bind transcription 
factors (Carr et al. 2007), therefore the reduced methylation at CpG 3 may not affect 
the binding of any such factors. 
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While drinking frequency was not correlated with an overall alteration in DNA 
methylation, site-specific methylation alterations were noted. Drinking frequency was 
correlated with a decrease in methylation at CpG 7 while a trend towards reduced 
methylation was noted at CpG 3. These findings corroborate the results obtained by 
Biermann et al. (2009), where alcohol-drinking patterns negatively correlated with 
methylation at five CpG sites found within the NR2B promoter (Biermann et al. 
2009). A possible reason for this preferential demethylation could again be attributed 
to the conformational structure of the chromatin in this region. 
3.4.2 EFFECT OF CONFOUNDERS ON DNA METHYLATION 
Besides age, none of the other confounders were found to influence the overall DNA 
methylation at IG-DMR. It is often thought that older age is associated with decreased 
methylation. However, studies have shown that methylation tends to increase with age 
at several loci, including the telomere maintenance loci (Siegmund et al. 2007, 
Christensen et al. 2009). IG-DMR is associated with a CpG island (Takada et al. 
2002). The age-related increase in methylation at this locus is consistent with 
literature that has demonstrated that age-related increases in methylation tend to be 
associated with loci found within CpG islands (Kwabi-Addo et al. 2007). 
An interesting observation was made regarding the proportion of men who participate 
in co-morbid smoking and drinking behavior. The proportion noted in this study 
strongly parallels what has been reported in the United States (Grant et al. 2004). In 
terms of DNA methylation, no alterations in methylation patterns were observed 
following smoking and illegal drug usage. This is contrary to other studies that have 
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shown smoking and drug use to be correlated with altered DNA methylation patterns 
(Launay et al. 2009, Nielsen et al. 2009, Breitling et al. 2011). A possible reason for 
the absence of a correlation between smoking and DNA methylation and between 
illegal drug use and DNA methylation in this study may be that methylation 
alterations were present in the sperm samples of smokers and drug users but that the 
alterations were present in only a minor pool of the spermatozoa, with the vast 
majority of the spermatozoa having normal methylation patterns and this could have 
masked the altered imprint patterns. 
3.4.3 INTER-INDIVIDUAL EPIGENETIC VARIATION 
Visual inspection of the overall methylation and individual CpG methylation between 
individuals in the same treatment group and between treatment groups showed high 
levels of inter-individual variation within and between the two treatment groups. This 
epigenetic variability in human germ cells has been noted previously (Flanagan et al. 
2006). The methylation levels of the control group were more tightly clustered but 
still showed a considerable level of inter-individual variation compared to the alcohol-
consuming group, which showed a greater spread of methylation levels. 
Age is known to influence DNA methylation at specific loci (Boks et al. 2009, 
Christensen et al. 2009), however the spread in methylation levels observed in the 
alcohol-consuming group could not be attributed to age since the age range of the 
control and alcohol-consuming group was comparable. The fact that the control 
individuals display epigenetic variation, albeit to a limited extent, suggests that this 
locus displays some epigenetic plasticity in the germ cells. In the alcohol-consuming 
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group, this plasticity may render this locus more susceptible to environmental 
influences such as alcohol and long-term exposure to alcohol could further increase 
the epigenetic variability observed. The observations reported here are similar to 
those reported by Li et al. (2011) who exposed identical mice to long-term methyl 
donor dietary supplements. The mice exposed to the methyl donors had higher levels 
of epigenetic variation compared to the controls and the variation was found to 
increase with an increase in the duration of exposure (Li et al. 2011). 
3.4.2 LACK OF ASSOCIATION BETWEEN ABNORMAL SPERM PARAMETERS AND 
DNA METHYLATION 
The main focus of this study was not to examine whether methylation alterations are 
present and could be responsible for abnormal sperm parameters. However, a number 
of the sperm samples used in this study were outside the normal range for at least one 
of the parameters. It was thus important to determine whether the abnormal 
parameters were correlated with altered methylation patterns and if the abnormal 
parameters may be correlated with the overall reduction in methylation observed 
following alcohol exposure. However, this question could not be assessed in this 
study due to the small sample size of the various sperm abnormality groups. It would 
be crucial to assess this question as other studies have shown that men with abnormal 
sperm parameters display altered methylation patterns at certain imprinted loci 
(Kobayashi et al. 2007, Marques et al. 2008, Marques et al. 2009, Poplinski et al. 
2010). These studies suggest that the defects in spermatogenesis could be a result of 
epigenetic dysregulation of imprinting in the male germ-line (as reviewed in 
Filipponi, Feil 2009). 
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3.4.5 ABNORMAL SPERM PARAMETERS AND ALCOHOL - No RELATIONSHIP 
The negative impact of alcohol on the male reproductive system has been known for 
decades. Not only is alcohol linked to male infertility but it has also been shown to 
alter testosterone production, disrupt spermatogenesis and adversely affect sperm 
concentration, morphology and motility in humans and animals (Pajarinen et al. 1996, 
Muthusami, Chinnaswamy 2005, Sermondade et al. 2010). The aim of this study was 
not to determine the cytotoxic effects of alcohol on sperm quality, however it was 
interesting to note that the alcohol-consuming group had a slightly higher number of 
individuals with abnormal sperm parameters than the control group, although this was 
not significant. This suggests that alcohol may not responsible for the disruption in 
spermatogenesis. A number of other environmental exposures and toxins such as 
therapeutic drugs, pesticides and irradiation (as reviewed in Delbes, Hales & Robaire 
2010) could be responsible for the abnormal parameters seen in this group of 
individuals. Alternatively, a lack of significance could be due to the relatively small 
sample sizes of the various sperm abnormality categories. 
3.4.6 THE EFFECT OF PATERNAL ALCOHOL CONSUMPTION ON OFFSPRING 
DEVELOPMENT 
The alterations in methylation patterns observed at the IG-DMR locus in sperm 
following paternal alcohol consumption could have negative consequences for the 
development of the offspring. It is plausible that sperm with subtle differences in 
DNA methylation may still have the ability to fertilize oocytes and give rise to 
embryos. However, these embryos would inherit the altered imprint from the paternal 
allele. While the paternal and maternal genomes undergo a wave of demethylation 
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during embryogenesis, the imprinted genes resist this wave of demethylation. 
Therefore the altered methylation pattern at IG-DMR would likely be stably 
maintained in the embryo, affecting the regulation of the DLK1/GTL210cus. This may 
affect the post-natal development of the offspring. 
A study done by Knezovich and Ramsay (awaiting publication) focused on the effects 
of preconception paternal alcohol consumption on imprinted loci in mouse sperm and 
their offspring. The results were contrary to those found in this study, as no 
significant demethylation was observed at the Ig-DMR locus between the sucrose-
treated and alcohol-exposed mouse sperm. However, significant decreases in 
methylation were observed at the imprinted loci in the offspring of the alcohol-treated 
males. These offspring were found to weigh significantly less during the weaning 
period, compared to the offspring fathered by the sucrose-fed males. The researchers 
suggested that alcohol could have potentially induced the oxidation of 5-
methylcytosine (5-mc) to form 5-hyroxymethylation (5-hmc) in the sperm. This 
intermediary modification would then later manifest as demethylated DNA in the 
offspring. Alternatively alcohol could have affected other epigenetic mechanisms and 
these alterations could have been inherited by the offspring. 
Besides DNA methylation, sperm cells are also capable of transmitting other 
epigenetic signals, such as ncRNAs and histone modifications, to the oocyte upon 
fertilization. Various cytoplasmic RNAs are transmitted by the sperm to the oocyte 
and are crucial for normal embryonic development including establishing of imprints, 
early embryo patterning and morphometric patterning (Ostermeier et al. 2004, as 
reviewed in Boerke, Dieleman & Gadella 2007). Studies done in mice have 
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demonstrated that RNAs transmitted by the sperm have the ability to epigenetic ally 
alter the phenotype of the offspring. In one study a microRNA, miRNA-124, 
important for the development of the nervous system, was injected into the male 
pronucleus upon fertilization. This resulted in a giant phenotype in the progeny, 
which was observed from the blastocyst stage through to adulthood (Grandjean et al. 
2009). Another study injected miRNA-I, important for cardiac growth, into the male 
pronucleus upon fertilization and found the progeny to suffer from cardiac 
hypertrophy (Wagner et al. 2008). Both these studies provide evidence that RNA 
species serve as an alternative mechanism of epigenetic inheritance. 
The other alternative mechanism of epigenetic inheritance is through histone 
modifications. Upon maturation the haploid genome in the sperm head undergoes 
compaction, which is achieved through the replacement of majority of the histones 
with protamines (Braun 2001). However, 5% to 15% of the genome is still bound to 
histones and these regions are significantly enriched at loci important for embryonic 
development, including promoters of miRNAs, imprinted genes and at genes of key 
transcription and signaling factors (Tanphaichitr et al. 1978, Hammoud et al. 2009). A 
study done by Gardiner-Garden et al. (1998) demonstrated the association of human 
sperm-derived histones with two globin genes actively transcribed in the embryonic 
yolk sac, while protamines were found to be associated with two globin genes that 
were silent in the embryonic sac (Gardiner-Garden et al. 1998). Another study done in 
zebrafish found a strong correlation between the genes bearing active chromatin 
marks in sperm and the expression of these genes in the early embryo. Most of these 
genes were involved in driving the cell cycle and promoting metabolism (Wu, Zhang 
& Cairns 2011). 
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Alcohol exposure is known to not only affect DNA methylation, but has also been 
shown to affect ncRNAs and histone modifications. The effect of alcohol on miRNAs 
and its potential role in teratology is gaining much interest. One study noted that the 
exposure of mouse fetal cerebral-cortex neurons to ethanol was associated with the 
suppression of a collection of miRNAs and a subsequent increase in the levels of 
mRNA associated with genes targeted by the respective miRNAs. This resulted in the 
premature maturation of the cortical stem and progenitor cells (Sathyan, Golden & 
Miranda 2007). Similarly, bioinformatics analysis of microarray data from a fetus 
affected with F AS identified an up regulation of the 3' untranslated regions of various 
mRNAs. miRNAs are known to bind to the 3' untranslated regions of target mRNAs 
to induce cleavage and prevent translation. Therefore the increased 3' untranslated 
regions were indicative of decreased capabilities of miRNAs to degrade the target 
mRNAs following alcohol consumption (Wang et al. 2008). This could be responsible 
for mediating alcohol teratology during development. 
The effects of alcohol on histone modifications have also drawn much attention. In a 
more recent study done in mice, perinatal ethanol exposure was found to decrease the 
expression and function of a histone acetyl transferase, CBP. This subsequently 
resulted in a decrease in the lysine H3 and H4 acetylation in the cerebellum resulting 
in neuro-developmental deficits (Guo et al. 2011). Studies done in rats have revealed 
that while alcohol leads to the acetylation of H3K9, it decreases methylation at the 
same residue resulting in the down regulation of various genes. Concurrently 
methylation at H3K4 is increased, resulting in the up regulation of various genes 
(Kim, Shukla 2006, Pal-Bhadra et al. 2007). An increase in acetylation following 
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alcohol exposure has been related to transcriptional activation (Park, Lim & Shukla 
2005). 
In summary, if alcohol has a negative impact on the regulation of miRNAs and 
significantly alters histone modifications and both these epigenetic regulatory 
mechanisms, together with DNA methylation, are transmitted to the oocyte during 
fertilization then it could be argued that preconception paternal alcohol consumption 
could have a detrimental impact on the life long health of the child by altering these 
three epigenetic processes, which are crucial for normal embryonic development and 
in maintaining the stability and integrity of the genome. The paternally mediated 
effects on F ASD may be more complicated than originally thought. 
3.5 LIMITATIONS OF THE STUDY 
The small sample size was the main weakness of this study. As a result of this, there 
was an uneven spread of the number of drinks consumed per month by individuals 
within the alcohol-consuming group. While the majority of the alcohol-consuming 
individuals drank less than 20 drinks per month, only one individual drank 360 drinks 
per month. Therefore, increasing the sample size would enable for a more accurate 
classification of the individuals into three distinct and mutually exclusive catergories: 
light, moderate and heavy drinkers. 
The current study only assessed the methylation status of one paternally methylated 
locus, IG-DMR. Alcohol is known to increase and decrease methylation in a locus-
specific manner. Therefore maternally imprinted loci and non-imprinted Alu 
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elements, both found to be hypomethylated in the male germ-line under normal 
circumstances, would have added valuable information if included in the study. 
Another drawback of this study is that the DNA methylation work presented here was 
not coupled with expression studies. Expression studies focusing on IG-DMR 
expression would provide valuable information on whether a reduction in DNA 
methylation is coupled with a reduction in gene expression. Alcohol consumption is 
thought to reduce the mRNA levels of the DNMT enzymes in sperm (Bielawski et al. 
2002). This decrease in mRNA levels would indicate a reduction in DNMT enzymes, 
which are crucial for maintaining the correct DNA methylation levels. Therefore 
expression studies on the DNMT enzymes in the sperm could explain whether the 
decrease in methylation at the IG-DMR locus is indeed due to a decrease in the 
DNMT enzymes levels or whether another mechanism exists to regulate DNA 
methylation patterns following alcohol exposure. 
3.6 CONCLUSION 
The findings of this study suggest that alcohol consumption, regardless of the amount 
consumed, is correlated with a modest, but significant, reduction in overall DNA 
methylation at a paternally imprinted locus, IG-DMR, in male sperm. These findings 
support the hypothesis that alcohol consumption can lead to hypomethylation of 
normally hypermethylated DMRs of specific imprinted genes in the human sperm and 
this in tum could have significant implications with regard to the regulation of 
developmentally significant genes in the zygote and fetus resulting in developmental, 
behavioral and neuro-cognitive disorders. 
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Only one out of the ten epG sites was significantly demethylated in the alcohol-
consuming group with another epG site showing a trend towards reduced 
methylation. Drinking frequency significantly reduced the methylation at this latter 
epG and showed a trend towards decreasing methylation former epG site. 
It is proposed that alcohol consumption could potentially negatively influence the 
other epigenetic regulatory mechanisms in the sperm, which are also transmitted to 
the oocyte during fertilization. This in conjunction with altered DNA methylation 
patterns at imprinted genes could have significant implications for the health of the 
offspring born to men who consume alcohol during the preconception period. 
However, the amount of alcohol and the duration of exposure that may be harmful are 
not known. In addition, it is likely that there are inter-individual differences with 
regard to susceptibility to do harm. 
F AS is a major health burden in South Africa and the attention has always been on 
maternal alcohol consumption during pregnancy. However, the results from this study 
and similar studies focusing on the effects of alcohol on epigenetic modifications in 
sperm could be used to develop more effective prevention strategies not only directed 
towards women but equally directed towards men. 
In conclusion, these findings contribute to understanding the role of epigenetic 
modifications as possible mechanisms for paternal alcohol related effects on a fetus. 
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4.1 RATIONALE FOR THE STUDY 
The majority of F AS research conducted thus far has focused on maternal and fetal 
genetic risk factors following maternal alcohol consumption during pregnancy. 
However, studies have shown that preconception paternal alcohol abuse could result 
in offspring born with characteristic F ASD symptoms. The mechanism by which this 
occurs is poorly understood and a number of recent studies have proposed that 
epigenetic mechanisms may have a part to play. This body of work therefore focused 
on exploring whether DNA methylation could serve as a possible epigenetic 
mechanism responsible for the paternal contribution to F ASD, a major health burden 
in South Africa. 
4.2 SUMMARY OF THE FINDINGS 
Two loci (RASGRFI and IG-DMR) were selected based on their functional role in 
normal embryonic development, growth regulation and memory. Abnormalities at 
these loci, in rodent models, result in phenotypes similar to those observed in 
offspring affected with F ASD. 
The imprint status of RASGRF 1 in humans was unknown at the start of this project. 
RASGRF 1 was chosen for investigation because it is paternally imprinted in rats and 
mice. A number of computational assessments were done to identify key imprinting 
features, while molecular techniques assessed the methylation status of various eGIs 
surrounding RASGRFI. The methylation levels at these eGIs suggested that 
RASGRF 1 is not differentially methylated in a parent-of-origin manner. Therefore the 
123 
CHAPTER 4 - CONCLUDING REMARKS 
effect alcohol on DNA methylation was only examined at the IG-DMR locus in 
human sperm samples. An overall reduction in methylation was observed in the 
alcohol-consuming group with certain CpG sites more demethylated than others. Age 
was independently and significantly correlated with an increase in overall DNA 
methylation at this locus. 
4.3 IMPLICATIONS OF THE FINDINGS 
This body of research has demonstrated that alcohol consumption has the potential to 
alter methylation patterns in human sperm DNA. However, could this modest effect 
have a physiological or phenotypic consequence for the offspring born to men who 
consume alcohol? It is known that alcohol can also disrupt alternative mechanisms of 
epigenetic inheritance, such as RNA interference and histone modifications. The 
outcome of these two mechanisms, together with DNA methylation, are transmitted 
through the sperm to the oocyte during fertilization and could therefore have serious 
implications for the normal development and lifelong health of a child born to a father 
who consumes alcohol in the preconception period. This has important public health 
implications, highlighting the need for urgent research focusing on the epigenetic 
mechanisms underlying the possible paternally mediated effects on F ASD. 
4.4 FUTURE DIRECTIONS 
As outlined in the study limitations in Chapter 3, future studies of this nature will 
require a larger sample size such that individuals can be classified into three distinct 
categories based on drinking frequency: light drinkers, moderate drinkers and heavy 
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drinkers. These categories will allow for more meaningful results when evaluating 
whether alcohol is correlated with methylation in a dose-dependant manner. 
In addition to increasing the sample size, future studies are required to explore the 
effects of alcohol on a repertoire of imprinted loci that include both paternally and 
maternally imprinted loci and transposable elements, such as the Alu elements, in 
sperm samples. It would be of great value to correlate the methylation data obtained 
from the imprinted loci with gene expression data of the associated genes. This could 
provide insight into the role of imprinting as a possible mechanism responsible for 
paternally mediated effects on F ASD. 
DNA methylation is known to act in concert with ncRNAs and histones to maintain 
the stability and integrity of the genome and alcohol is known to disrupt all three 
epigenetic modifications in the sperm. Therefore in conjunction with the DNA 
methylation analysis, future studies should assess the effect of alcohol on RNA 
species and histone modifications. This could give a clearer picture of the paternally 
mediated effects on F ASD. 
Lastly, an invaluable study would be to start a cohort, where samples would be 
collected from men who consume alcohol, wives or partners who do not consume 
alcohol and their biological children. The children would be followed preferably from 
birth throughout childhood into adulthood. Microarray analysis would be done in the 
sperm samples to determine which genes are up and down regulated. In addition, 
alterations in the various epigenetic modifications would be characterized. Various 
tissue types would be collected from the children and microarray analysis would be 
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done to detennine whether gene expression is influenced by the changes identified in 
the spenn. The various epigenetic modifications in the different tissue types would 
need to be characterised and compared. The reason for using different tissue types is 
that epigenetic modifications are tissue-specific and are influenced by stochastic and 
temporal events (Schneider et al. 2010). This cohort study could assist in confinning 
whether the epigenetic alterations in spenn samples, following alcohol consumption, 
do indeed affect the nonnal development of the child. In addition, this study could 
assist in answering questions related to alcohol dosage effects and the effects of inter-
individual DNA methylation variation in spenn and the resulting consequences in the 
children. If alterations in DNA methylation in human spenn are transmitted to the 
oocyte, could the epigenetic variation lead to variable penetrance of diseases and 
disorders in offspring? 
One key question arising from this body of research remains to be answered: 
• How many spenn cycles should pass following abstinence from alcohol to 
ensure that the effects of alcohol are not passed onto the subsequent 
generation? 
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ETHICS CLEARANCE CERTIFICATES 
ApPENDICES - ApPENDIX A: ETHICS CLEARANCE CERTIFICATES 
A.I Ethics clearance certificate for random control samples (blood) 
IlPMM ''HARQlJjTBICS COMMD'TII tMBDICAL) 
Jll4149 a-ayJSooclyalet at 
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A.2 Ethics clearance certificate for current study 
UNIVERSITY OF THE WITWATERSRAND. JOHANNESBURG 
Division of the DeputY Registrar CR.esearch) 
HUMAN RESEARCH ETHICS COMMiTTEE <MEDICAL) 
R14/49 Misses P PitamberlS Patel 
CLEARANCE CERTIFICATE 
PROJECT 
INVESTIGATORS 
DEPARTMENT 
DATE CONSIDERED 
DECISION OF THE COMMITTEE· 
Unless otherw 
application. 
2009109114 
M09055S 
P: methylation Profiling of Two Patemal1y 
Imprinted loci, RASGRF and IG-DMR, in Male 
Gametes following Alcohol ExposurelS: Profiling 
the Epigenetic Signatures attbe H19 DMR in 
Spenn, of Alcoholic Males-Implications for Fetal... 
Misses P PitamberlS Patel. 
School ofPathologylDivision of Human Genetics 
09.05.29 
Approved unconditionally 
·Guidelines for written 'informed consent' attached where applicable 
co: Supervisor: ProfM Ramsay 
------------.-----------------------
DECLARATION OF INVESTIGATORCs) "~~~=R 
To be completed in duplicate and ONE COpy returned to the Secretary at Room I 
Senate House, University. 
IIWe fully understand the conditions under which I amlwe are authorized to cany out the abovementioned 
research and IIwe guarantee to ensure compliance with these conditions. Should any departure to be 
contemplated from the research procedure as approved IIwe undertake to resubmit the protocol to the 
Committee. I agree to a completion of a yearly progress report. 
PLEASE QUOTE THE PROTOCOL NUMBER IN ALL ENQUIRIES .•. 
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ApPENDICES - ApPENDIX B: CONSENT FORM, INFORMATION SHEET AND QUESTIONNAIRE 
B.1 Consent form 
Study Titles: 
1) Methylation Profiling of Two Paternally Imprinted loci, RASGRF and IG-DMR, in Male 
Gametes following Alcohol Exposure 
2) Profiling the Epigenetic Signatures at the H19 DMR in Sperm of Alcoholic Males-
Implications for Fetal Alcohol Spectrum Disorders (F ASD) 
Investigators: Miss Punita Navnitlal Pitamber and Miss Sanam Harishkumar Patel 
Site ofInvestigation: ....................... . 
Date: .......................................... . 
Code: ......................................... . 
Consent Form 
The information that you divulge in the questionnaire will be kept confidential 
Do you understand the information related to this study? 
Do you have any questions about the research? 
Do we have your permission to administer the questionnaire? 
Are you willing to contribute a semen sample? 
Do we have your permission to conduct the described 
research on your semen sample? 
Do you give permission for storage of your sample, to be used 
for future research on the effect of alcohol on sperm? 
Full Name of Participant 
(Participation in these studies can be anonymous): 
Signature: __________________________ ___ 
Date: 
-----------------------
Yes 
Yes 
Yes 
Yes 
Yes 
Yes 
I have answered all the questions from the participant to the best of my ability. 
Name of Study Co-ordinator: ____________________ _ 
Signature: ______________________ _ 
No 
No 
No 
No 
No 
No 
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B.2 Participant information sheet 
The National Health Laboratory Service 
University of the Witwatersrand, School Of Pathology 
Division Human Genetics 
Hospital Street, Johannesburg 2001 
Telephone: +27-11-489-9224/9223/9211 
PO Box 1038, Johannesburg 2000 
Telefax: +27-11-489-9226 or +27-11-489-9209 
Prof A Christianson 489-9239 
Prof H Soodyall 489·9208 
STUDY TITLES: 
Prof A Krause 489·9219 
Dr T Lane 489·9221 
Information Sheet 
Prof M Ramsay 489 ·9214 
1) Methylation Profiling of Two Paternally Imprinted loci, RASGRF and IG-DMR, in Male 
Gametes following Alcohol Exposure 
2) Profiling the Epigenetic Signatures at the Hl9 DMR III Sperm of Alcoholic Males-
Implications for Fetal Alcohol Spectrum Disorders (F ASD) 
INVESTIGATORS: Miss Punita Navnitlal Pitamber and Miss Sanam Harishkumar Patel 
(MSc [Med] Research Students) 
Good Day, 
We, Punita Pitamber and Sanam Patel, master's students from the Division of Human 
Genetics at the NHLS would like to invite you to participate in our research studies. Both 
studies focus on the effect of alcohol consumption on sperm DNA and your participation in 
this study is entirely voluntary. You can withdraw from the studies at any point without 
consequence to you by contacting the project investigators. Before agreeing to participate, it 
is important that you read the following document to understand the purpose of the studies. If 
you have any questions about the studies or the terms used, please do not hesitate to ask one 
of the study co-ordinators. 
We know that children born to mothers who drink during pregnancy can develop a range of 
disorders known as Fetal Alcohol Spectrum Disorders (F ASD). Children with any of these 
disorders can show symptoms such as brain damage, growth problems and facial 
morphologies. However, recent research in mice has shown that some symptoms of F ASD 
such as growth retardation can develop in babies born to fathers who drank before conception 
and mothers who drank no alcohol before or during pregnancy. One way that this could 
happen is through alcohol changing the sperm at the level of the DNA. Specific patterns in 
the father's sperm DNA are unique and different from the patterns on the mother's DNA. 
These patterns are very important for normal development of children during pregnancy. 
Sperm DNA contains all the information that is passed from father to child. If alcohol 
changes the patterns on the DNA, in sperm, then the child could develop symptoms ofFASD. 
The aim of our studies is to understand how alcohol can change the patterns contained in the 
DNA of sperm and in doing so affect the normal development of children. 
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B.2 Participant information sheet (cont'd) 
The National Health Laboratory Service 
University of the Witwatersrand, School Of Pathology 
Division Human Genetics 
Hospital Street, Johannesburg 2001 
Telephone: +27-11-489-9224/9223/9211 
PO Box 1038, Johannesburg 2000 
Telefax: +27-11-489-9226 or +27 -11-489-9209 
Prof A Christianson 489-9239 
Prof H Soodyall 489-9208 
Prof A Krause 489-9219 
Or T Lane 489·9221 
Prof M Ramsay 489·9214 
If you volunteer to participate in these studies we would request that you complete a 
questionnaire, which will take about 30-45minutes to complete. You will be asked to answer 
questions about your family and ethnic history, sexual health, drinking, smoking and drug use 
patterns. A few questions will be asked about your parents' drinking habits. Some of the 
questions may be sensitive and if you feel you cannot answer them, you may leave them 
unanswered. You may participate in this study without giving your name. If you reveal 
information that may have serious legal implications we may be obligated to disclose it if 
compelled by a court of law. 
After completing the questionnaire, we will ask you to provide us with a semen sample. A 
private room will be made available for this purpose. Semen should only be given if you have 
not ejaculated in the past two days. In the laboratory, specific tests will be performed on the 
sperm DNA to determine if any changes have occurred in the DNA patterns. We shall not test 
for any general health conditions (e.g. sexually transmitted diseases). If you permit, on 
completion of these studies your samples will be stored in the lab for future research. This 
future research will be carried out subject to approval by the Human Research Ethics 
Committee (Medical). If not, your samples will be destroyed on completion of these studies. 
The samples will be given a unique identification code to ensure anonymity. The results from 
the test are for this research only and will not be returned to you. However, should you wish 
to discuss further any issues related to or raised in the course of this research, you could 
approach the investigators with regard to appropriate referral for counselling. 
Thank you for your time. 
Sincerely, 
Punita Pitamber 
SanamPatel 
Tel: (011) 4899225 
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B.3 Participant questionnaire 
Study Titles: 
1) Methylation Profiling of Two Paternally Imprinted loci, RASGRF and IG-DMR, in Male 
Gametes following Alcohol Exposure 
2) Profiling the Epigenetic Signatures at the HJ9 DMR in Sperm of Alcoholic Males-
Implications for Fetal Alcohol Spectrum Disorders (F ASD) 
Investigators: Miss Punita Navnitlal Pitamber and Miss Sanam Harishkumar Patel 
Site ofInvestigation: ....................... . 
Date: ......................................... .. 
Code: ................................... . 
Questionnaire 
Please answer the following questions: 
A. Personal History 
1. Age:_ 
2. Your first language: 
3. Your place of birth: 
4. Mother's first language: 
5. Mother's place of birth: 
6. Father's first language: 
7. Father's place of birth: 
8. Have you ever conceived a child? 
9. Have your genitals ever been seriously injured? 
Yes No 
Yes No 
10. Have you ever contracted any sexually transmitted diseases? Yes No 
11. Have you ejaculated in the past 2 days? Yes No 
B. sMAST Questions 
Please circle the appropriate answer 
1. Do you feel you are a normal drinker of alcohol? 
2. Do you ever feel bad about drinking? 
3. Do friends or relatives think you are a normal drinker? 
4. Do your spouse/partner or parents worry or complain about 
your drinking? 
Yes No 
Yes No 
Yes No 
Yes No 
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B.3 Participant questionnaire (cont'd) 
5. Are you always able to stop drinking when you want to? 
6. Have you ever attended a meeting of Alcoholics Anonymous 
or any similar group? 
7. Has drinking ever created problems between you and your spouse? 
8. Have you ever gotten into trouble at work because of drinking? 
9. Have you ever neglected your obligations, your family, or your 
work for 2 days or more days in a row because you were drinking? 
10. Have you ever gone to anyone for help about your drinking? 
11. Have you ever been in hospital because of drinking? 
12. Have you ever been arrested, even for a few hours, because of 
drinking? 
13. Have you ever been arrested for drunk driving or driving after 
drinking? 
c. Drinking Frequency 
1. How old were you when you started drinking regularly? __ 
2. How often do you drink? (Tick the one that fits you best) 
i. Never vi. 1-2 days a week 
ii. Once a year at most vii. Almost every day 
iii. Several times a year viii. Everyday 
iv. Once a month xi. Not sure 
v. 2-3 times a month 
3. Have you stopped drinking? 
If yes at what age? 
4. What is your usual beverage or beverages? 
5. On days that you drink, how many drinks do you have? 
D. Family Drinking History 
Mother 
1. Is he / she alive? Yes No 
2. Cause of death? 
3. Current age of parent or age at death? 
4. Does he / she drink alcohol regularly? Yes No 
5. If not currently a drinker did they drink when you 
were growing up? Yes No 
Yes No 
Yes No 
Yes No 
Yes No 
Yes No 
Yes No 
Yes No 
Yes No 
Yes No 
Yes No 
Father 
Yes No 
Yes No 
Yes No 
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B.3. Participant questionnaire (cont'd) 
E. Smoking 
1. When did you last use tobacco (smoke or chew) or snuff? 
Never 
More than a year ago 
In the past year 
In the past 30 days 
Don't recall 
2. How old were you when you first smoked or used tobacco? ____ _ 
3. Are you still smoking or using tobacco? Yes No 
4. How old where you when you stopped using tobacco? _____ _ 
5. How many cigarettes a day do/did you smoke? ______ _ 
F. Other Drug Use 
1. Have you ever used any drugs regularly? Yes No 
2. What drugs have you used? _________ _ 
(e.g. dagga, glue, ecstasy (XTC, E, Adam), marijuana, cocaine, heroin, sugars, 
mandrax, 
amphetamines (bennies, dexies), Ice (meth, crystal), CAT) 
3. How old were you when you started using drugs regularly? ____ _ 
4. How often do/did you use drugs? 
i. Never 
ii. Once a year at most 
iii. Several times a 
year 
iv. Once a month 
v. 2-3 times a month 
5. When did you last use drugs? 
Never 
More than a year ago 
In the past year 
1-6 months ago 
In the past 30 days 
Don't recall 
vi. 1-2 days a week 
vii. Almost every day 
viii. Everyday 
ix. Not sure 
Thank you very much for your co-operation © 
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ApPENDICES - APPENDIX C: REAGENT AND EQUIPMENT SUPPLIERS 
Table C.I List of reagent suppliers 
Reagent Supplier 
QIAamp® DNA Micro Kit Qiagen, Valencia, CA, United States of America 
EZ DNA methylation kit Zymo Research, Orange, CA, United States of America 
dNTPs Bioline, London, United Kingdom 
Primers lOT, Iowa, United States of America 
AmpliTaq Gold Taq polymerase, lOx Buffer & MgCh Applied Biosystems, NJ, United States 
Agarose (Molecular Grade) Whitehead Scientific, Brackenfell, South Africa 
Ethidium Bromide aqueous solution Sigma Aldrich, MO, United States of America 
50bp ladder New England Biolabs, MA, United States of America 
Sepharose Beads HP GE Health, Uppsala, Sweden 
Table C.2 List of equipment suppliers 
Equipment Supplier 
Microfuge® 18 Microcentrifuge Beckman Coulter, Brea, CA, United States of America 
Nanodrop® NO-lOOO Spectrophotometer Thermo Fisher Scientific, MA United States of America 
PSQ 96 MA Pyrosequencer™ Biotage, Uppsala, Sweden 
GeneAmp 2720 thermal cycler Applied Biosystems, NJ, United States of America 
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APPENDICES - APPENDIX D: PREPARATION OF SOLUTIONS 
1x Tris EDTA (TE) buffer 
10ml 1M Tris-HCI (pH 8.0) 
2ml 0.5M EDTA 
Make up to 1 L with dH20 
1M Tris-HCI (pH 8.0) 
121.1g Tris 
Dissolve in 800ml with dH20, adjust pH to 8.0 with HCl. Make up to lL with dH20. 
0.5MEDTA 
93.06gEDTA 
Dissolve in 400ml with dH20, adjust pH to 8.0 with NaOH. EDTA will only dissolve if the pH is 
correct. Make up to 500ml with dH20. 
10M NaOH 
4g Sodium Hydroxide 
Make up to 10ml with dH20 
3% (w/v) Agarose gel 
3g Agarose (Molecular Grade) per 100mi dH20 
3~1 Ethidium bromide (lOmg/ml) per 100mlix TBE 
lOx Tris boric EDTA 
216g Tris 
1 109 Boric Acid 
18.6g EDTA 
Make up to 2L with dH20 
dNTPs 
12.5 ~l dATP (lOmM) 
12.5 ~l dTTP (lOmM) 
12.5 ~l dCTP (lOmM) 
12.5 ~l dGTP (lOmM) 
Make up to Iml using ddH20 
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Binding buffer (pH 7.6) 
1.21g Tris 
117g Sodium Chloride 
O.292gEDTA 
1ml Tween20 
Make up to 900ml with ddH20, adjust pH to 7.6 with HCI. Add 1 ml Tween20 and make up to 
1L with ddH20. 
Annealing buffer (pH 7.6) 
2.42g Tris 
0.43g Magnesium Acetate Tetrahydrate 
Make up to 900ml with ddH20, adjust pH to 7.6 with acetic acid. Make up to 1L with ddH20. 
70% Ethanol 
700ml Absolute Ethanol 
Make up to 1L with ddH20 
Denaturation solution (0.2M Sodium Hydroxide) 
8g Sodium Hydroxide 
Make up to 1L with ddH20 
Washing buffer (pH 7.6) 
1.21g Tris 
Make up to 900ml with ddH20, adjust pH to 7.6 with acetic acid. Make up to 1L with ddH20. 
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ApPENDICES - ApPENDIX E: PARTICIPANT INFORMATION 
Table E.1 Participant information 
# of Years Drinking Frequency Total Sperm Normal Sperm Sperm Motility 
Sam2leID *Ethnicit~ AKe DrinkinK ~units/month~ SmokinK DruK Use Concentration pOA6/ml~ Mo!!holoK~ ~%) 0.5 hrs ~%~ 
HSS 019 B 25 0 0 No No 110 15 60 
HSS 025 B 38 0 0 No No 44 5 60 
HSS 027 28 0 0 No No 54 20 60 
HSS 031 B 32 0 0 No No 30 7 45 
HSS 032 W 29 Stopped for the last 4 years No No 13 II 50 
HSS 033 I 36 Stopped for the last 6 years Yes No 85 15 50 
HSS 035 B 29 0 0 No No 18 10 40 
HSS 037 B 33 Stopped for the last 4 years No No 137 7 60 
HSS 038 B 37 0 0 No No 23 8 60 
HSS 042 B 40 Stopped for the last 9 years No No 18 12 50 
HSS 046 B 33 0 0 No No 77 5 50 
HSS 050 I 50 Stopped for the last 20 years No No 42 4 40 
HSS 055 C 29 Stopped for the past 2 years No No 22 6 60 
HSS 056 B 30 0 0 Yes No 21 11 50 
HSS 070 B 34 0 0 No No 73 14 70 
HSS 074 B 30 0 0 No No 72 6 40 
HSS 075 B 40 0 0 No No 36 16 70 
HSS 077 28 0 0 No No 39 5 50 
HSS 079 B 39 0 0 No No 167 20 50 
HSS 082 22 0 0 No No 56 15 65 
HSS 085 B 38 0 0 No No 57 10 50 
HSS 088 38 0 0 Yes No 28 13 65 
HSS 089 B 38 0 0 No No 36 15 70 
HSS 094 28 0 0 No No 83 16 65 
HSS 096 B 36 0 0 No No 23 10 40 
HSS 097 B 36 0 0 No No 11 1 40 
HSS 107 43 0 0 Yes No 68 16 55 
HSS 116 B 45 0 0 No No 52 19 55 
HSS 121 28 0 0 No No 53 18 70 
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HSS 131 C 33 0 0 No No 70 10 50 
HSS 136 B 36 0 0 No No 37 21 50 
HSS 141 W 37 0 0 Yes No 32 1 30 
HSS 142 C 36 Stopped for the past 6 years Yes No 65.5 3 70 
HSS 149 B 33 0 0 No Yes 14 9 60 
# Years Drinking Frequency Total Sperm Normal Sperm Sperm Motility 
SameleID *Ethnicit~ A~e Drinkin~ ~units/month~ Smokin~ Dru~Use Concentration pOJ\6/ml~ Moreholo~ ~%~ 0.5 hrs ~%~ 
HSS 001 B 23 6 30 Yes No 76 15 60 
HSS 003 W 31 12 15 Yes No 102 18 50 
HSS 004 W 27 9 72 Yes No 96 14 60 
HSS 005 W 28 4 6 No No 70 19 65 
HSS 006 W 38 20 3 No No 10 13 60 
HSS 008 W 22 6 60 Yes No 24 15 60 
HSS 010 B 35 10 6 No No 16 9 60 
HSS 011 B 20 2 75 No No 40 20 60 
HSS 016 W 26 7 6 No No 62 12 60 
HSS 017 B 31 21 15 Yes No 110 11 60 
HSS 018 B 34 4 15 No No 28 14 60 
HSS 020 B 34 16 120 No No 18 18 60 
HSS 021 W 34 16 72 Yes No 8.8 2 60 
HSS 022 W 29 11 30 No No 4.4 10 50 
HSS 023 W 33 12 6 Yes Yes 280 17 40 
HSS 024 I 33 15 No No 128 12 60 
HSS 028 C 36 18 1 No No 81 19 60 
HSS 036 B 40 22 36 No No 44 5 45 
HSS 040 B 38 22 18 No Yes 14 10 50 
HSS 043 29 10 9 No No 86 16 50 
HSS 044 B 34 13 2 Yes No 10 1 45 
HSS 048 B 37 17 60 No No 11 1 40 
HSS 051 35 15 4 Yes No 110 9 45 
HSS 052 B 39 21 60 No No 10 5 60 
HSS 053 C 33 15 84 No Yes 70 16 70 
HSS 054 30 7 14 Yes No 80 5 65 
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HSS 057 
HSS 058 
HSS 061 
HSS 062 
HSS 064 
HSS 067 
HSS 068 
HSS 069 
HSS 071 
HSS on 
HSS 073 
HSS 076 
HSS 078 
HSS 081 
HSS 083 
HSS 084 
HSS 086 
HSS 090 
HSS 092 
HSS 095 
HSS 098 
HSS 102 
HSS 103 
HSS 105 
HSS 110 
HSS 111 
HSS 112 
HSS 114 
HSS 117 
HSS 118 
HSS 119 
HSS 120 
HSS 122 
HSS 123 
HSS 124 
HSS 125 
w 
w 
w 
w 
C 
B 
W 
W 
B 
B 
B 
B 
W 
B 
B 
B 
W 
W 
W 
B 
B 
B 
W 
W 
W 
W 
B 
B 
W 
B 
W 
B 
W 
B 
W 
W 
40 
34 
35 
29 
35 
36 
39 
35 
34 
35 
46 
28 
45 
34 
39 
37 
39 
25 
27 
28 
35 
41 
31 
36 
35 
33 
42 
49 
31 
48 
30 
35 
31 
36 
29 
34 
19 
17 
19 
12 
17 
18 
22 
16 
7 
15 
28 
8 
15 
13 
14 
18 
21 
9 
12 
5 
20 
13 
15 
18 
16 
12 
22 
24 
15 
13 
11 
18 
13 
16 
10 
16 
150 
36 
8 
2 
n 
30 
12 
24 
6 
6 
36 
15 
30 
5 
24 
6 
45 
108 
144 
48 
60 
2 
1 
9 
23 
42 
60 
7 
5 
4 
15 
6 
144 
42 
15 
Yes 
No 
No 
Yes 
No 
No 
Yes 
No 
Yes 
Yes 
No 
Yes 
Yes 
No 
No 
No 
No 
Yes 
Yes 
No 
No 
No 
No 
No 
Yes 
Yes 
No 
Yes 
Yes 
No 
Yes 
No 
No 
No 
No 
Yes 
No 
No 
No 
No 
No 
No 
No 
No 
No 
No 
No 
No 
No 
No 
No 
No 
No 
No 
No 
No 
No 
No 
Yes 
No 
No 
No 
No 
No 
No 
No 
No 
No 
No 
No 
No 
No 
27 
99 
76 
162 
6.3 
45 
38 
20 
7 
25 
24 
176 
43 
123 
54 
29 
83 
28 
58 
4.2 
48 
11 
151.2 
310 
16 
28 
6 
9 
5.9 
8 
28 
49 
155 
62 
36 
17 
4 
12 
15 
20 
4 
20 
14 
15 
12 
15 
10 
20 
17 
18 
19 
16 
20 
9 
8 
5 
19 
2 
2 
14 
1 
6 
8 
2 
6 
1 
15 
17 
25 
20 
11 
50 
60 
70 
75 
20 
45 
55 
50 
40 
70 
40 
65 
40 
65 
70 
60 
60 
60 
60 
60 
70 
30 
70 
60 
40 
60 
45 
50 
50 
20 
50 
30 
65 
60 
60 
60 
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HSS 126 I 29 8 3 No No 63 4 70 
HSS 127 B 30 5 36 No No 56 10 70 
HSS 128 W 29 11 6 No No 12 1 50 
HSS 129 B 41 16 36 Yes No 66 16 60 
HSS 130 B 32 17 360 Yes No 58 7 60 
HSS 132 B 39 18 42 No No 95 15 60 
HSS 133 B 33 18 96 No No 5.3 3 60 
HSS 134 B 33 15 12 Yes No 47 15 65 
HSS 135 B 33 9 10 No No 55 8 60 
HSS 137 W 34 16 No No 23 4 50 
HSS 140 W 32 14 9 Yes No 101 16 70 
HSS 143 C 33 16 10 Yes No 18 2 50 
HSS 144 B 31 6 15 No No 37 10 50 
HSS 145 W 38 17 30 Yes No 27 4 60 
HSS 146 34 14 60 No Yes 124 15 60 
HSS 147 B 26 10 18 No No 28 17 60 
HSS 148 B 39 18 10 No No 162 3 60 
*Ethnicity Key - B : Black 
W: White 
C: Coloured 
I : Indian 
Spenn parameters in bold represent values lower than the WHO lower reference limits (Cooper et al. 2010). 
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Table E.2 Ethnicity breakdown within two treatment groups 
Controls Alcohol Consumers 
Sample size (N) 34 78 
Count (Frequency) Count (Frequency) 
Ethnicity: 
White 2 (5.77%) 32 (41.03%) 
Black 20 (58.82%) 37 (47.44%) 
Colored 3 (8.82%) 4 (5.13%) 
Indian 9 (26.47%) 5 (6.41 %) 
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ApPENDICES - ApPENDIX F: SPERM DNA EXTRACTION PROTOCOL, DNA CONCENTRATION AND 
PURITY OF SAMPLES 
The following protocol "Purification of DNA from epithelial cells mixed with sperm cells using 
the QIAamp® DNA Micro Kit" is the supplementary protocol to the QIAamp® DNA Micro Kit. 
This protocol is designed for purification of total (genomic and mitochondrial) DNA from fabrics 
or swabs containing epithelial cells mixed with sperm cells using the QIAamp DNA Micro Kit. 
Protocol: 
1. Place the swab or a piece of fabrics (~0.5cm2) in a 2 ml microcentrifuge tube (not 
provided).Separate the cotton or DACRON® swab from its shaft by hand or using 
scissors. In our case approximately 900 fll of sperm sample was added to the 
microcentrifuge tube. 
2. Add 20 ~l proteinase K and 500~1 Buffer ATL to the sample. Close the cap and mix by 
pulse-vortexing for 10 s. 
3. Place the 2 ml tube in a thermomixer or heated orbital incubator, and incubate at 56°C 
with shaking at 900 rpm for at least 1 h. 
4. Briefly centrifuge the 2 ml tube to remove drops from the inside of the lid. 
5. Remove the solid material from the tube. 
6. Centrifuge the tube for 5 min at full speed. Carefully transfer all but 30 ~l of the 
supernatant to a new tube without disturbing the pellet. 
Note: For isolation of DNA from epithelial cells, transfer 300 ~l of the supernatant into a 2 ml 
microcentrifuge tube and continue with step 12. 
7. Resuspend the pellet in 500 ~l Buffer ATL. Close the lid and mix by pulse-vortexing for 
lOs. Centrifuge the tube for 5 min at full speed. Carefully aspirate and discard all but 30 
~l of the supernatant without disturbing the pellet. 
8. Repeat step 7 at least three times. 
Note: The ratio of epithelial cells to sperm cells influences the number of repeats needed for 
purification of sperm nuclei. 
9. Add 300 ~l Buffer A TL, 1 0 ~l proteinase K, and 1 0 ~l 1 M DTT to the pellet. Close the 
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lid and mix by pulse-vortexing for 10 s. 
10. Place the 2 ml tube in a thermomixer or heated orbital incubator, and incubate at 56°C 
with shaking at 900 rpm for at least 1 hour. 
11. Briefly centrifuge the tube to remove drops from the inside of the lid. 
12. Add 300 ~l Buffer AL, close the lid, and mix by pulse-vortexing for 10 s. 
Note: To ensure efficient lysis, it is essential that the sample and Buffer AL are thoroughly mixed 
to yield a homogeneous solution. A white precipitate may form when Buffer AL is added to 
Buffer ATL. The precipitate does not interfere with the QIAamp procedure and will dissolve 
during incubation in step 13. 
Note: If carrier RNA is required (see the QIAamp DNA Micro Handbook), add 1 ~g dissolved 
carrier RNA to 300 ~l Buffer AL. Note that carrier RNA does not dissolve in Buffer AL. It must 
first be dissolved in Buffer AE and then added to Buffer AL. 
13. Place the tube in the thermomixer or heated orbital incubator, and incubate at 70°C with 
shaking at 900 rpm for 10 min. 
14. Centrifuge the tube at full speed (20,000 x g; 14,000 rpm) for 1 min. 
15. Carefully transfer the supernatant from step 14 to the QIAamp MinElute® column 
without wetting the rim. 
16. Close the lid, and centrifuge at 6000 x g (8000 rpm) for 1 min. Place the QIAamp 
MinE lute column in a clean 2 ml collection tube, and discard the collection tube 
containing the flow-through. 
Note: If the lysate has not completely passed through the membrane after centrifugation, 
centrifuge again at a higher speed until the QIAamp MinElute Column is empty. 
17. Carefully open the QIAamp MinElute column and add 500 ~l Buffer AWl without 
wetting the rim. Close the lid and centrifuge at 6000 x g (8000 rpm) for 1 min. Place the 
QIAamp MinElute column in a clean 2 ml collection tube, and discard the collection tube 
containing the flow-through. 
18. Carefully open the QIAamp MinElute column and add 500 ~l Buffer AW2 without 
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wetting the rim. Close the lid and centrifuge at 6000 x g (8000 rpm) for 1 min. Place the 
QIAamp MinElute column in a clean 2 ml collection tube, and discard the collection tube 
containing the flow-through. 
19. Centrifuge at full speed (20,000 x g; 14,000 rpm) for 3 min to dry the membrane 
completely. 
Note: This step is necessary, since ethanol carryover into the eluate may interfere with some 
downstream applications. 
20. Place the QIAamp MinElute column in a clean 1.5 ml microcentrifuge tube and discard 
the collection tube containing the flow-through. Carefully open the lid of the QIAamp 
MinElute column and apply 20-50 III Buffer AE or distilled water to the center of the 
membrane. 
Important: Ensure that Buffer AE or distilled water is equilibrated to room temperature (15-
25°C). Dispense Buffer AE or distilled water onto the center of the membrane to ensure complete 
elution of bound DNA. 
21. Close the lid and incubate at room temperature (15-25°C) for 1 min. Centrifuge at full 
speed (20,000 x g; 14,000 rpm) for 1 min. Incubating the QIAamp MinElute column 
loaded with Buffer AE or water for 5 min at room temperature before centrifugation 
generally increases DNA yield. 
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Table F.l. DNA concentration and purity for all sperm samples used in the study 
Sample 
HSS 001 
HSS003 
HSS004 
HSS005 
HSS006 
HSS008 
HSSOIO 
HSSOll 
HSS016 
HSS017 
HSS018 
HSS019 
HSS020 
HSS021 
HSS022 
HSS023 
HSS024 
HSS025 
HSS027 
HSS028 
HSS031 
HSS 032 
HSS033 
HSS035 
HSS036 
HSS037 
HSS038 
HSS040 
HSS042 
HSS043 
HSS044 
HSS046 
HSS048 
HSS050 
HSS051 
HSS052 
HSS053 
HSS054 
HSS055 
HSS056 
HSS057 
HSS058 
HSS061 
HSS062 
HSS 064 
HSS 067 
HSS 068 
HSS 069 
DNA Concentration (ngl,..l) 
53.2 
85.56 
49.19 
66.81 
76.85 
57.94 
59.74 
44.85 
64.63 
55.42 
65 
58.83 
57.06 
72.56 
79.12 
94.39 
94.36 
66.69 
86.4 
92.3 
60.3 
39.8 
101.5 
68.4 
86.8 
188.8 
226.9 
31.2 
82.1 
51.1 
46.1 
47 
49.1 
67.6 
42.7 
76.4 
106.1 
237.3 
43.1 
39.7 
70.7 
39.8 
60.8 
60 
62.2 
44.2 
47.2 
69.2 
Purity Ratio (260:280) 
2.00 
1.85 
2.10 
1.93 
2.07 
2.06 
2.06 
2.00 
2.06 
2.01 
2.05 
1.98 
1.94 
2.04 
2.04 
1.97 
2.03 
1.96 
2.03 
2.03 
1.88 
1.99 
1.97 
1.95 
2.04 
1.88 
1.94 
2.00 
1.91 
2.09 
1.87 
2.02 
1.73 
2.01 
2.06 
2.06 
1.98 
1.46 
2.03 
1.97 
2.07 
2.02 
1.95 
2.06 
1.99 
1.93 
2.03 
1.99 
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HSS 070 98.4 2.06 
HSS071 28.56 2.07 
HSS on 32.2 2.05 
HSS 073 n 1.99 
HSS 074 43.3 2.09 
HSS 075 70.4 1.91 
HSS 076 89.1 1.99 
HSS 077 17 1.40 
HSS 078 99.7 2.06 
HSS 079 48.3 2.06 
HSS 081 37.5 2.13 
HSS 082 64.6 1.95 
HSS 083 39.2 1.70 
HSS 084 30.2 1.47 
HSS 085 80.2 2.06 
HSS 086 78.8 1.92 
HSS 088 38.4 2.02 
HSS 089 48.4 2.02 
HSS 090 67 2.03 
HSS 092 52.9 2.04 
HSS 094 96.5 2.10 
HSS 095 59.7 1.43 
HSS 096 33.7 2.09 
HSS097 34.47 1.94 
HSS 098 29.9 2.05 
HSS102 55.98 1.83 
HSS 103 89.3 2.03 
HSS 105 74.1 2.08 
HSS 107 61.6 2.00 
HSS 110 26.5 2.10 
HSS 111 119 1.68 
HSSl12 77.27 1.87 
HSS 114 50.3 2.10 
HSS 116 n 1.87 
HSS 117 51.5 2.09 
HSS118 75.22 1.89 
HSS 119 17.6 2.03 
HSS 120 40.3 2.14 
HSS 121 31.7 2.06 
HSS 122 86.7 1.94 
HSS 123 73.2 1.93 
HSS 124 28.8 2.07 
HSS 125 31.9 1.2 
HSS 126 61.5 1.84 
HSS 127 80.3 2.08 
HSS 128 41.5 2.00 
HSS 129 67 1.75 
HSS 130 80.1 1.96 
HSS 131 111.7 2.06 
HSS 132 134 2.06 
HSS 133 79.6 2.01 
HSS 134 69 2.11 
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HSS 135 108.3 1.86 
HSS 136 34.9 2.08 
HSS 137 65.9 2.04 
HSS 140 80.2 1.97 
HSS 141 59.2 2.19 
HSS 142 35.4 1.99 
HSS 143 55.7 2.13 
HSS 144 48.8 2.03 
HSS 145 28.5 1.89 
HSS 146 66.8 1.96 
HSS 147 52.5 2.00 
HSS 148 39.6 2.07 
HSS 149 45.8 1.88 
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The following protocol was taken from the Zymo Research's EZ DNA Methylation-Gold™ Kit 
instruction manual. 
Reagent preparation: 
• Preparation of CT Conversion Reagent 
The CT Conversion Reagent supplied within this kit is a solid mixture and must be prepared prior 
to first use. Prepare as follows: 
l. Add 900 J.lI water, 300 J.lI ofM-Dilution Buffer, and 50 J.lI M-Dissolving Buffer to a tube 
of CT Conversion Reagent. 
2. Mix at room temperature with frequent vortexing or shaking for 10 minutes. 
• Preparation ofM-Wash Buffer 
Add 96 ml of 100% ethanol to the 24 ml M -Wash Buffer concentrate before use. 
Protocol for bisulfite modification: 
l. Add 130 J.lI of the CT Conversion Reagent to 20 J.lI of your DNA sample in a PCR tube. If 
the volume of the DNA sample is less than 20 J.lI, make up the difference with water. 
Mix the sample by flicking the tube or pipetting the sample up and down, then centrifuge 
the liquid to the bottom of the tube. 
2. Place the sample tube in a thermal cycler and perform the following steps: 
• 98°C for lO minutes 
• 64°C for 2.5 hours 
• 4 °c storage up to 20 hours. 
3. Add 600 J.lI ofM-Binding Buffer to a Zymo-Spin™ IC Column and place the column into 
a provided collection tube. 
4. Load the sample (from Step 2) into the Zymo-Spin™ IC column containing the M-
Binding buffer. Close the cap and mix by inverting the column several times. 
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5. Centrifuge at full speed (>10,000 x g) for 30 seconds. Discard the flow-through. 
6. Add 100 ~l ofM-Wash Buffer to the column. Centrifuge at full speed for 30 seconds. 
7. Add 200 ~l ofM-Desulphonation Buffer to the column and let stand at room temperature 
(20°C - 30°C) for 15 - 20 minutes. After the incubation, centrifuge at full speed for 30 
seconds. 
8. Add 200 ~l of M-Wash Buffer to the column. Centrifuge at full speed for 30 seconds. 
Add another 200 ~l ofM-Wash Buffer and centrifuge for an additional 30 seconds. 
9. Place the column into a 1.5 ml microcentrifuge tube. Add 10 ~l of M-Elution Buffer 
directly to the column matrix. Centrifuge for 30 seconds at full speed to elute the DNA. 
The elution volume can be > 10 ~l depending on the requirements of your experiments, but small 
elution volumes will yield more concentrated DNA. 
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ApPENDICES - APPENDIX H: PYROSEQUENCING PROTOCOL 
Once the PCR is complete, the products should be run on a 3% agarose gel to ensure PCR was 
successful. 
Setting up PSQ run 
1. Clean the needles of the vacuum prep: 
• Aliquot 80 ~1 of ddH20 into all wells of a 96 well plate. Switch on the vacuum pump 
and lower the vacuum prep tool onto the plate for 20 sec so that all the ddH20 is 
taken up my the vacuum prep tool (all wells should be empty after this). 
2. Immobilization of PCR products to beads: 
• Use all remaining PCR products for this. 
• Shake the bottle of streptavidin sepharose beads until a homogenous solution IS 
obtained. 
• Make up a master mix of sepharose and binding buffer so that there is 6 ~1 of 
sepharose and 40 ~1 of binding buffer for each sample. 
• Aliquot 43 ~1 of the sepharoselbinding buffer mix to each sample. 
• Over the 96 well plate with a plastic seal and place on a shaker for 10 min at 300 rpm. 
• Prepare the PSQ 96 well plate with the sequencing primer and annealing buffer. For 
each sample add 1.6 ~1 of 10 ~M sequencing primer to 38.4 ~1 of annealing buffer. 
• Aliquot 40 ~1 into each well of the PSQ plate. 
3. Strand separation ofPCR products: 
• Place four troughs on the Vacuum Prep work station in the following order and fill 
each 
trough with the following: 
i. 70% Ethanol 
11. Denaturation buffer 
iii. Washing Buffer 
IV. ddH20 
• Turn the vacuum pup on and apply the vacuum to the 96 well plate containing the 
samples 
sepharoselbinding buffer mix. The beads with the immobilized templates will be 
captured 
on the filter probes of the vacuum prep tool. 
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• Make sure all the liquid has been captured onto the filter probes. Move the vacuum 
prep 
tool to the 70% ethanol trough for 60 sec, then to the denaturation buffer trough for 60 
sec, 
then to the washing buffer trough for 60 sec and lastly to the ddH20 trough for 60 sec. 
• Hold the vacuum prep tool up at 90° to all for all the liquid to completely drain from it 
for 
a few seconds and return to a horizontal position. 
• Tum the vacuum off to release the vacuum. 
• Place the PSQ 96 well plate on the workstation and release the beads from the filter 
probes 
onto the plate by shaking the vacuum prep tool while allowing the filter probes to rest 
on 
the bottom of the wells. 
4. Primer annealing: 
• Heat the PSQ plate with the sequencing primer and annealing buffer on a heating 
block set 
at 80°C for 3 min. 
• Allow to cool to room temperature. 
5. Cartridge preparation 
• Add the required amount of enzyme, substrate and dNTPs into the cartridge, as 
specified 
by the software one all the necessary information has been entered. 
• Place the PSQ plate and cartridge into the pyrosequencer and start the run. 
Analysis 
Click on the run once it is complete and press analyze to analyze all the samples. 
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RASGRFl DATA 
• CGI 1973 
NOTE: Boxes encompassing replicate data sets at individual CpG sites indicate the exclusion of that specific CpG site from the analysis. This is 
due the a greater than 6% methylation difference between the replicates. 
Average Methylation 
Sample ID epG Sites Analyzed (010) per Sample 
HBS 001 
HBS 002 
HBS 003 
HBS 004 
HBS 005 
peRl 
peR2 
peR3 (excluded) 
Average Methylation (%) 
peRl 
peR2 
peR3 
Average Methylation (%) 
peRl 
peR2 
peR3 
Average Methylation (%) 
peRl 
peR2 
peR3 
Average Methylation (%) 
peRl 
peR2 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 
50500 
00350 
20460 
3 043 0 
4 
3 
4 
4 
7 
7 
7 
7 
2 
o 
3 
2 
4 
4 
o 
3 
4 rn 0 220
6 18 0 
480 
7 
6 
6 
6 
5 
5 
o 
3 
o 
o 
o 
o 
000 
000 
000 
o 0 0 
3 0 3 
302 
400 
302 
000 
000 
050 
020 
3 
3 
5 
4 
o 
o 
3 
1 
3 
o 
5 
3 
2 
5 
4 
4 
2 rn5 0 o 16 0 
3 4 3 
2 12 1 
3 
o 
3 
2 
o 6 
2 0 
o 0 
1 3 
5 
2 
o 
2 
o 
o 
o 
o 
o 
o 
o 
o 
o 
o 
3 
1 
o 
o 
o 
o 
o 
o 
3 
1 
o 
o 
o 
o 
3 
o 
6 
3 
4 
2 
o 
2 
2 
o 
4 
2 
004 
340 
332 
222 
3 
o 
3 
2 
4 
o 
o 
1 
2 
2 
o 
1 
10 13 3 
10 13 4 
10 16 2 
10 14 3 
o 
o 
o 
o 
o 
2 
o 
1 
2 
2 
o 
1 
o 3 42 4 13 4 
o 0 48 7 14 0 
o 38 4 37 5 4 
o 2 45 6 14 2 
o 
o 
o 
o 
2 
3 
2 
2 
o 
o 
o 
o 37 3 
o 39 5 
o 40 3 
o 39 4 
1 
o 
o 
o 
2 
3 
2 
2 
37 4 
36 0 
39 5 
37 3 
2 
2 
o 
1 
3 
3 
3 
3 
2 
o 
o 
1 
o 90 95 39 88 59 6 
7 
8 
7 
2 
4 
6 
4 
37 
36 
35 
36 
o 90 95 41 86 59 
o 88 92 41 84 63 
o 89 94 40 86 60 
16 15 6 5 16 0 3 2 5 0 4 4 13 24 0 0 0 11 0 0 0 
16 15 6 5 15 2 4 2 4 0 2 4 12 21 4 5 5 11 4 6 0 
4 
2 
7 
22 
163 
HBS 006 
HBS 007 
HBS 008 
HBS 009 
(excluded) 
HBS 010 
HSS 027 
(excluded) 
HSS033 
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peR3 (excuded) 5 5 6 6 12 6 0 20 7 0 8 0 16 20 14 9 10 13 11 6 0 
Average Methylation (%) 1615 6 5 16 1 4 2 5 0 3 4 13 23 2 3 3 11 2 3 0 
peRl 
peR2 
peR3 (excluded) 
Average Methylation (%) 
peRl 
peR2 
peR3 (excluded) 
Average Methylation (%) 
peRl 
peR2 
peR3 (excluded) 
Average Methylation (%) 
peRl 
peR2 
peR3 
Average Methylation (%) 
peRl 
peR2 (excluded) 
peR3 
Average Methylation (%) 
peRl 
peR2 
Average Methylation (%) 
peRl 
2 0 3 2 0 0 0 0 0 0 0 2 0 18 0 0 8 8 13 0 0 
o 0 4 4 0 0 4 0 0 0 0 0 0 16 2 1 9 7 14 3 2 
7 7 4 5 0 8 4 5 0 0 0 0 6 16 2 2 9 7 14 3 2 
1 0 4 3 0 0 2 0 0 0 0 1 0 17 1 1 9 8 14 2 1 
1 
o 
4 
1 
o 20 16 0 16 0 2 
o 20 17 0 15 0 0 
13 7 
12 8 
18 5 
17 6 
o 4 
18 6 
13 0 
15 0 
o 4 
14 0 
2 
o 
3 
1 
12 22 82 2 
14 21 83 4 5 
2 
3 
2 
5 
3 
4 
0650400 
o 20 17 0 16 0 1 
5 0 13 21 88 3 
13 8 13 22 83 3 
16 0 4 0 0 4 5 0 0 0 0 10 18 3 3 0 2 
17 0 4 4 0 3 5 0 0 0 0 11 17 2 0 0 2 
456509000000021 2 
17 0 4 2 0 4 5 0 0 0 0 11 18 3 2 0 2 
o 
7 
2 
3 
o 
6 
o 
2 
3 
7 
2 
4 
21 0 8 
33 0 26 
19 5 7 
20 3 8 
3 
11 
3 
6 
3 
o 
4 
2 
2 
5 
2 
3 
2 
5 
2 
3 
o 
o 
o 
o 
5 5 8 4 5 
o 20 15 0 0 
8 6 9 0 6 
7 6 9 2 6 
o 
o 
o 
o 
4 
o 
o 
2 
407564644 
7 9 12 9 0 9 0 8 0 
6 5 10 7 3 7 3 6 2 
045 
005 
o 48 4 
o 17 5 
46 0 
8 4 
49 8 
34 4 
10 0 
81 3 
68 11 
53 5 
o 
2 
9 
4 
o 8 11 20 84 6 4 
o 
2 
3 
4 
4 
5 
5 
o 30 0 23 3 
o 8 11 21 83 
081121844 
o 7 4 7 
o 24 8 0 
o 16 6 4 
5 
2 
4 
4 
o 
2 
3 4 
o 2 
2 3 
o 3 0 0 
000 3 
202 2 
o 2 0 2 
o 
o 
o 
o 
3 
o 
2 
3 
7 
o 
3 
o 
2 
4 
2 
3 4 
2 2 
3 3 
8 
11 
7 
4 
3 
6 
5 
5 
2 
4 
9 
2 
o 
4 
o 
4 
5 
3 
4 
2 
3 
00220400002002 2 0 020 
6 
3 
11 
3 
8 
10 
4 
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peR2 
Average Methylation (%) 
peRl 
peR2 
Average Methylation (%) 
peRl 
peR2 
Average Methylation (%) 
peRl 
peR2 
Average Methylation (%) 
peRl 
peR2 
Average Methylation (%) 
peRl 
peR2 
Average Methylation (%) 
peRl 
peR2 
Average Methylation (%) 
002004003040330040040 
002104002030231130030 
o 
2 
1 
2 
2 
2 
2 
2 
2 
o 
1 
2 
3 
3 
o 2 0 0 
o 2 2 0 
o 2 1 0 
o 3 2 0 
o 3 3 0 
o 3 3 0 
422 
o 3 2 0 
1 4 2 1 
o 2 0 2 
o 0 6 0 
o 1 3 1 
o 2 14 3 
643 3 
3 3 9 3 
200 
000 
100 
3 0 0 
3 0 
310 
1 
000 
111 
202 
o 0 0 
101 
020 
634 
332 
o 
o 
o 
o 
o 
o 
o 
o 
o 
o 
o 
o 
o 
6 
3 
o 
o 
o 
o 
o 
o 
o 
o 
o 
o 
o 
o 
o 
3 
2 
o 
o 
o 
o 
o 
o 
2 
o 
1 
o 
o 
o 
o 
4 
2 
202 
203 
203 
o 9 0 0 18 0 0 0 
2 9 2 0 17 2 0 3 
1 9 1 0 18 1 0 2 
o 
o 
o 
o 
1 
2 
4 
3 
o 
o 
o 
1 
3 
2 
o 
o 
o 
o 
1 
2 
o 
1 
o 
o 
o 
4 
5 
5 
6 
5 
6 
5 
5 
5 
3 
3 
3 
o 
3 
2 
o 
o 
o 
o 
2 
1 
o 
4 
2 
5 
o 
3 
o 
o 
o 
o 
o 
o 
o 
1 
o 
3 
2 
o 
o 
o 
o 
3 
2 
o 
o 
o 
4 
3 
4 
3 
4 
4 
3 
3 
3 
o 
3 
2 
o 
o 
o 
o 
2 
1 
o 
2 
1 
4 
2 
3 
o 
3 
2 
o 
o 
o 
o 
2 
1 
2 
3 
3 
2 
2 
2 
o 
3 
2 
5 
o 
3 
o 
3 
2 
4 
5 
5 
3 
2 
3 
o 
4 
2 
o 
o 
o 
o 14 3 0 3 4 0 3 2 
o 16 4 0 1 3 5 2 
o 15 4 0 2 4 1 4 2 
o 
2 
1 
3 
4 
4 
3 
3 
3 
4 
4 
4 
o 
o 
o 
3 
o 
2 
1 
1 
2 
2 
1 
2 
3 
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ApPENDICES - ApPENDIX I: PYROSEQUENCING DATA 
• CGI 1974 
Sample ID CpG Sites Analyzed 
1 2 3 4 5 6 
HBS 001 peRl 87 100 90 90 85 97 
peR2 91 99 91 92 90 95 
peR3 92 96 92 92 84 95 
Average Methylation (%) 90 98 91 91 86 96 
HBS 002 peRl 93 100 91 92 88 99 
peR2 88 100 90 91 89 99 
peR3 88 100 85 92 85 100 
Average Methylation (%) 90 100 89 92 87 99 
HBS003 peRl lill 98 84 92 88 94 peR2 94 100 87 94 89 96 peR3 82 98 88 90 86 100 Average Methylation (%) 87 99 86 92 88 97 
HBS004 peRl 86 100 81 89 84 94 
(excluded) peR2 81 98 88 91 85 99 
peR3 87 100 90 92 73 92 
Average Methylation (%) 85 99 86 91 81 95 
HBS 005 peRl 89 100 85 84 79 95 
peR2 89 100 89 89 83 97 
peR3 (excluded) 90 100 87 91 87 100 
Average Methylation (%) 89 100 87 87 81 96 
HBS 006 peRl 88 100 88 
rn 
90 94 
peR2 87 100 89 88 84 100 
peR3 90 100 89 96 87 100 
Average Methylation (%) 88 100 89 90 87 98 
HBS 007 peRl 88 100m 89 87 94 peR2 90 0  90 86 82 94 
peR3 94 100 91 85 84 100 
Average Methylation (%) 91 100 88 87 84 96 
HBS008 peRl 90 100 84 85 84 97 
peR2 86 94 89 91 85 100 
peR3 (excluded) 92 100 91 85 78 93 
Average Methylation (%) 88 97 87 88 85 99 
HBS009 peRl 91 100 90 92 88 95 
peR2 88 100 84 93 87 96 
peR3 85 98 90 94 89 94 
Average Methylation (%) 88 99 88 93 88 95 
7 
85 
89 
89 
88 
86 
87 
87 
87 
87 
91 
89 
89 
84 
89 
84 
86 
82 
88 
84 
85 
85 
90 
90 
88 
84 
86 
88 
86 
80 
88 
86 
84 
88 
86 
89 
88 
Average Methylation (%) 
per Sample 
91 
92 
92 
89 
89 
92 
91 
90 
91 
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ApPENDICES - ApPENDIX I: PYROSEQUENCING DATA 
HBS 010 
HSS027 
(excluded) 
HSS 033 
HSS035 
HSS038 
HSS 048 
HSS 061 
HSS 077 
(excluded) 
HSS 078 
Sample ID 
HBS 001 
peRl (excluded) 
peR2 
peR3 
Average Methylation (%) 
peRl 
peR2 
Average Methylation (%) 
peRl 
peR2 
Average Methylation (%) 
peRl 
peR2 
Average Methylation (%) 
peRl 
peR2 
Average Methylation (%) 
peRl 
peR2 
Average Methylation (%) 
peRl 
peR2 
Average Methylation (%) 
peRl 
peR2 
Average Methylation (%) 
peRl 
peR2 
Average Methylation (%) 
• CGI 1975 
peRl 
peR2 
86 100 81 91 79 100 83 
89 100 87 86 84 93 81 
90 100 90 82 78 91 81 
90 100 89 84 81 92 81 
96 100 93 88 83 97 87 
94 100 92 96 90 100 93 
95 100 93 92 87 99 90 
96 100 94 100 91 100 89 
100 96 100 95 90 100 89 
98 98 97 98 91 100 89 
92 98 92 95 100 100 92 
91 99 86 94 94 100 89 
92 99 89 95 97 100 91 
94 100 90 100 100 100 89 
95 100 92 96 94 100 94 
95 100 91 98 97 100 92 
100 100 93 100 100 99 93 
94 100 90 97 94 100 93 
97 100 92 99 97 100 93 
100 100 100 95 96 100 93 
94 97 95 89 100 100 87 
97 99 98 92 98 100 90 
84 100 89 89 85 100 87 
96 100 92 97 93 100 92 
90 100 91 93 89 100 90 
90 100 91 95 93 100 91 
93 100 94 93 90 100 88 
92 100 93 94 92 100 90 
CpG Sites Analysed 
1 2 3 4 5 6 7 
84 93 78 57 73 87 100 
89 88 84 57 72 92 97 
88 
94 
96 
94 
96 
97 
96 
93 
94 
Average Methylation 
(%) per Sample 
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ApPENDICES - ApPENDIX I: PYROSEQUENCING DATA 
HBS 002 
HBS 003 
HBS 004 
HBS 005 
HBS 006 
HBS 007 
HBS 008 
HBS 009 
HBS 010 
HSS027 
peR3 (excluded) 80 81 85 48 76 94 100 
Average methylation (%) 87 91 81 57 73 90 99 
peRl 91 94 77 57 78 91 93 
peR2 (excluded) 81 80 74 51 81 85 86 
peR3 88 89 73 54 79 92 96 
Average methylation (%) 90 92 75 56 79 92 95 
peRl 92 93 76 67 77 93 100 
peR2 90 94 77 67 75 94 95 
peR3 88 88 75 63 76 100 100 
Average methylation (%) 90 92 76 66 76 96 98 
peRl 90 92 80 55 74 91 100 
peR2 (excluded) 81 84 73 63 76 93 98 
peR3 89 90 82 58 76 94 100 
Average methylation (%) 90 91 81 57 75 93 100 
peRl 90 89 73 57 75 90 94 
peR2 87 90 71 55 74 92 95 
peR3 (excluded) 83 91 66 55 75 93 100 
Average methylation (%) 89 90 72 56 75 91 95 
peRl 90 93 78 60 73 94 100 
peR2 (excluded) 87 88 80 60 97 94 75 
peR3 89 92 77 61 78 94 100 
Average methylation (%) 90 93 78 61 76 94 100 
peRl 
peR2 
86 86 76 55 72 93 100 
88 89 77 51 68 90 95 
peR3 86 84 78 55 74 94 100 
Average methylation (%) 87 86 77 54 71 92 98 
peRl 90 94 75 59 74 91 100 
peR2 89 100 74 56 74 93 100 
peR3 87 94 71 62 72 92 95 
Average methylation (%) 89 96 73 59 73 92 98 
peRl 93 91 79 61 76 93 95 
peR2 (excluded) 82 92 81 58 71 100 92 
peR3 91 91 77 61 79 95 100 
Average methylation (%) 92 91 78 61 78 94 98 
peRl 
peR2 
peR3 
89 93 78 59 71 94 100 
84 92 79 57 74 91 100 
86 91 72 55 74 94 100 
Average methylation (%) 86 92 76 57 73 93 100 
peRl 88 83 96 93 78 90 94 
peR2 87 82 100 92 83 92 100 
Average methylation (%) 88 83 98 93 81 91 97 
82 
82 
85 
84 
81 
84 
81 
83 
84 
83 
90 
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ApPENDICES - ApPENDIX I: PYROSEQUENCING DATA 
HSS 033 peRl 97 
peR2 93 
Average methylation (%) 95 
HSS035 peRl 100 
peR2 94 
Average methylation (%) 97 
HSS038 peRl 95 
peR2 96 
Average methylation (%) 96 
HSS 048 peRl 87 
peR2 92 
Average methylation (%) 90 
HSS 061 peRl 92 
peR2 91 
Average methylation (%) 92 
HSS077 peRl 90 
peR2 95 
Average methylation (%) 93 
HSS078 peRl 95 
peR2 95 
Average methylation (%) 95 
SNRPNDATA 
Sample ID 
HSS032 peRl 
peR2 
peR3 
Average Methylation (%) 
HSS037 peRl 
peR2 
peR3 
Average Methylation (%) 
HSS038 peRl 
peR2 
96 
91 
94 
100 
94 
97 
89 
95 
92 
100 
94 
97 
94 
100 
97 
100 
100 
100 
100 
96 
98 
95 98 
93 96 
94 97 
100 95 
96 99 
98 97 
89 97 
94 98 
92 98 
100 98 
96 97 
98 98 
92 100 
90 100 
91 100 
100 93 
96 99 
98 96 
93 96 
92 95 
93 96 
CpG Sites 
Analyzed 
76 
81 
79 
86 
87 
87 
87 
85 
86 
83 
87 
85 
83 
86 
85 
85 
88 
87 
86 
89 
88 
123 4 
4 4 4 5 
4 0 4 4 
0 0 0 0 
3 1 3 3 
0 3 0 4 
5 6 5 6 
0 0 0 7 
2 3 2 6 
6 0 0 5 
0 0 0 0 
95 94 
95 100 
95 97 93 
93 100 
94 97 
94 99 95 
95 97 
94 100 
95 99 94 
91 100 
94 100 
93 100 94 
90 100 
94 100 
92 100 94 
94 100 
100 100 
97 100 96 
94 100 
94 96 
94 98 94 
Average Methylation (%) 
per Sample 
2 
3 
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ApPENDICES - ApPENDIX I: PYROSEQUENCING DATA 
peR3 5 5 4 5 
Average Methylation (%) 4 2 1 3 3 
HSS085 peRl 0 0 0 3 
peR2 0 5 4 4 
peR3 0 0 0 5 
Average Methylation (%) 0 2 1 4 2 
HSS088 peRl 0 0 0 0 
peR2 5 0 0 0 
peR3 5 0 4 0 
Average Methylation (%) 3 0 1 0 1 
HSS 005 peRl 4 0 0 0 
peR2 0 0 0 0 
peR3 0 0 0 0 
Average Methylation (%) 1 0 0 0 0 
HSS 006 peRl 6 5 6 6 
peR2 0 0 0 8 
peR3 4 5 5 7 
Average Methylation (%) 3 3 4 7 4 
HSS 017 peRl 0 5 0 7 
peR2 4 4 0 7 
peR3 0 0 2 4 
Average Methylation (%) 1 3 1 6 3 
HSS 018 peRl 0 0 0 0 
peR2 0 0 0 0 
peR3 0 4 5 5 
Average Methylation (%) 0 1 2 2 1 
HSS 020 peRl 0 0 0 5 
peR2 0 6 5 7 
peR3 4 5 5 6 
Average Methylation (%) 1 4 3 6 4 
HSS 022 peRl 0 0 0 0 
peR2 0 0 0 0 
peR3 0 0 0 0 
Average Methylation (%) 0 0 0 0 0 
HSS023 peRl 6 6 4 4 
peR2 3 3 3 4 
peR3 6 7 6 7 
Average Methylation (%) 5 5 4 5 5 
HSS 024 peRl 3 0 4 4 
peR2 0 0 0 9 
peR3 4 4 5 6 
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ApPENDICES - ApPENDIX I: PYROSEQUENCING DATA 
Average Methylation (%) 2 1 3 6 3 
HSS043 PCRI 0 0 0 0 
PCR2 4 0 0 0 
PCR3 5 3 4 5 
Average Methylation (%) 3 1 1 2 2 
HSS 048 PCRI 4 5 5 5 
PCR2 0 6 0 9 
PCR3 5 4 0 5 
Average Methylation (%) 3 5 2 6 4 
HSS 054 PCRI 3 0 0 5 
PCR2 4 0 0 5 
PCR3 6 5 4 7 
Average Methylation (%) 4 2 1 6 3 
HSS067 PCRI 6 5 0 7 
PCR2 6 3 4 4 
PCR3 3 5 0 5 
Average Methylation (%) 5 4 1 5 4 
HSS 073 PCRI 4 4 4 4 
PCR2 0 0 0 0 
PCR3 3 0 3 4 
Average Methylation (%) 2 1 2 3 2 
HSS 081 PCRI 0 0 0 0 
PCR2 0 4 0 6 
PCR3 0 0 0 0 
Average Methylation (%) 0 1 0 2 1 
HSS 122 PCRI 0 0 0 4 
PCR2 0 0 0 0 
PCR3 5 0 0 0 
Average Methylation (%) 2 0 0 1 1 
HSS 128 PCRI 0 0 0 0 
PCR2 4 3 5 4 
PCR3 0 0 5 6 
Average Methylation (%) 1 1 3 3 2 
HSS 129 PCRI 5 0 6 7 
PCR2 0 0 0 6 
PCR3 0 4 5 6 
Average Methylation (%) 2 1 4 6 3 
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Sample ID 
HSS 019 
HSS 025 
HSS 027 
HSS 031 
HSS 032 
HSS 033 
HSS 035 
HSS 037 
HSS 038 
ApPENDICES - ApPENDIX I: PYROSEQUENCING DATA 
IG-DMRData 
CpG Sites Analyzed 
123456789 
peRl 91 93 
peR2 93 93 
peR3 93 95 
Average Methylation (%) 92 94 
peRl 95 95 
peR2 93 94 
peR3 94 92 
Average Methylation (%) 94 94 
98 69 80 
98 69 82 
98 68 79 
98 69 80 
99 63 80 
98 62 78 
95 64 79 
97 63 79 
98 
95 
98 
97 
98 
98 
97 
98 
98 92 
98 90 
92 89 
96 90 
98 85 
98 86 
98 85 
98 85 
98 
99 
99 
99 
99 
99 
98 
99 
10 
99 
98 
99 
99 
97 
97 
96 
97 
peRl 92 94 97 66 74 94 99 90 97 99 
peR2 95 96 
peR3 95 94 
Average Methylation (%) 94 95 
97 69 77 
95 68 75 
96 68 75 
97 99 89 
96 99 89 
96 99 89 
97 
97 
97 
99 
99 
99 
peRl 97 94 100 71 80 97 99 86 99 98 
peR2 96 95 100 70 80 97 99 89 98 98 
peR3 96 95 100 69 81 97 99 88 98 98 
Average Methylation (%) 96 95 100 70 80 97 99 88 98 98 
peRl 94 93 
peR2 92 93 
peR3 92 94 
Average Methylation (%) 93 93 
peRl 94 92 
peR2 94 93 
peR3 95 93 
Average Methylation (%) 94 93 
peRl 93 95 
peR2 93 94 
peR3 93 95 
Average Methylation (%) 93 95 
peRl 93 94 
peR2 93 94 
peR3 92 94 
Average Methylation (%) 93 94 
peRl 94 95 
peR2 94 95 
peR3 92 94 
Average Methylation (%) 93 95 
97 66 77 
97 67 79 
97 67 78 
97 67 78 
95 71 81 
94 71 80 
95 69 77 
95 70 79 
98 66 70 
98 69 71 
98 68 69 
98 68 70 
97 66 73 
97 68 75 
97 67 73 
97 67 74 
99 66 75 
99 63 72 
99 61 70 
99 63 72 
94 
96 
95 
95 
97 
97 
93 
96 
95 
95 
94 
95 
90 
93 
91 
91 
95 
94 
94 
94 
98 89 
98 88 
98 90 
98 89 
98 89 
98 89 
95 84 
97 87 
98 84 
98 87 
98 87 
98 86 
98 89 
98 89 
98 89 
98 89 
97 84 
98 86 
98 85 
98 85 
98 
97 
98 
98 
98 
98 
96 
97 
96 
96 
96 
96 
98 
98 
98 
98 
97 
98 
97 
97 
98 
98 
98 
98 
98 
98 
95 
97 
98 
98 
98 
98 
98 
98 
98 
98 
98 
98 
98 
98 
Average Methylation (%) 
per Sample 
91 
90 
91 
92 
91 
91 
90 
90 
90 
172 
HSS 042 
HSS 046 
HSS 050 
HSS 055 
HSS056 
HSS 070 
HSS 074 
HSS 075 
HSS 077 
HSS 079 
HSS 082 
ApPENDICES - ApPENDIX I: PYROSEQUENCING DATA 
peRl 91 92 
peR2 94 94 
peR3 94 94 
Average Methylation (%) 93 93 
100 70 78 
100 68 78 
98 70 78 
99 69 78 
peRl 94 95 97 69 78 
peRl 94 96 97 71 79 
peR3 93 94 99 69 80 
Average Methylation (%) 94 95 98 70 79 
peRl 
peR2 
peR3 
Average Methylation (%) 
93 94 100 81 78 
92 93 100 76 80 
92 94 100 76 79 
92 94 100 78 79 
peRl 93 95 
peR2 92 93 
peR3 93 95 
Average Methylation (%) 93 94 
peRl 93 94 
peR2 93 94 
peR3 91 92 
Average Methylation (%) 92 93 
peRl 92 94 
peR2 93 95 
peR3 94 92 
Average Methylation (%) 93 94 
peRl 94 94 
peR2 94 94 
peR3 93 93 
Average Methylation (%) 94 94 
peRl 93 95 
peR2 91 95 
peR3 94 95 
Average Methylation (%) 93 95 
peRl 
peR2 
peR3 
Average Methylation (%) 
92 90 
94 93 
94 92 
93 92 
peRl 90 91 
peR2 91 91 
peR3 93 94 
Average Methylation (%) 91 92 
97 61 75 
97 62 77 
97 57 72 
97 60 75 
97 65 71 
97 69 75 
98 67 75 
97 67 74 
99 65 78 
98 67 79 
95 64 79 
97 65 79 
98 68 79 
98 68 79 
98 66 79 
98 67 79 
97 71 82 
97 70 78 
97 72 82 
97 71 81 
96 67 79 
97 68 81 
100 69 80 
98 68 80 
96 77 81 
95 81 83 
98 78 82 
96 79 82 
99 100 89 
98 99 89 
98 99 90 
98 99 89 
97 96 89 
97 97 90 
98 97 88 
97 97 89 
97 96 83 
98 100 88 
98 97 88 
98 98 86 
96 
97 
94 
96 
92 
94 
94 
93 
98 
98 
98 
98 
97 
98 
98 
98 
98 
98 
98 
98 
98 87 
98 88 
95 84 
97 86 
99 89 
98 86 
99 88 
99 88 
98 89 
99 88 
98 88 
98 88 
98 90 
99 88 
99 88 
99 89 
99 91 
98 89 
98 91 
98 90 
98 98 87 
97 98 89 
98 100 89 
98 99 88 
97 100 
97 99 
97 99 
97 99 
98 
99 
99 
99 
97 
98 
98 
98 
98 
99 
97 
98 
91 
97 
97 
95 
98 
98 
98 
98 
98 
98 
98 
98 
98 
97 
98 
98 
97 
98 
98 
98 
97 
97 
97 
97 
97 
98 
98 
98 
98 
98 
97 
98 
98 
97 
98 
98 
98 
98 
98 
98 
97 
97 
97 
97 
99 
99 
99 
99 
98 
98 
99 
98 
97 100 89 100 
98 100 91 99 
96 100 89 99 
97 
99 
99 
98 97 100 90 99 
peRl 
peR2 
90 92 98 60 78 99 100 90 99 99 
95 95 97 62 79 98 100 91 99 99 
92 
91 
92 
89 
90 
91 
91 
92 
91 
92 
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HSS 085 
HSS 088 
HSS 089 
HSS094 
HSS 096 
HSS 097 
HSS 107 
HSS 116 
HSS 121 
HSS 131 
ApPENDICES - ApPENDIX I: PYROSEQUENCING DATA 
PCR3 94 94 98 58 76 96 100 89 98 99 
Average Methylation (%) 93 94 98 60 78 98 100 90 99 99 
PCRI 94 94 98 61 78 97 99 89 
PCR2 95 95 98 60 78 97 98 88 
PCR3 94 94 98 62 79 97 98 88 
Average Methylation (%) 94 94 98 61 78 97 98 88 
PCRI 
PCR2 
PCR3 
Average Methylation (%) 
PCRI 
PCR2 
PCR3 
Average Methylation (%) 
95 95 
94 97 
96 93 
95 95 
89 92 
93 96 
92 96 
91 95 
98 68 80 
97 65 79 
97 67 81 
97 67 80 
97 59 72 
100 60 73 
97 63 77 
98 61 74 
99 
98 
98 
98 
93 
93 
96 
94 
PCRI 94 95 98 66 80 97 
PCR2 94 95 100 66 79 97 
PCR3 93 93 98 67 79 97 
Average Methylation (%) 94 94 99 66 79 97 
PCRI 94 95 100 74 78 96 
PCR2 96 97 98 75 78 97 
PCR3 95 96 97 74 80 97 
Average Methylation (%) 95 96 98 74 79 97 
PCRI 94 95 
PCR2 93 93 
PCR3 94 94 
Average Methylation (%) 94 94 
PCRI 94 95 
PCR2 94 95 
PCR3 95 95 
Average Methylation (%) 94 95 
98 67 75 
98 66 77 
98 66 75 
98 66 76 
98 72 78 
98 72 78 
98 72 77 
98 72 78 
98 
98 
97 
98 
96 
96 
96 
96 
99 90 
99 90 
99 91 
99 90 
97 85 
97 87 
98 89 
97 87 
98 88 
98 89 
98 88 
98 88 
98 89 
98 90 
98 90 
98 90 
93 86 
98 88 
98 88 
96 87 
98 89 
98 88 
98 89 
98 89 
98 
97 
97 
97 
97 
97 
97 
97 
96 
96 
97 
96 
97 
97 
98 
97 
97 
97 
98 
97 
97 
96 
96 
96 
98 
97 
97 
97 
98 
98 
98 
98 
97 
97 
97 
97 
97 
98 
98 
98 
97 
97 
97 
97 
99 
99 
99 
99 
98 
98 
98 
98 
97 
97 
97 
97 
PCRI 89 92 98 66 76 94 96 86 96 97 
PCR2 94 95 98 65 74 94 95 84 96 96 
PCR3 91 93 98 70 79 98 100 87 99 99 
Average Methylation (%) 91 93 98 67 76 95 97 86 97 97 
PCRI 94 96 96 63 74 94 98 88 97 98 
PCR2 94 95 96 65 76 96 98 88 97 98 
PCR3 92 94 96 63 73 94 97 88 97 98 
Average Methylation (%) 93 95 96 64 74 95 98 88 97 98 
PCRI 94 94 97 59 76 97 99 88 96 97 
PCR2 95 95 96 59 75 95 99 89 96 97 
PCR3 94 95 98 60 75 95 98 88 96 97 
Average Methylation (%) 94 95 97 59 75 96 99 88 96 97 
91 
92 
89 
91 
92 
90 
91 
90 
90 
90 
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HSS 136 
HSS 141 
HSS 142 
HSS 149 
HSS 001 
HSS003 
HSS 004 
HSS 005 
HSS 006 
HSS008 
HSS 010 
ApPENDICES - ApPENDIX I: PYROSEQUENCING DATA 
peRl 94 94 95 70 79 97 98 89 
98 87 
99 89 
98 88 
peR2 92 94 96 69 79 97 
peR3 94 95 95 70 80 98 
Average Methylation (%) 93 94 95 70 79 97 
peRl 91 93 97 68 81 
peR2 90 93 100 68 81 
peR3 91 92 97 65 78 
Average Methylation (%) 91 93 98 67 80 
peRl 94 94 
peR2 93 93 
peR3 93 94 
Average Methylation (%) 93 94 
peRl 93 93 
peR2 94 94 
peR3 93 93 
Average Methylation (%) 93 93 
peRl 88 92 
peR2 92 93 
peR3 88 95 
Average Methylation (%) 89 93 
peRl 93 95 
peR2 94 94 
peR3 94 95 
Average Methylation (%) 94 95 
98 64 80 
98 65 80 
97 63 79 
98 64 80 
95 72 76 
96 74 77 
95 73 76 
95 73 76 
98 57 73 
97 61 73 
98 59 77 
98 59 74 
98 57 76 
96 60 77 
98 58 75 
97 58 76 
97 99 86 
97 99 87 
97 99 85 
97 99 86 
98 
98 
97 
98 
98 
99 
99 
99 
90 
93 
95 
93 
93 
95 
94 
94 
97 86 
97 88 
97 86 
97 87 
97 87 
97 88 
97 87 
97 87 
94 85 
97 88 
99 92 
97 88 
97 89 
97 89 
96 86 
97 88 
97 
97 
98 
97 
97 
97 
97 
97 
97 
96 
96 
96 
98 
98 
98 
98 
94 
98 
97 
96 
97 
97 
97 
97 
98 
98 
98 
98 
98 
98 
96 
97 
98 
98 
98 
98 
98 
98 
97 
98 
97 
98 
99 
98 
97 
97 
97 
97 
peRl 95 94 96 64 75 87 96 91 99 95 
peR2 93 94 96 67 78 92 96 90 99 95 
peR3 92 94 96 69 80 92 96 91 100 95 
Average Methylation (%) 93 94 96 67 78 90 96 91 99 95 
peRl 92 93 95 58 66 95 98 86 97 96 
peR2 93 94 98 58 67 94 98 85 97 96 
peR3 94 95 98 60 68 96 98 87 97 96 
Average Methylation (%) 93 94 97 59 67 95 98 86 97 96 
peRl 93 94 99 62 74 92 98 89 97 98 
peR2 93 94 99 64 77 95 98 88 97 98 
peR3 93 95 99 66 77 95 98 88 97 98 
Average Methylation (%) 93 94 99 64 76 94 98 88 97 98 
peRl 92 94 97 54 74 94 95 83 95 
96 
95 
95 
97 
97 
96 
97 
peR2 94 96 97 55 71 92 96 86 
peR3 92 93 100 58 77 95 96 86 
Average Methylation (%) 93 94 98 56 74 94 96 85 
peRl 90 90 95 61 72 89 97 90 89 98 
91 
90 
90 
91 
89 
89 
90 
88 
90 
88 
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HSS 011 
HSS 016 
HSS 017 
HSS 018 
HSS020 
HSS 021 
HSS 022 
HSS 023 
HSS 024 
HSS 028 
ApPENDICES - ApPENDIX I: PYROSEQUENCING DATA 
peR2 94 95 96 66 77 95 97 89 98 98 
peR3 94 95 97 64 75 93 97 90 98 98 
Average Methylation (%) 93 93 96 64 75 92 97 90 95 98 
peRl 94 95 
peR2 94 95 
peR3 94 96 
Average Methylation (%) 94 95 
peRl 
peR2 
peR3 
Average Methylation (%) 
peRl 
peR2 
peR3 
Average Methylation (%) 
peRl 
peR2 
peR3 
Average Methylation (%) 
peRl 
peR2 
peR3 
Average Methylation (%) 
peRl 
peR2 
peR3 
Average Methylation (%) 
peRl 
peR2 
peR3 
Average Methylation (%) 
peRl 
peR2 
peR3 
Average Methylation (%) 
peRl 
peR2 
peR3 
Average Methylation (%) 
peRl 
peR2 
peR3 
Average Methylation (%) 
92 93 
92 93 
92 93 
92 93 
92 92 
93 94 
93 94 
93 93 
90 91 
92 94 
92 94 
91 93 
92 96 
93 92 
92 96 
92 95 
91 90 
93 91 
93 91 
92 91 
94 95 
93 95 
93 95 
93 95 
93 95 
93 95 
93 94 
93 95 
94 92 
94 93 
94 94 
94 93 
89 93 
86 89 
91 93 
89 92 
94 55 77 96 94 84 98 
95 54 75 98 95 83 98 
96 57 77 97 100 84 99 
95 55 76 97 96 84 98 
89 52 73 
91 52 73 
89 48 70 
90 51 72 
97 64 71 
97 58 70 
97 59 73 
97 60 71 
98 57 67 
97 56 66 
98 59 71 
98 57 68 
98 71 80 
98 72 79 
98 70 80 
98 71 80 
95 52 76 
95 54 78 
95 55 79 
95 54 78 
98 68 81 
98 70 81 
98 67 80 
98 68 81 
98 65 76 
98 69 79 
98 69 79 
98 68 78 
98 63 78 
97 62 77 
98 66 82 
98 64 79 
98 55 73 
98 55 72 
97 55 73 
98 55 73 
95 
96 
92 
94 
95 
94 
93 
94 
89 
93 
92 
91 
97 
97 
97 
97 
91 
95 
95 
94 
98 
98 
98 
98 
93 
96 
96 
95 
97 
97 
97 
97 
92 
92 
92 
92 
95 84 
95 84 
95 85 
95 84 
96 79 
96 81 
96 83 
96 81 
97 87 
97 87 
97 87 
97 87 
98 89 
98 89 
98 90 
98 89 
96 87 
96 84 
96 86 
96 86 
98 88 
98 90 
98 89 
98 89 
97 89 
98 89 
97 88 
97 89 
98 88 
97 86 
97 89 
97 88 
98 85 
98 86 
98 85 
98 85 
97 
97 
97 
97 
95 
96 
96 
96 
95 
96 
95 
95 
98 
98 
98 
98 
97 
98 
98 
98 
97 
97 
98 
97 
98 
98 
98 
98 
97 
97 
97 
97 
97 
97 
97 
97 
98 
98 
98 
98 
98 
98 
98 
98 
98 
97 
97 
97 
98 
96 
97 
97 
98 
98 
98 
98 
98 
98 
98 
98 
98 
98 
98 
98 
97 
98 
98 
98 
97 
97 
97 
97 
98 
98 
97 
98 
89 
89 
87 
88 
88 
92 
88 
92 
91 
90 
88 
176 
HSS 036 
HSS 040 
HSS 043 
HSS 044 
HSS 048 
HSS 051 
HSS 052 
HSS053 
HSS054 
HSS057 
HSS058 
ApPENDICES - ApPENDIX I: PYROSEQUENCING DATA 
peRl 
peR2 
peR3 
Average Methylation (%) 
97 95 
95 95 
96 95 
96 95 
peRl 95 94 
peR2 96 96 
peR3 94 95 
Average Methylation (%) 95 95 
peRl 
peR2 
peR3 
Average Methylation (%) 
peRl 
peR2 
peR3 
Average Methylation (%) 
peRl 
peR2 
peR3 
Average Methylation (%) 
peRl 
peR2 
peR3 
Average Methylation (%) 
94 95 
94 95 
94 95 
94 95 
91 93 
92 94 
91 93 
91 93 
94 93 
93 94 
94 95 
94 94 
92 90 
92 90 
92 90 
92 90 
100 65 75 
100 68 77 
98 66 78 
99 66 77 
96 66 79 
96 67 80 
96 65 79 
96 66 79 
98 61 76 
97 66 78 
98 63 78 
98 63 77 
97 58 74 
94 59 75 
95 57 74 
95 58 74 
96 59 67 
98 58 66 
98 59 65 
97 59 66 
96 70 77 
96 69 75 
97 70 77 
96 70 76 
96 100 86 
96 99 88 
96 99 86 
96 99 87 
98 99 87 
98 99 88 
98 100 86 
98 99 87 
98 
98 
97 
98 
94 
95 
94 
94 
91 
90 
90 
90 
97 
96 
97 
97 
99 88 
98 90 
98 89 
98 89 
97 86 
97 86 
97 85 
97 86 
95 85 
95 85 
94 84 
95 85 
98 79 
98 81 
98 82 
98 81 
peRl 94 95 98 74 79 96 96 87 
98 100 84 peR2 94 96 97 71 78 
peR3 94 96 98 73 80 98 96 88 
Average Methylation (%) 94 96 98 73 79 97 97 86 
peRl 94 94 
peR2 94 94 
peR3 95 94 
Average Methylation (%) 94 94 
peRl 92 93 
peR2 94 92 
peR3 92 93 
Average Methylation (%) 93 93 
peRl 91 93 
peR2 95 95 
peR3 92 93 
Average Methylation (%) 93 94 
97 70 77 
97 69 76 
97 70 77 
97 70 77 
96 93 86 
96 98 87 
96 98 87 
96 96 87 
Unable to Obtain Data 
98 71 82 
98 71 84 
98 71 82 
98 71 83 
97 98 86 
96 100 90 
96 98 88 
96 99 88 
97 73 74 98 
97 72 75 98 
96 74 76 97 
97 73 75 98 
98 85 
98 85 
90 87 
95 86 
97 
97 
97 
97 
98 
98 
98 
98 
97 
98 
97 
97 
97 
97 
97 
97 
97 
98 
96 
97 
96 
95 
95 
95 
97 
97 
98 
97 
98 
97 
98 
98 
96 
97 
96 
96 
99 
99 
99 
99 
97 
97 
97 
97 
97 
97 
96 
97 
97 
98 
98 
98 
98 
98 
98 
98 
98 
98 
98 
98 
98 
98 
99 
98 
97 
96 
97 
97 
99 
98 
98 
98 
97 
97 
97 
97 
99 
99 
99 
99 
91 
91 
91 
88 
87 
89 
91 
91 
91 
91 
177 
HSS 061 
HSS062 
HSS 064 
HSS 067 
HSS 068 
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HSS 071 
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HSS073 
HSS076 
HSS 078 
ApPENDICES - ApPENDIX I: PYROSEQUENCING DATA 
peRl 94 94 
peR2 94 92 
peR3 91 89 
Average Methylation (%) 93 92 
peRl 
peR2 
peR3 
Average Methylation (%) 
peRl 
peR2 
peR3 
Average Methylation (%) 
peRl 
peR2 
peR3 
Average Methylation (%) 
peRl 
peR2 
peR3 
Average Methylation (%) 
93 94 
93 94 
96 94 
94 94 
93 90 
93 90 
93 89 
93 90 
87 55 
87 55 
85 56 
86 55 
94 94 
90 94 
95 94 
93 94 
peRl 95 95 
peR2 94 95 
peR3 94 95 
Average Methylation (%) 94 95 
99 62 73 
96 63 72 
96 65 74 
97 63 73 
90 99 87 
94 100 86 
92 98 87 
92 99 87 
96 66 80 
97 67 79 
96 66 79 
96 66 79 
95 68 78 
96 71 79 
96 69 78 
96 69 78 
99 71 80 
99 73 80 
99 72 80 
99 72 80 
95 65 76 
97 64 77 
97 65 76 
96 65 76 
98 
97 
98 
98 
98 
98 
98 
98 
98 
98 
98 
98 
99 
99 
98 
99 
98 73 81 100 
97 76 80 99 
97 74 80 99 
97 74 80 99 
96 88 
96 89 
95 88 
96 88 
98 87 
97 88 
98 87 
98 87 
97 87 
97 89 
97 89 
97 88 
98 89 
98 87 
98 87 
98 88 
89 88 
88 91 
88 90 
88 90 
98 
97 
98 
98 
98 
98 
97 
98 
97 
96 
96 
96 
97 
97 
96 
97 
99 
99 
99 
99 
95 
95 
95 
95 
99 
98 
99 
99 
98 
98 
99 
98 
98 
98 
98 
98 
97 
97 
97 
97 
98 
98 
97 
98 
96 
96 
98 
97 
peRl 92 93 96 61 78 97 98 87 98 98 
peR2 92 92 97 62 78 97 97 86 98 98 
peR3 95 94 95 63 79 97 98 88 98 98 
Average Methylation (%) 93 93 96 62 78 97 98 87 98 98 
peRl 
peR2 
peR3 
92 91 
95 96 
92 93 
95 65 79 
96 63 79 
93 64 78 
96 97 87 
95 100 87 
95 97 88 
96 
96 
96 
97 
97 
96 
Average Methylation (%) 93 93 95 64 79 95 98 87 96 97 
peRl 95 95 
peR2 95 94 
peR3 94 94 
Average Methylation (%) 95 94 
peRl 91 94 
peR2 92 95 
peR3 88 91 
Average Methylation (%) 90 93 
98 69 74 
98 72 76 
98 70 76 
98 70 75 
98 65 77 
98 64 76 
98 65 77 
98 65 77 
97 98 88 
98 98 87 
98 100 88 
98 99 88 
98 99 88 
97 100 88 
97 98 87 
97 99 88 
peRl 
peR2 
peR3 
94 94 98 76 81 97 
93 92 96 72 79 97 
94 89 96 75 81 97 
98 88 
98 87 
98 89 
96 
97 
97 
97 
98 
97 
97 
97 
97 
97 
96 
98 
98 
98 
98 
99 
98 
98 
98 
98 
98 
98 
89 
91 
90 
87 
91 
91 
90 
90 
91 
90 
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HSS 081 
HSS 083 
HSS 084 
HSS086 
HSS090 
HSS092 
HSS095 
HSS098 
HSS 102 
HSS 103 
HSS 105 
ApPENDICES - ApPENDIX I: PYROSEQUENCING DATA 
Average Methylation (%) 94 92 97 74 80 97 98 88 97 98 
peRl 95 94 98 71 66 98 93 90 100 100 
peR2 94 94 99 73 66 98 93 91 99 99 
peR3 94 94 99 74 67 98 93 91 99 99 
Average Methylation (%) 94 94 99 73 66 98 93 91 99 99 
peRl 91 91 
peR2 94 96 
peR3 92 93 
Average Methylation (%) 92 93 
peRl 94 95 
peR2 95 96 
peR3 95 95 
Average Methylation (%) 95 95 
peRl 93 95 
peR2 95 95 
peR3 94 94 
Average Methylation (%) 94 95 
peRl 96 96 
peR2 95 95 
peR3 95 95 
Average Methylation (%) 95 95 
peRl 94 95 
peR2 94 95 
peR3 93 95 
Average Methylation (%) 94 95 
peRl 93 93 
peR2 92 93 
peR3 93 92 
Average Methylation (%) 93 93 
peRl 83 95 
peR2 84 95 
peR3 84 96 
Average Methylation (%) 84 95 
peRl 91 93 
peR2 91 95 
peR3 92 92 
Average Methylation (%) 91 93 
peRl 93 96 
peR2 92 95 
peR3 92 95 
Average Methylation (%) 92 95 
96 64 80 99 
97 65 80 98 
93 64 80 98 
95 64 80 98 
98 87 
98 87 
98 88 
98 87 
94 
93 
94 
94 
97 68 79 98 99 89 98 
98 68 79 98 100 89 100 
97 68 78 98 99 87 99 
97 68 79 98 99 88 99 
98 68 80 
97 70 82 
97 69 79 
97 69 80 
93 67 78 
98 67 78 
98 68 80 
96 67 79 
98 71 79 
97 70 78 
98 73 81 
98 71 79 
98 63 76 
96 64 75 
97 64 77 
97 64 76 
97 69 78 
97 70 79 
97 71 81 
97 70 79 
96 71 78 
97 70 78 
94 71 79 
96 71 78 
95 68 77 
96 69 77 
96 69 77 
96 69 77 
97 98 90 
97 98 90 
97 98 89 
97 98 90 
97 98 87 
97 98 87 
97 98 87 
97 98 87 
97 96 88 
97 95 88 
98 97 89 
97 96 88 
97 98 85 
97 98 87 
97 98 87 
97 98 86 
96 92 89 
95 91 90 
97 92 91 
96 92 90 
98 99 88 
97 98 88 
98 99 88 
98 99 88 
97 99 89 
96 98 86 
97 99 88 
97 99 88 
98 
98 
98 
98 
97 
97 
97 
97 
97 
98 
98 
98 
97 
97 
98 
97 
96 
96 
96 
96 
98 
97 
98 
98 
98 
97 
97 
97 
99 
99 
99 
99 
98 
99 
98 
98 
97 
97 
97 
97 
98 
98 
98 
98 
97 
97 
98 
97 
98 
99 
98 
98 
96 
96 
96 
96 
99 
98 
98 
98 
99 
99 
99 
99 
peRl 93 93 98 72 79 97 98 90 98 97 
91 
91 
90 
92 
92 
91 
91 
90 
90 
91 
91 
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HSS 110 
HSS 111 
HSS 112 
HSS 114 
HSS 117 
HSS118 
HSS 119 
HSS 120 
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HSS 123 
ApPENDICES - ApPENDIX I: PYROSEQUENCING DATA 
peR2 93 94 98 70 77 96 98 88 
98 90 
98 89 
peR3 92 93 98 72 80 97 
Average Methylation (%) 93 93 98 71 79 97 
peRl 94 95 
peR2 93 94 
peR3 93 95 
Average Methylation (%) 93 95 
peRl 
peR2 
peR3 
Average Methylation (%) 
peRl 
peR2 
peR3 
Average Methylation (%) 
peRl 
peR2 
peR3 
Average Methylation (%) 
peRl 
peR2 
peR3 
Average Methylation (%) 
peRl 
peR2 
peR3 
Average Methylation (%) 
94 93 
92 92 
94 94 
93 93 
94 95 
94 94 
93 93 
94 94 
96 93 
94 95 
94 95 
95 94 
95 92 
93 94 
94 95 
94 94 
94 95 
95 95 
94 94 
94 95 
peRl 91 92 
peR2 95 95 
peR3 93 96 
Average Methylation (%) 93 94 
peRl 93 94 
peR2 94 93 
peR3 93 93 
Average Methylation (%) 93 93 
peRl 92 92 
peR2 97 96 
peR3 92 94 
Average Methylation (%) 94 94 
98 71 78 
98 71 78 
98 73 79 
98 72 78 
96 64 80 
95 69 82 
97 66 79 
96 66 80 
97 72 80 
98 72 81 
97 71 80 
97 72 80 
96 78 80 
98 73 78 
98 73 79 
97 75 79 
97 57 78 
98 58 77 
97 58 78 
97 58 78 
97 73 76 
98 74 78 
98 75 80 
98 74 78 
98 98 86 
98 100 86 
98 98 88 
98 99 87 
97 
97 
97 
97 
98 
98 
98 
98 
97 
96 
97 
97 
97 
97 
96 
97 
97 
97 
98 
97 
97 85 
98 86 
97 86 
97 86 
98 88 
98 90 
98 90 
98 89 
98 88 
98 89 
98 89 
98 89 
98 84 
98 86 
97 87 
98 86 
96 86 
97 87 
97 88 
97 87 
96 68 79 97 100 89 
96 71 80 97 99 88 
99 69 79 98 99 86 
97 69 79 97 99 88 
96 61 77 98 100 88 
97 60 77 98 98 89 
96 61 77 99 98 89 
96 61 77 98 99 89 
99 62 74 
98 64 75 
98 66 79 
98 64 76 
93 
95 
97 
95 
97 91 
97 91 
95 86 
96 89 
98 
98 
98 
98 
99 
98 
98 
96 
97 
98 
97 
98 
97 
98 
98 
98 
98 
98 
98 
97 
97 
97 
97 
52 
51 
50 
51 
98 
98 
98 
98 
98 
98 
98 
98 
96 
96 
98 
97 
97 
97 
97 
98 
98 
98 
98 
97 
97 
98 
97 
98 
98 
98 
98 
97 
98 
97 
97 
97 
97 
97 
97 
98 
98 
98 
98 
98 
99 
98 
98 
97 
98 
97 
97 
98 
98 
98 
98 
peRl 94 94 97 76 80 97 100 89 99 97 
peR2 96 95 100 79 82 97 99 90 98 99 
peR3 95 94 99 81 82 99 100 91 99 99 
Average Methylation (%) 95 94 99 79 81 98 100 90 99 98 
91 
92 
90 
92 
92 
89 
87 
91 
90 
90 
93 
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HSS 124 
HSS 125 
HSS 126 
HSS 127 
HSS 128 
HSS 129 
HSS 130 
HSS 132 
HSS 133 
HSS 134 
HSS 135 
ApPENDICES - ApPENDIX I: PYROSEQUENCING DATA 
PCRI 92 93 95 60 74 94 
PCR2 88 91 95 60 73 94 
PCR3 92 93 97 60 78 96 
Average Methylation (%) 91 92 96 60 75 95 
PCRI 93 91 97 64 80 98 
PCR2 92 91 96 63 79 98 
PCR3 91 92 96 66 80 98 
Average Methylation (%) 92 91 96 64 80 98 
PCRI 95 95 97 64 83 98 
PCR2 93 93 98 64 81 99 
PCR3 93 94 97 64 81 97 
Average Methylation (%) 94 94 97 64 82 98 
PCRI 95 94 98 72 74 98 
PCR2 93 94 98 73 75 98 
PCR3 93 93 98 72 74 99 
Average Methylation (%) 94 94 98 72 74 98 
PCRI 94 89 96 58 80 98 
PCR2 92 92 97 58 79 98 
PCR3 92 94 96 56 78 98 
Average Methylation (%) 93 92 96 57 79 98 
PCRI 94 93 100 71 78 97 
PCR2 92 92 98 71 79 97 
PCR3 92 93 98 70 80 97 
Average Methylation (%) 93 93 99 71 79 97 
PCRI 94 93 99 58 79 98 
PCR2 94 94 96 61 80 98 
PCR3 94 93 98 60 79 98 
Average Methylation (%) 94 93 98 60 79 98 
PCRI 93 94 97 75 79 98 
PCR2 93 95 97 75 78 98 
PCR3 93 96 98 74 78 97 
Average Methylation (%) 93 95 97 75 78 98 
95 85 
95 84 
97 87 
96 85 
97 86 
97 89 
97 88 
97 88 
99 91 
99 89 
99 91 
99 90 
97 87 
97 88 
97 87 
97 87 
98 88 
98 86 
98 86 
98 87 
97 89 
97 89 
97 89 
97 89 
98 87 
98 87 
98 88 
98 87 
98 90 
97 87 
98 90 
98 89 
PCRI 91 93 96 72 81 98 100 90 
PCR2 92 93 
PCR3 92 94 
Average Methylation (%) 92 93 
PCRI 
PCR2 
PCR3 
Average Methylation (%) 
95 93 
93 94 
95 95 
94 94 
96 72 81 99 98 90 
95 70 80 98 98 90 
96 71 81 98 99 90 
97 64 79 
96 61 78 
95 59 78 
96 61 78 
97 
97 
96 
97 
98 86 
98 86 
98 87 
98 86 
96 
96 
97 
96 
99 
99 
99 
99 
78 
78 
78 
78 
96 
95 
96 
96 
98 
98 
98 
98 
97 
97 
97 
97 
98 
98 
98 
98 
97 
98 
98 
98 
97 
97 
97 
97 
97 
97 
97 
97 
98 
97 
98 
98 
98 
98 
98 
98 
99 
99 
99 
99 
98 
98 
98 
98 
98 
98 
98 
98 
97 
98 
98 
98 
97 
97 
97 
97 
98 
99 
98 
98 
99 
99 
99 
99 
98 
99 
99 
99 
PCRI 
PCR2 
92 94 99 66 79 98 99 86 98 96 
90 93 99 68 79 97 99 88 98 97 
88 
90 
90 
91 
90 
91 
90 
92 
92 
90 
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HSS 137 
HSS 140 
HSS 143 
HSS 144 
HSS 145 
HSS 146 
HSS 147 
HSS 148 
ApPENDICES - APPENDIX I: PYROSEQUENCING DATA 
peR3 91 94 98 65 80 98 99 87 98 97 
Average Methylation (%) 91 94 99 66 79 98 99 87 98 97 
peRl 92 92 97 64 79 97 98 88 
98 90 
99 89 
98 89 
peR2 94 94 96 66 80 97 
peR3 92 92 100 64 79 97 
Average Methylation (%) 93 93 98 65 79 97 
peRl 93 94 
peR2 93 95 
peR3 93 94 
Average Methylation (%) 93 94 
peRl 94 93 
peR2 92 93 
peR3 93 94 
Average Methylation (%) 93 93 
peRl 
peR2 
peR3 
Average Methylation (%) 
peRl 
peR2 
peR3 
Average Methylation (%) 
peRl 
peR2 
peR3 
Average Methylation (%) 
peRl 
peR2 
peR3 
Average Methylation (%) 
95 93 
94 94 
94 94 
94 94 
94 93 
93 94 
93 93 
93 93 
93 93 
93 93 
94 94 
93 93 
94 93 
93 93 
93 93 
93 93 
96 72 80 94 
96 73 79 97 
97 71 78 97 
96 72 79 96 
99 89 
99 89 
99 91 
99 90 
96 64 80 
95 66 81 
95 64 80 
95 65 80 
98 100 86 
97 66 77 
97 67 80 
97 68 78 
97 67 78 
98 70 78 
97 69 79 
97 69 80 
97 69 79 
95 70 81 
95 70 82 
97 70 81 
96 70 81 
97 68 82 
97 69 80 
97 67 79 
97 68 80 
98 97 88 
99 97 89 
98 98 88 
96 
94 
97 
96 
97 
97 
98 
97 
98 
99 
99 
99 
98 
97 
97 
97 
98 86 
98 89 
98 87 
98 87 
98 87 
98 89 
98 89 
98 88 
98 86 
98 88 
99 87 
98 87 
98 88 
97 87 
97 86 
97 87 
peRl 86 48 98 74 79 97 100 87 
peR2 87 48 98 72 79 97 98 88 
peR3 87 48 98 74 78 97 97 87 
Average Methylation (%) 87 48 98 73 79 97 98 87 
96 
96 
96 
96 
97 
97 
97 
97 
98 
97 
98 
98 
98 
97 
97 
97 
97 
98 
98 
98 
98 
97 
98 
98 
98 
97 
97 
97 
98 
98 
97 
98 
97 
97 
98 
97 
98 
98 
98 
98 
98 
97 
98 
98 
97 
97 
97 
97 
97 
98 
98 
98 
98 
99 
98 
98 
97 
98 
98 
98 
98 
97 
97 
97 
91 
90 
91 
91 
91 
91 
91 
91 
86 
182 
ApPENDIXJ 
MULTIPLE REGRESSION ANALYSIS 
ApPENDICES - ApPENDIX J: MULTIPLE REGRESSION ANALYSIS 
Table J.t: Multiple regression analysis for CpG5 
Methylation 
Variable % SE P-value 
Alcohol Consumption 
CpG5 Intercept 74.02 2.20 0.000 
Treatment -0.09 0.65 0.895 
Age 0.10 0.05 0.056 
Adjusted R2= 0.02 
When examining the effect of potential confounders on the methylation levels of 
individual CpG sites, the methylation levels at CpG 5 was found to increase 
significantly as age increased (Spearman's rho=O.189, p=O.046). However, when age 
was incorporated into the mutliple regression model together with treatment (no 
alcohol consumption vs. alcohol consumption), age was not found to be a significant 
predictor of methylation in the presence of alcohol consumption at this site. 
184 
ApPENDIXK 
ABNORMAL SPERM PARAMETERS AND 
DNA METHYLATION 
ApPENDICES - ApPENDIX K: ABNORMAL SPERM PARAMETERS AND DNA METHYLA nON 
Table K.l: Number of individuals with normal and abnormal sperm parameters within 
the control group 
Sperm Abnormality Categories Sample Size 
Sperm Concentration 
Sperm Morphology 
Sperm Concentration & Sperm Morphology 
Sperm Morphology & Sperm Motility 
Normozoospermia 
§Oligozoospermia 
Normozoospermia 
tTeratozoospermia 
Normozoospermia 
Oligozoospermia & Teratozoospermia 
Normozoospermia 
Teratozoospermia & ~ Asthenozoospermia 
§ Oligozoospermic - Individuals with sperm concentration levels less than 15 million per ml. 
t Teratozoospermic - Individuals with a sperm morphology percentage less than four percent. 
~ Asthenozoospermic - Individuals with a total sperm motility percentage less than 40%. 
(N) 
29 
2 
29 
29 
29 
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ApPENDIXL 
ABNORMAL SPERM PARAMETERS AND 
ALCOHOL CONSUMPTION 
ApPENDICES - ApPENDIX L: ABNORMAL SPERM PARAMETERS AND ALCOHOL CONSUMPTION 
Table L.t: Fisher's exact test comparing the number of individuals with abnormal 
sperm parameters in the two treatment groups 
Sperm Abnormality Controls Alcohol Consumers §Fisher's Exact 
Categories (N=34) (N=78) 
Count (Frequency) P-value 
Sperm N ormozoospermia 29 (25.89%) 55 (49.11%) 
Concentration 0.295 
Oligozoospermia 2 (1.79%) 8 (7.14%) 
Sperm N ormozoospermia 29 (25.89%) 55 (49.11%) 
Morphology 0.344 
Teratozoospermia 1 (0.89%) 5(4.46%) 
Sperm Normozoospermia 29 (25.89%) 55 (49.11%) 
Motility 0.659 Asthenozoospermia 0(0.00%) 1 (0.89%) 
Sperm Normozoospermia 29 (25.89%) 55 (49.11%) 
Concentration and Oligozoospermia and 1 (0.89%) 6 (5.36%) 0.260 
Sperm Morphology Teratozoospermia 
Sperm Normozoospermia 29 (25.89%) 55 (49.11%) 
Concentration and Oligozoospermia and 0(0.00%) 1 (0.89%) 0.659 
Sperm Motility Asthenozoospermia 
Sperm Morphology Normozoospermia 29 (25.89%) 55 (49.11%) 
and Sperm Motility 0.353 Teratozoospermia 1 (0.89%) 0(0.00%) 
and 
Asthenozoospermia 
Sperm N ormozoospermia 29 (25.89%) 55 (49.11%) 
Concentration, 0.437 
Sperm Morphology 
Oligozoospermia, 0(0.00%) 2 (1.79%) 
Teratozoospermia 
and Sperm Motility 
and 
Asthenozoospermia 
§One-tailed test 
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